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 1 Introduction 
1.1 The tropical disease malaria 
1.1.1 Epidemiology of malaria 
The tropical disease malaria represents one of the most devastating infectious diseases 
of the world. Despite partial success in combating malaria there are still more than 3.3 
billion people living at risk of an infection which accounts to almost half of the world’s 
population. According to the latest World Malaria Report of the World Health Organi-
zation (WHO, 2012a), an estimated 219 million clinical cases occurred in 2010 and 
660 000 people died. More than 100 countries are endemic for malaria, however more 
than 80 % of reported cases occurred in sub-Saharan Africa (Fig. 1.1). Young children 
are most vulnerable for the disease. Malaria has been reported to be the third most fre-
quent cause of death in children younger than five years world-wide (Liu et al., 2012; 
Black et al., 2010). About 86 % of malaria-caused death cases were found in this age 
group in 2010 (WHO, 2012a). The causative agents of malaria are protozoan parasites 
of the genus Plasmodium. There are five different species infecting man: Plasmodium 
falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae and Plasmo-
dium knowlesi. The latter was known to infect monkeys and was only recently identified 
as a human pathogen (White, 2008; reviewed in Cox-Singh, 2012). Most malaria cases 
are due to infection with P. falciparum and/or P. vivax. 
 
Fig. 1.1: Countries and territories affected by malaria in 2010 (WHO, 2012b). 
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In the past six years the goal shifted from malaria control to malaria elimination and 
eradication (Roberts and Enserink, 2007; Feachem et al., 2010; Moonen et al., 2010; 
Tanner and Hommel, 2010; Tatem et al., 2010; reviewed in Alonso et al., 2011). Thus, 
funding committed to malaria prevention, treatment and research increased (Roll Back 
Malaria Partnership, 2008; Alonso and Tanner, 2013). However, from 2010 onwards, a 
stagnation was observed (Alonso and Tanner, 2013). Beside the human burden of mala-
ria in endemic countries, malaria also represents an enormous economical burden (re-
viewed in Kokwaro, 2009). It is estimated that African countries spend up to 40 % of 
their health budget on malaria control and treatment. Families of highly endemic re-
gions lose up to 25 % of their income due to sickness of malaria (reviewed in Kokwaro, 
2009). Thus, it is of uttermost importance to further improve malaria prevention and 
control to continue approaching the goal of malaria eradication. 
1.1.2 Pathogenesis and symptomatology 
Upon infection with a malaria parasite, the first symptoms can be observed after a min-
imum of seven days for P. falciparum, nine days for P. vivax, ten days for P. ovale and 
15 days for P. malariae. At the beginning of an infection unspecific symptoms like 
headache, myalgia or faintness dominate. In general, symptoms associated with malaria 
are for instance fever, chills, sweating, dyspnea, arthralgia, headache, myalgia, abdo-
minal pain, dizziness, diarrhea, nausea, and vomiting (da Silva-Nunes and Ferreira, 
2007; Karunaweera et al., 1998). If untreated, the infection will commonly result in 
anemia, thrombocytopenia, splenomegalie and mild icterus. In the case of severe mala-
ria organ dysfunctions, respiratory distress, pulmonary edema and coma can be ob-
served (WHO, 2000). Originally only described in P. falciparum, the number of cases 
of severe malaria in P. knowlesi and P. vivax is increasing (Daneshvar et al., 2009; 
Singh et al., 2011; Lacerda et al., 2012; Willmann et al., 2012). 
A key player during infection of P. falciparum is the protein PfEMP1 (P. falciparum 
erythrocyte membrane protein 1) which is expressed on the surface of the infected eryt-
hrocyte. PfEMP1 locates to knob-like electron dense structures. It mediates adherence 
of the parasite-infected red blood cell (RBC) to the vascular endothelium via endothelial 
receptors such as ICAM1 (intercellular adhesion molecule 1) and CD36 (cluster of dif-
ferentiation 36) (reviewed in Miller et al., 2002 and Miller et al., 2013). Binding of 
PfEMP1 to CD36 and other receptor proteins expressed on uninfected RBCs results in 
rosetting, the formation of aggregates of parasitized and uninfected RBCs. Aggregate 
formation between infected RBCs and platelets mediated via binding of PfEMP1 to C36 
is referred to as clumbing (reviewed in Miller et al., 2002). Sequestration of infected 
RBCs to the endothelium, aggregate formation as well as induction of coagulation and 
thrombosis via adhering infected RBCs block the blood flow in the microvasculature 
resulting in limited oxygen supply to organs. The consequences are organ damage and 
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failure in heart, lung, brain, liver, kidney and subcutaneous tissues that can result in co-
ma and deaths of the patient (reviewed in Miller et al., 2002). In pregnant woman se-
questration of parasitized RBCs to the placenta is a major risk factor to the unborn child. 
Adherence is mediated mainly via chondroitin sulfate A and often results in premature 
delivery, low birth weight and an increased risk of death of the newborn, (reviewed in 
Miller et al., 2002). 
1.2 Plasmodium falciparum, transmitting agent of malaria 
tropica 
1.2.1 Systematics 
Plasmodium spp. are unicellular eukaryonts. They belong to the phylum Alveolata. The 
organisms of this taxum possess a pellicle of trilaminar appearance consisting of the 
plasma membrane and cortical vesicles (alveoli). The taxum is divided into three sub-
groups, Dinoflagellata, Ciliaphora and Apicomplexa, the latter comprising the family of 
Plasmodiidae. Apicomplexa are characterized by the apical complex which is located at 
the anterior cell pole and is formed by several organelles. The five Plasmodium spp. 
infecting humans belong to different clades (Ayala et al., 1999). Whilst P. falciparum 
belongs to the subgenus Lavarania, the other four species have been assigned to the 
sub-genus Plasmodium (Bray, 1963; Garnham, 1964). 
1.2.2 The life cycle of P. falciparum 
The malaria parasite is transmitted by female mosquitoes of the genus Anopheles. More 
than 30 different vector species are known (Kiszewski et al., 2004). The infectious spo-
rozoites reside in the salivary glands of the mosquito. During a blood meal of the mos-
quito sporozoites are injected with the saliva into the human host. The parasites migrate 
through the avascular skin and finally invade a blood vessel (Matsuoka et al., 2002; 
Vanderberg and Frevert, 2004; Amino et al., 2008). Via the blood system the sporo-
zoites reach the liver where they leave the sinusoid capillaries. They glide along the 
sinusoidal epithelium and traverse Kupfer cells or fenestrated endothelial cells to cross 
the space of Disse (Pradel und Frevert, 2001; Frevert et al., 2005; Baer et al., 2007; Ta-
veres et al., 2013). After reaching the liver parenchyma parasites traverse several hepa-
tocytes before they finally invade a hepatocyte (Mota et al., 2001; Frevert et al., 2005). 
During invasion a parasitophorous vacuole (PV) is formed, which separates the parasite 
from the host cytosol. Subsequently the parasites multiply via exo-erythrocytic schizo-
gony. From one liver schizont up to 30 000 merozoites are derived (Meis and Verhave, 
1988). Upon parasite-induced rupture of the PV membrane (PVM) merozoites are re-
leased into the liver sinusoid within merosomes, vesicles derived from the host cell 
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plasma membrane (Sturm et al., 2006; reviewed in Wirth and Pradel, 2012). After the 
merozoites were liberated from the merosome membrane they invade RBCs. Within the 
RBC the parasites are again surrounded by a PV which is formed during invasion. The 
parasites first develop into ring stages. Thereafter, parasites enter a metabolically highly 
active phase, the tropohozoite stage, in which parasites rapidly increase in size (Gabay 
and Ginsburg, 1993). Via erythrocytic schizogony the parasites multiply again and up to 
32 merozoites evolve from one schizont (Fig. 1.2). Already few hours after invasion of 
the RBC the parasites synthesize adhesion proteins which are expressed on the RBC 
surface. These proteins mediate cytoadhesion. The parasitized cells attach to endothelial 
walls, to other parasitized cells (autocoagulation) as well as to non-parasitized RBCs 
(rosetting). This so-called sequestration of elder trophozoites and schizonts results in 
perturbation of circulation and finally may lead to a severe outcome of the disease due 
to organ damage (see 1.1.2). Beside sequestration another important factor contributing 
to pathogenesis is the release of inflammatory substances. This occurs during parasite-
induced rupture of a mature schizont. 
 
Fig. 1.2: Schematic of the life cycle of P. falciparum (Ménard, 2005). 
The merozoites that are released into the blood subsequently invade a new RBC. After 
several rounds of asexual replication a proportion of parasites will differentiate and en-
ter the sexual phase of the life cycle (see 1.3). The sexual development starts with the 
formation of male and female gametocytes within the RBC. When these are taken up by 
a mosquito during its blood meal, the gametocytes are able to percept the change of sur-
rounding conditions (see 1.3.3). This will trigger them to form male and female gametes 
that subsequently undergo fertilization. The resulting diploid zygote undergoes meiotic 
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division and becomes tetraploid. It further develops into a motile ookinete (Janse et al., 
1986). The ookinete passes the peritrophic matrix which surrounds the blood meal and 
also traverses the midgut epithelium. Between midgut epithelium and basal lamina the 
ookinete settles down to form an oocyst. Within the oocyst up to 10 000 haploid sporo-
zoites develop. These then make their way to the salivary glands. The sporozoites in-
vade the distal lateral lobes and the median lobes (Carter and Graves, 1988). During the 
next blood meal of the mosquitoes the sporozoites are prepared to infect another human 
when they are injected with the saliva. 
1.3 The sexual phase of the life cycle 
1.3.1 Gametocyte formation 
Gametocytes are the parasite stage that enables transmission of the parasites from hu-
man host to the insect vector. The formation of gametocytes is thus crucial for ensuring 
the continuation of the life cycle in the mosquito. At the same time, parasites pass 
through a population bottleneck during the sexual phase of the life cycle. Of approx-
imately 10 000 gametocytes taken up during a blood meal, only 1 000 ookinetes are 
formed and only 1 to 5 parasites develop into oocysts (Fig. 1.3) (Sinden, 1999; Sinden 
and Billingsley, 2001; Sinden, 2010). In the past years gametocytes raised the interest of 
malaria research due to their importance for transmission of the disease. The compara-
bly small parasite numbers of gametocytes as compared to the billions of asexual blood 
stage parasites rendered them an attractive target for intervention strategies (see 1.4.3). 
OOKINETE
OOCYST
10 - 103
 
Fig. 1.3: Dynamics of parasite population in the course of the life cycle. Both the development 
from gametocyte to oocyst and the transmission of sporozoites to the human host during a mos-
quito’ bite are considered life cycle bottlenecks (adapted from Vogel, 2010; Sinden, 2010). 
In P. falciparum, the formation of sexual parasite stages is induced only after several 
cycles of asexual replication. Several factors have been discussed to induce the forma-
tion of gametocytes, the sexual precursor cells. These factors have in common that they 
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would negatively influence the development of the parasites within the human host 
(Stephens and Christophers, 1908). Examples for such stress factors are for instance 
high parasitaemia, drug treatment, anemia or immune response of the host (reviewed in 
Talman et al., 2004; Baker, 2010). The molecular background of induction of gameto-
cytogenesis remains unsolved, however some genes that seem to influence gametocyte 
formation have been reported (Eksi et al., 2012; reviewed in Guttery et al., 2012). 
The determination of parasites to enter sexual development has been postulated to occur 
in the schizont stage (Bruce et al., 1990). All merozoites released from such schizont 
will develop into gametocytes of the same gender (Smith et al., 2000; Silvestrini et al., 
2000; reviewed in Dixon et al., 2008). Male and female gametocytes undergo five stag-
es of sexual development (Field and Shute, 1956; Hawking et al., 1971). The develop-
ment of gametocytes of P. falciparum into mature stage V gametocytes takes approx-
imately 8 to 12 days (Fig. 1.4) (Sinden, 1982; Sinden, 1998; reviewed in Liu et al., 
2011). Only from stage IV onwards genders can be discriminated (reviewed in Talman 
et al., 2004). Stage I – IV gametocytes are not circulating in the blood vessel, but instead 
are sequestered. In early studies bone-marrow and spleen had been discussed as site of 
gametocyte sequestration (Thompson, 1935; Smalley et al., 1981). A recent study sug-
gested the sequestration of stage II – IV gametocytes in the extravascular space of the 
bone marrow (Farfour et al., 2012). After approximately 10 days of maturation the ma-
ture stage V gametocytes leave the bone marrow and circulate in the peripheral blood 
where they can be taken up by a mosquito during its blood meal (Eichner et al., 2001; 
reviewed in Bousema and Drakely, 2011).  
 
Fig. 1.4: Schematic of gametocyte morphogenesis in P. falciparum. The young stage I – IIa 
gametocyte is spherical and difficult to distinguish from asexual parasites via light microscopy. 
Stage IIB gametocytes elongate and exhibit a D-shape. Stage IV gametocytes have undergone 
further elongation and appear spindle-like. Stage V gametocytes show the typical crescent-like 
shape. Hz, hemozoin, IMC, inner membrane complex (subpellicular membrane complex), MC, 
Maurer’s clefts, MT longitudinal microtubules; Ob, osmiophilic bodies (adapted from Dixon et 
al., 2012). 
Introduction 7 
 
1.3.2 Gametocyte morphology 
Gametocytes of P. falciparum show the typical crescent shape, of which the name of 
this species was derived from (Lavaran, 1880). On the contrary, gametocytes of all other 
malaria parasites infecting humans are spherical. After Giemsa staining female gameto-
cytes appear blue whilst male gametocytes turn pink. The female macrogametocyte 
shows a small nucleus with a nucleolus and concentrated malaria pigment. Microgame-
tocytes on the other hand possess a larger nucleus with no visible nucleolus. The hemo-
zoin is distributed more diffusely in the male gametocyte. Female stage V gametocytes 
contain a network of rough endoplasmatic reticulum (ER) and numerous ribosomes – 
prerequisite for protein biosynthesis upon gametocyte activation (Sinden, 1982). Nu-
merous oval shaped electron dense vesicles can be found underneath the surface of ma-
crogametocytes (Fig. 1.4) (Severini et al., 1999). These organelles are termed osmio-
philic bodies and can be found in male gametocytes as well, however in much lower 
abundancy (Sinden, 1982). Osmiophilic bodies play a crucial role in egress of the ma-
crogametocytes (see 1.4.1) (de Koning-Ward et al., 2008). Microgametocytes possess a 
microtubule organizing center and kinetochores attached to the chromosomes, thus be-
ing prepared for rapid mitosis upon gametocyte activation (reviewed in Liu et al., 2011). 
Gametocytes of both genders possess one branched mitochondrion and one apicoplast 
(Okamoto et al., 2009). Gametocytes possess a pellicule comprising three layers of 
membrane: the plasma membrane and the flattened subpellicular membrane vacuoles, 
which are lined by longitudinally oriented microtubules (Fig. 1.4) (Sinden, 1982). 
1.3.3 Gametogenesis 
In the mosquito midgut two factors are perceived by the gametocytes that lead to induc-
tion of gamete formation within 15 seconds (Billker et al., 1998). The first factor is the 
drop in temperature by at least 5 degrees (Sinden; 1983, Carter and Graves, 1988; Sin-
den et al., 1996). The second triggering factor is the mosquito-derived molecule xanthu-
renic acid (XA) (Billker et al, 1998, Garcia et al., 1998) which is a byproduct of the 
ommochrome synthesis pathway (Beard et al., 1995) and can be found ubiquitously in 
the mosquito body. In vitro, XA can be replaced by a pH of 8.0 - 8.2 in the surrounding 
medium, instead of the physiological pH of 7.4 found in the blood (Sinden, 1983, Nij-
hout and Carter, 1978). 
After induction of gametogenesis gametocytes round up and egress from their host cells. 
Male gametocytes undergo three rounds of DNA replication and endomitotic division 
(Janse et al., 1988) followed by exflagellation of the newly developed microgametes. 
During this process eight flagella-shaped microgametes detach from the residual body 
of the microgametocyte by means of fast pulsating movements. The moving microga-
metes adhere to neighboring infected and uninfected erythrocytes, as well as to macro-
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gametes (Templeton et al., 1998). Approximately 10 min after gametocyte activation the 
formation of microgametes is completed (Billker et al., 1998). The process of exflagel-
lation is believed to promote egress of microgametes. The mechanisms underlying 
egress of the amotile macrogamete in contrast are so far widely unknown. Within ap-
proximately 20 min after gametocyte activation fertilization has been completed and 
development of the zygote has started (Carter et al., 1979). 
1.3.4 Signal transduction during gametogenesis 
Several signal molecules and enzymes have been identified that are involved in signal 
transduction controlling gamete formation (Fig. 1.5). Most information has been gained 
on the formation of male gametes due to the fact, that the formation of the motile mi-
crogametes can be investigated microscopically more easily as compared to formation 
of macrogametes. Three secondary messengers are involved in the signaling cascade 
resulting in gamete formation: cGMP (Kawamoto et al, 1990; Kawamoto et al., 1993), 
Ca2+ (Kawamoto et al. 1990) and inositol 1,4,5-triphosphate (IP3, Ogwan’g et al 1993; 
Martin et al., 1994). Upon gametocyte activation the cytosolic Ca2+ concentration in-
creases as early as 10 sec after activation (Billker et al., 2004). Recently, ryanodine re-
ceptors have been reported to be involved in the increase of Ca2+ concentration (Raabe 
et al., 2011). Furthermore, the activation of gametocytes results in hydrolysis of phos-
phatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and IP3 by a mem-
brane-associated phosphoinositide phospholipase C (PI-PLC) (Martin et al., 1994). The 
activation of PI-PLC occurs both via Ca2+ and upstream of the Ca2+ signal (Elabbadi et 
al., 1994; Raabe et al., 2011). Thus, a positive feedback loop is probable. In response to 
the increase of cytosolic Ca2+ concentration the Calcium-dependent protein kinase 
CDPK4 is activated (Billker et al., 2004; Ranjan et al., 2004). In the rodent malaria 
agent P. berghei CDPK4 has been shown to mediate genome replication and mitosis in 
microgametocytes (Billker et al., 2004). As a possible substrate of CDPK4 the mitogen-
activated protein kinase Map-2 has been suggested. Map-2 is essential for axoneme mo-
tility, DNA condensation and cytokinesis in the developing microgametes (Tewari et al, 
2005). Independently of the Ca2+ signal a membrane-associated guanylate cyclase is 
activated upon induction of gametogenesis via XA and the temperature drop (Muhia et 
al., 2001). The guanylate cyclase mediates the formation of cGMP. Increased cytosolic 
cGMP levels activate the protein kinase G which induces rounding up of gametes of 
both sexes (McRobert et al., 2008). The cGMP signal is terminated by the PDEδ in 
P. falciparum, which returns the cGMP levels to the basal level. After gamete formation 
and fertilization two protein kinases, Pbnek-2 and Pbnek-4, have been described to in-
duce genome replication in the zygote, resulting in a tetraploid genome (Khan et al., 
2005; Reininger et al., 2005; Reininger et al., 2009). Despite the knowledge of several 
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components of the XA-induced signal pathway the molecular details on how XA and 
the reduction of temperature are perceived by the parasite remain elusive. 
 
 
Fig. 1.5: Schematics of the signaling pathway culminating in gametogenesis. Activation of male 
gametocytes is initiated in the mosquito midgut by xanthurenic acid and the decreased tempera-
ture. It leads to formation of male gametes via exflagellation. The signal mediated by XA has to 
cross three membranes from the exterior to the gametocyte cytosol. GC, guanylate cyclase; 
PDE, phosphodiesterase; PKG, protein kinase G; PLC, phospholipase C; PPM, parasite plasma 
membrane; PVM, parasitophorous vacuole membrane; RBCM, red blood cell membrane 
(Adapted from Tewari et al., 2005; Kuehn and Pradel, 2010). 
1.4 Sexual stage-specific proteins 
1.4.1 Adhesion proteins of the sexual parasite stages 
In order to prepare for the switch from the human to the mosquito host the malaria para-
site expresses a large number of genes specifically during the sexual phase (reviewed in 
Pradel, 2007). More than 40 % of blood stage proteins are present exclusively in game-
tocytes (Khan et al., 2005). Above several regulatory proteins governing developmental 
processes during the sexual phase were described (see 1.3.4). Adhesion proteins are 
another group of proteins of great importance for the sexual stages as they ensure com-
munication with the changing environment. Sequencing of the genome of P. falciparum 
(Gardner et al., 2002) as well as analyses of the proteome (Florens et al., 2002; Lasond-
er et al., 2002) enabled the identification of so far uncharacterized proteins comprising 
putative adhesion motifs and signal peptides. These tools of the postgenomic era for 
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instance revealed the PfCCp protein family (Pradel et al., 2004). These and other sex-
ual-stage adhesion proteins are described in the following: 
The PfCCp protein family 
The members of the PfCCp protein family are characterized by their protein structure 
comprising multiple adhesion domains. Five of the proteins, PfCCp1 to PfCCp5 possess 
an LCCL (Limulus coagulation factor C-like) domain which gave rise to the name of 
the protein family (Fig. 1.6) (Pradel et al., 2004). A sixth protein was included, despite 
lacking the LCCL domain, due to its structural similarity to PfCCp5. In P. berghei the 
protein family was described under the term PbLAP protein family (LCCL-lectin adhe-
sive-like proteins) (Trueman et al., 2004; Raine et al., 2007). Beside the LCCL domain 
the proteins contain multiple protein motifs the adhesive properties of which have been 
well described in other organisms (reviewed in Kuehn et al., 2010).  
 
Fig. 1.6: Schematic depicting the domain structure of the PfCCp proteins that comprise multiple 
adhesion domains (modified from Kuehn et al., 2010). 
The expression of the pfccp genes is restricted to sexual parasite stages. It starts in ga-
metocytes of stage II and increases with gametocyte maturation. Upon gametogenesis 
and zygote formation the expression ceases (Pradel et al., 2004; Scholz et al., 2008). 
PfCCp1, PfCCp2 and PfCCp3 show a punctuate expression pattern and localize to the 
gametocyte surface in association with the plasma membrane (Fig. 1.7) (Pradel et al., 
2004). PfCCp5 and PfFNPA are localized at the cell poles (Scholz et al., 2008). In con-
trast to all other PfCCp proteins, pfccp5 is not only expressed in sexual parasite stages, 
but also in schizonts (Pradel et al., 2004; Scholz et al., 2008). PfCCp4 is already present 
in gametocytes of stage I. It is distributed homogeneously and remains associated with 
the gamete surface after gametogenesis (Fig. 1.7) (Scholz et al., 2008). On the contrary, 
for PfCCp1 to PfCCp3 it has been shown that they are shed to some extent during ga-
mete formation (Pradel et al., 2004). The study of PfCCp2- and PfCCp3-deficient para-
sites suggested a role of the proteins in parasite development in the mosquito vector. 
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Whilst development of the mutant parasites until formation of oocyst sporozoites was 
comparable to wild-type parasites, the transition of sporozoites from the oocyst to the 
salivary glands was disturbed (Pradel et al., 2004). PfCCp4 on the other hand seems to 
be dispensable for the development in the mosquito (Scholz et al., 2008). 
 
Fig. 1.7: A. Expression pattern of PfCCp proteins in mature gametocytes. Erythrocytes were 
counterstained with Evans Blue. B. Electron micrograph of immunogold-labeled PfCCp1 (arrow 
heads). (Panel B from Pradel et al., 2004). 
The 6-Cys protein family 
The 6-Cys protein family comprises ten proteins characterized by the possession of one 
to seven cysteine-rich double domains (Templeton und Kaslow, 1999; Gerloff et al., 
2005). Eight of the genes encoding the 6-Cys proteins are arranged in tandems on the 
same chromosome, respectively. It is assumed that the paralogs were formed via gene 
duplication events (Thompson, J. et al., 2001). The protein family is unique to and well 
conserved in Plasmodium spp. (Templeton and Kaslow, 1999; Thompson, J. et al., 
2001). All proteins comprise a signal peptide (Templeton and Kaslow, 1999; Sanders et 
al., 2005; Ishino et al., 2005; Gerloff and al., 2005). Four genes encoding members of 
the protein family are exclusively transcribed in gametocytes. These genes encode the 
proteins Pfs48/45, Pfs47, Pfs230 and Pfs230p (also termed PfsMR5) (summarized in 
van Dijk et al., 2010). The most prominent proteins of this protein family are Pfs48/45 
and Pfs230 which have been described as candidates for the generation of transmission 
blocking vaccines almost three decades ago (see 1.4.3) (Rener et al., 1983; Vermeulen 
et al., 1985). 
Pfs230 is the largest protein of the 6-Cys protein family. It possesses 7 cysteine-rich 
double domains and has a molecular weight of 360 kDa. It is present in gametocytes 
from stage II onwards and localizes to the outer leaflet of the gametocyte plasma mem-
brane (Vermeulen et al., 1986). Expression persists until the gamete stage. During ga-
metocyte activation the protein is proteolytically cleaved (Williamson et al., 1996; 
Brooks and Williamson, 2000). Pfs230 is a hydrophilic, secreted protein. It forms a sta-
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ble complex with Pfs48/45 which is covalently bound to the gametocyte surface via a 
glycosyl-phosphatidyl inositol (GPI) anchor (Kumar, 1987; Kumar and Wizel, 1992). 
Pfs230-deficient parasite mutants form gametocytes and gametes comparably to wild-
type parasites. However, male gametocytes are not able to attach to RBCs, thus the for-
mation of exflagellation centers is dramatically reduced. The formation of oocysts in the 
midgut is also strongly impeded (Eksi et al., 2006). In the rodent parasite P. berghei on 
the contrary, exflagellation center formation is not affected in the absence of Pbs230. 
There, reduced binding of microgametes to female gametes was observed resulting in a 
dramatically reduced fertilization rate (van Dijk et al., 2010). 
PfsMR5 (also called Pfs230p) is located on chromosome 2 upstream of its paralog 
Pfs230. With a molecular weight of 293 kDa and only 6.5 cysteine-rich double domains 
it is smaller than Pfs230 (Fig. 1.8). Highest transcript levels of pfsmr5 were detected in 
gametocytes of stage III and IV. The protein is present exclusively in male stage V ga-
metocytes (Eksi and Williamson, 2002). Expression ceases rapidly after gametocyte 
activation. Only three minutes after induction of gametogenesis the protein in not de-
tectable anymore. In contrast to Pfs230 PfsMR5 does not show an obvious peripheral 
expression pattern, although it possesses a signal for secretion of the protein. It has thus 
been suggested that it might locate to intracellular vesicles (Eksi and Williamson, 2002). 
The gene encoding the P. berghei ortholog of PfsMR5, termed P230p, was disrupted 
and the P230p deficient mutants did not show alterations in gametocyte formation, ga-
metogenesis or fertilization rate as compared to wild-type parasites (van Dijk et al., 
2010). 
 
Fig. 1.8: Schematic of the EGF-like domain containing proteins Pfs25 and Pfs28 and the cyste-
ine-rich motif proteins Pfs230, PfsMR5, Pfs48/45 and Pfs47 (modified from Kuehn et al., 
2010). 
Pfs48/45 possesses 1.5 cysteine-rich double domains (van Dijk et al., 2001). Its expres-
sion starts in gametocytes of stage II and persists until the gamete stage. Pfs48/45 is 
covalently bound to the parasite surface via a GPI anchor (Vermeulen et al., 1986; 
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Kocken et al., 1993).The study of Pfs48/45-deficient parasites showed that Pfs48/45 is 
important for fertility of male gametes. While the protein is dispensable for gametocyte 
and gamete formation, the microgametocytes are unable to attach to and fuse with ma-
crogametes (van Dijk et al., 2001). The orthologous protein in P. berghei seems to have 
the same function (van Dijk et al., 2001). The lack of Pfs48/45 and Pbs45/48 resulted in 
a dramatically reduced infectivity to the mosquito, respectively (van Dijk et al., 2001). 
In contrast to its paralog, Pfs47 is expressed exclusively in female gametocytes. Its tran-
scription starts between gametocyte stage II and III and increases from stage IV on-
wards (van Schaijk et al., 2006). After gamete formation it can be found on the surface 
of the macrogamete. In parasites deficient for Pfs47 gametocyte formation, sex ratio and 
gametogenesis were comparable to wild-type parasites (van Schaijk et al., 2006). In 
P. falciparum the protein does not play a role during fertilization, ookinete development 
or oocyst development (van Schaijk et al., 2006). In contrast, in P. berghei female ga-
metes are infertile. It has been suggested that Pbs47 is essential for attachment of mi-
crogametes (van Dijk et al., 2010). 
The EGF-like domain containing proteins Pfs25 and Pfs28 
Likewise the proteins of the protein family around Pfs230, Pfs25 and Pfs28 are arranged 
as tandem on chromosome 10 (Duffy and Kaslow, 1997). Both paralogous proteins pos-
sess four epidermal growth factor (EGF)-like domains, an N-terminal signal peptide and 
a GPI anchor sequence, respectively, that links the proteins to the parasite plasma mem-
brane (Kaslow et al., 1988). The EGF-like domain can be found in many proteins of 
animals, in particular in the extracellular parts of membrane proteins. In many cases it 
has been reported to play important roles in protein-protein interactions (reviewed in 
Appella et al., 1988). Both Pfs25 and Pfs28 are conserved in Plasmodium spp. For bet-
ter inter-species comparisons they are termed P25 and P28 as suggested by Tomas et al. 
(2001). 
Pfs25 is located on the surface of gametes, zygotes and ookinetes and can also be de-
tected in lower abundance in mature gametocytes (Vermeulen et al., 1985; 1986). In 
gametocytes the protein is concentrated in intracellular vesicles (Scholz et al., 2008). 
Only after gametocyte activation the protein is transported to the gamete cell surface as 
shown for the rodent parasite P. berghei (Billker et al., 1997). After fertilization the 
expression is dramatically increased (Vermeulen et al., 1985). Pfs28 is also present on 
zygote stages, however it is mainly found on retort stages and ookinetes (Duffy and 
Kaslow, 1997). Expression of both Pfs25 and Pfs28 is transcriptionally regulated. The 
mRNA of the proteins is already present in gametocytes, however translation is only 
initiated upon gametocyte activation (Paton et al., 1993; Mair et al., 2006). Translation-
al repression is mediated by the binding of mRNAs by the RNA helicase DOZI (devel-
opment of zygote inhibited) and CITH (CAR-I/Trailer Hitch Homolog) which are part 
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of a messenger ribonucleoprotein particle located in the cytoplasm (Mair et al., 2006; 
2010). 
The crystal structure of Pvs25, the Pfs25 ortholog in P. vivax, was determined to have a 
triangular shape. It is assumed that P25 covers the parasite surface in a tile-like manner 
(Saxena et al., 2006). This is in agreement with the study of P25/P28 double knockout 
in P. berghei which suggested a role in protection from hostile midgut factors (Tomas et 
al., 2001). Furthermore, a role in oocyst formation (Sidén-Kiamos et al., 2000; Tomas 
et al., 2001) and in crossing of the midgut epithelium has been postulated for P25 and 
P28 (reviewed in Baton and Randford-Cartwright., 2005). Yeast two hybrid assays re-
vealed both the formation of P25 homodimers and the formation of P25-P28 heterodi-
mers (Sidén-Kiamos et al., 2000). P25 proteins of P. vivax and P. berghei interact with 
midgut proteins (Arrighi et al., 2002; Rodriguez et al., 2007; reviewed in Saxena et al., 
2007). 
Pfg377 
Pfg377 is a gametocyte-specific protein which is associated with the osmiophilic bodies 
in a membrane-bound form (Alano et al., 1995). The osmiophilic bodies are characteris-
tic for maturing macrogametocytes (see 1.3.2), and thus, Pfg377 is found predominantly 
in female gametocytes of stage III – V (Severini et al., 1999). As the osmiophilic bodies 
are detectable only from stage IV onwards, a role of Pfg377 in formation or maturation 
of these organells has been proposed (Rudzinska und Trager, 1968; Severini et al., 
1999). The study of Pfg377-deficient parasites provided evidence, that the protein is 
critical for the formation of osmiophilic bodies (de Koning-Ward, 2008). It is antic-
ipated that osmiophilic bodies secrete their content upon gametocyte activation (Aikawa 
et al., 1984; Alano et al., 1995) and the presence of osmiophilic bodies is important for 
egress of macrogametocytes and macrogamete formation (de Koning-Ward et al., 
2008). Pfg377 possesses a signal peptide, which together with the subsequent 60 amino 
acids is sufficient to target the protein to the osmiophilic bodies (Sannella et al., 2012). 
Pfpeg3/Pfmdv-1 
As for reported for Pfg377, the expression of Pfpeg3 (P. falciparum protein of early 
gametocytes), also referred to as Pfmdv-1, (P. falciparum male development gene 1) is 
restricted to gametocytes. The expression of Pfpeg3, however starts in gametocytes of 
stage I already, at approximately 30 – 40 h upon invasion of the RBC (Carter et al., 
1989; Alano et al., 1991; Silvestrini et al., 2005). Pfpeg3 locates to the PVM and mem-
brane systems derived from the PVM like the food vacuole and cleft like structures in 
the RBC cytosol (Silvestrini et al., 2005; Furuya et al., 2005; Lanfrancotti et al., 2007). 
In Pfpeg3-deficient parasites several membrane structures showed a disturbed appear-
ance (Furuya et al., 2005). In P. berghei the protein was shown to localize to osmiophil-
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ic bodies of macrogametocytes (Ponzi et al., 2009). The protein plays an important role 
in egress of both macro- and microgametocytes, however detailed information on its 
mechanism of action is missing (Furaya et al., 2005; Lal et al., 2009; Ponzi et al., 
2009). 
Pfs16 
Pfs16 is expressed in gametocytes of stage I – V and its expression starts approximately 
six hours earlier than Pfpeg3 (Bruce et al., 1994). It is a transmembrane protein of the 
PVM (Baker et al., 1994; Bruce et al., 1994). It co-localizes with Pfpeg3 in the PVM 
and PVM-derived membranes as well as in cleft-like membrane structures of the game-
tocyte-infected RBC (Lanfrancotti et al., 2007). 
1.4.2 Multimeric protein complexes of the sexual stages of P. falciparum 
The gametocyte proteome contains a vast number of secreted proteins as assumed from 
the prediction of signal peptides from their amino acid sequence. Only few of them pos-
sess a GPI anchor sequence that would ensure retention of the proteins to the parasite 
surface. This observation as well as the fact that several of the supposedly secreted pro-
teins possess predicted adhesion domains, lead to the assumption that various protein-
protein interactions occur at the sexual stage parasite surface. 
Likewise to the proteins of the PfCCp protein family Pfs230 is a hydrophilic secreted 
protein. Hence, it was assumed that it is retained to the parasite surface via interacting 
with other proteins attached to the parasite plasma membrane (Kumar, 1985). Indeed, a 
stable protein complex is formed between Pfs230 and the GPI-anchored Pfs48/45 (Ku-
mar, 1987; Kumar and Wizel, 1992). In Pfs48/45-deficient gametocytes Pfs230 localiz-
es to the parasite surface as it is the case in wild-type parasites. However, in Pfs48/45-
deficient gametes Pfs230 was detected in low abundance in a rather vesicular distribu-
tion (Eksi et al., 2006). The presence of Pfs48/45 therefore seems to be essential for 
correct localization of Pfs230 after gametocyte egress. 
It has been shown that almost all proteins of the PfCCp protein family are interacting 
with each other (Wagner et al., 2006; Simon et al., 2009). Furthermore, select proteins 
interact with the sexual stage-specific proteins Pfs25, Pfs230 and Pfs48/45 (Scholz et 
al., 2008; reviewed in Kuehn et al., 2010). PfCCp1 to PfCCp3 are co-localizing at the 
plasma membrane of gametocytes (Pradel et al., 2006). Interestingly, the proteins of the 
PfCCp protein family are expressed in a co-dependent manner. This is reflected in such 
way, that in mutants with a single pfccp gene disrupted, all PfCCp proteins are absent or 
detectable only in low amounts. As the transcription of pfccp genes is not affected in 
these mutants, an interdependency on translational or post-translational level is assumed 
(Pradel et al., 2006; Simon et al., 2009). 
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Recently, a so far uncharacterized protein has been identified as potential component of 
the multi-protein complex comprising the PfCCp proteins. In co-immunoprecipitation 
assays on gametocyte lysate followed by mass spectrometry a WD40-domain containing 
protein has been detected as interaction partner of PfCCp1 (see 1.5.2) (Simon, 2012). 
1.4.3 Transmission blocking vaccines 
The transmission of the malaria parasites from the human host to insect vector occurs 
via sexual precursor cells, the gametocytes. However, it is the asexual parasite stages, 
which are responsible for pathogenesis of malaria. As a consequence antimalarial drugs 
are targeting asexual blood stage parasites. Gametocytes on the contrary, are rather in-
sensitive to these drugs (Lang-Unnasch and Murphy, 1998; Peatey et al., 2009). Due to 
this peculiarity of the malaria parasite it is essential to include intervention strategies 
targeting parasite transmission, when aiming at eradication of malaria. Transmission 
blocking vaccines (TBV) are considered as a potential tool for malaria elimination. 
TBVs would induce the production of antibodies in the human that are directed against 
surface proteins of the mosquito stages gametes, zygotes and ookinetes (reviewed in 
Stowers and Carter, 2001; Sauerwein 2007; Saul, 2007). Taken up together with the 
blood meal of the mosquito the antibodies would inhibit parasite development via com-
plement-mediated lysis of parasites or via blocking of essential parasite receptors (re-
viewed in Stowers and Carter, 2001; Dinglasan and Jacobs-Lorena, 2008). Transmission 
blocking antibodies have already been described more than three decades ago (Carter 
and Chen, 1976; Gwadz, 1976). The proteins that were identified first as potential can-
didates for TBV generation are Pfs230, Pfs48/45 and Pfs25 (Rener et al., 1983; Ver-
meulen et al., 1985; Quakyi et al., 1987). For antibodies directed against Pfs230 a com-
plement-mediated killing of parasites has been suggested as mechanism responsible for 
inhibiting parasite development in the mosquito (Read et al., 1994; Williamson et al., 
1995). One advantage of the pre-fertilization surface proteins Pfs230 and Pfs48/45 is 
that they are expressed already in gametocytes in the human host. Therefore, a boosting 
of the antibody response is possible (reviewed in Cater et al., 2000). Indeed, antibodies 
directed against Pfs230 and Pfs48/45 are produced during natural infections (Graves et 
al., 1988; Ong et al., 1990; Mulder et al., 1993, 1994; Premawansa et al., 1994; Healer 
et al., 1997; Ouédraogo et al., 2011). However, the expression of correctly folded re-
combinant variants of Pfs230 and Pfs48/45 seems to be difficult. Recently, a wheat 
germ cell-free system and plant-produced Pfs230 recombinant protein provided new 
approaches (Williamson et al., 1995; Tachibana et al., 2011; Farrance et al., 2011). The 
wheat-germ expressed fragment of Pfs230 showed transmission blocking activity even 
in absence of complement, suggesting an alternative mechanisms of action. For 
Pfs48/45 expression of a correctly folded recombinant protein has been improved re-
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cently by codon-harmonized expression in Escherichia coli and the green algae Chla-
mydomonas reinhardtii (Chowdhury et al. 2009; Jones et al., 2013). 
Most progress has been made with the TBV candidate P25, as yeast expression systems 
have been shown to be well suited for production of the immunogen. The derived anti-
bodies showed good transmission-blocking activity (Hisaeda et al., 2000, reviewed in 
Carter 2001). P25 of P. falciparum and P. vivax have been tested in phase I clinical tri-
als already. Both transmission blocking efficacy and antibody titers were promising 
(Malkin et al., 2005; Wu et al., 2008; reviewed in Kaslow, 2002). As P25 and P28 have 
been shown to complement for each other in gene-disruptant parasites a combined vac-
cine targeting both proteins has been suggested. Membrane feeding assays testing a 
mixture of antisera directed against both P25 and P28 significantly reduced the oocyst 
production in the mosquito (reviewed in Stowers and Carter, 2001). One disadvantage 
of P25 and P28 is that as post-fertilization surface proteins they are only expressed in 
the mosquito midgut, therefore a boosting of the human antibody response during natu-
ral infections is not possible. 
More recently, several new candidate proteins have been identified as targets for trans-
mission blocking vaccines. These include the proteins of the above described PfCCp 
protein family (see 1.4.1). The suitability of the PfCCp proteins has been anticipated as 
for PfCCp2 and PfCCp3 an essential role for the development in the mosquito had been 
shown (Pradel et al., 2004). Anti-PfCCp antisera caused a complement-mediated inhibi-
tion of microgamete formation in vitro (Scholz et al., 2008). The efficacy of anti-PfCCp 
antibodies on the development in the mosquito remains to be investigated. As PfCCp 
proteins are expressed on the gametocyte surface in the human host, the formation of 
natural antibodies boosting the immune response upon vaccination is possible. Further 
recently discovered Plasmodium spp. candidate proteins are the chitinase expressed in 
ookinetes which is essential for traversal of the peritrophic matrix that surrounds the 
blood meal. A transmission-blocking efficacy of chitinase-neutralizing antibodies has 
been shown (Langer et al., 2002; Li et al., 2005). Another protein with an essential role 
for parasite development in the mosquito is CTRP (circumsporozoite and TRAP related 
protein) (Dessens et al., 1999; Yuda et al., 1999). The microneme proteins SOAP (se-
creted ookinete adhesive protein) and MOAP (membrane attack ookinete protein) are 
essential for invasion of the midgut epithelium (Dessens et al., 2003; Kadota et al., 
2004). As the for the PfCCp proteins, the essential function of these surface expressed 
or secreted proteins renders them attractive as targets of transmission blocking antibo-
dies. 
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1.5 WD40-motif proteins 
1.5.1 The WD40-motif 
The WD40 protein domain is one of the ten most abundant types of protein motifs 
found in eukaryotes (reviewed in Li and Roberts, 2001; Stirnimann et al., 2010; Xu and 
Min, 2011). It was first described in 1986 in the bovine β-transducin, as part of the tri-
meric G protein transducin complex (Fong et al., 1986). Typical characteristics of the 
WD40 motif are a length of 44 – 60 amino acids, glycine and histidine residues at posi-
tions 11 – 24 of the protein motif and the eponymous tryptophan-aspartic acid (WD) 
dipeptide at the C-terminus (Fong et al. 1986; Neer et al., 1994; Smith et al., 1999). 
Each WD40 motif folds into a four-stranded antiparallel β-sheet (Wu et al., 2010).The 
beta-sheets of generally seven neighboring WD40 motifs form a circularized so-called 
propeller fold that is stabilized via a network of hydrogen bonds (Wu et al., 2010; re-
viewed in Li and Roberts, 2001; Stirnimann et al., 2010). As there are usually seven or a 
multiple of seven WD40 domains per protein, they are also referred to as WD40 repeats. 
WD40 propeller folds are quite large domains providing three surfaces for interactions 
with other proteins, peptides or DNA: The top region of the propeller, the bottom and 
the circumference (reviewed in Stirnimann et al., 2010). These multiple interaction sites 
render the WD40 domain a scaffold for large protein complexes comprising multiple 
interaction partners. The functions of WD40 domain-containing proteins are manifold 
and include for instance signal transduction, regulation of transcription, cell division, 
organization of cytoskeleton and apoptosis (Neer et al., 1994; Smith et al., 1999; Yu et 
al., 2000; reviewed in Stirnimann et al., 2010; Xu and Min, 2011). Until now, no WD40 
protein has been described to possess catalytic function (reviewed in Stirnimann et al., 
2010). 
1.5.2 The WD40 motif-containing protein PfWLP1 
The sexual stages of P. falciparum form multimeric protein complexes at the parasite 
plasma membrane (see 1.4.2). During the search for further components of these protein 
complexes a so far uncharacterized protein was discovered. Co-immunoprecipitation 
assays followed by mass spectrometry identified the protein with the PlasmoDB iden-
tifier PF3D7_1443400 (formerly PF14_0412) as interaction partner of PfCCp1 and con-
sequently as potential component of the multi-protein complex assembled around 
PfCCp proteins (Simon, 2012). The protein sequence comprises 819 amino acids and 
the protein possesses a molecular weight of 95.8 kDa. The search for protein domains 
with the SMART database revealed that the protein contains 5 WD40 repeat domains 
(see Fig. 1.9). However, one of them comprises 120 amino acids, thus it is likely that 
this domain forms three propeller blades consisting of approximately 40 amino acids 
each. This would result in seven propeller blades in total, as observed in most WD40 
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motif-containing proteins. Another probability for formation of the stable propeller fold 
is the supplementation with a propeller blade of an interacting protein (reviewed in Xu 
and Min, 2011). Due to the possession of the WD40 repeats the so far undescribed pro-
tein was named PfWLP1 (WD repeat protein-like protein 1) (Nkwouano Ngongang, 
2012).  
 
Fig. 1.9: Domain structure of the uncharacterized WD40 repeat-containing protein PfWLP1. 
The WD40 domains were depicted according to the SMART protein domain database 
(http://smart.embl-heidelberg.de/). 
1.6 Invasion and motility of P. falciparum 
1.6.1 Morphology of invasion stages 
During the complex life cycle of P. falciparum, the parasites egress from host cells and 
subsequently invade a next host cell several times. There are three different invasive 
stages that share most of the morphological features: Merozoites, ookinetes and sporo-
zoites. The invasive parasite stages share with gametocytes in common the possession 
of the trilaminar pellicle comprising the plasma membrane and flat membrane cisternae. 
The more or less elongated shape of the invasive stages is determined by an array of 
microtubules subtending the pellicle. The microtubules emanate from the apical polar 
rings, representing the microtubule-organizing center (Russel and Burns, 1984). They 
confer polarity and stability to the parasite, important prerequisites for motility and in-
vasion (Hepler et al., 1966; Stokkermans et al., 1996). Beside the trilaminar pellicule 
another feature common to all invasive stages of Apicomplexan parasites is the apical 
complex. It comprises several organelles that play important roles during invasion 
processes (reviewed in Preiser et al., 2000; Cowman and Crabb, 2006; Baum et al., 
2008). The cigar-shaped micronemes secrete their contents including proteases like 
PfSUB2 and adhesions like PfAMA-1 during host cell invasion (Healer et al., 2002; 
Harris et al., 2005). The larger club-shaped rhoptries release adhesion proteins like 
RON4 that are needed for attachment to the host cell and proteins that are important for 
PV formation like ROM1 (Fig. 1.10) (Richard et al., 2010; Vera et al., 2011). The 
spherical dense granules secrete their content into the PV, thereby contributing to the 
establishment of the PV (Culvenor et al., 1991). Another group of vesicles, the ex-
onemes have so far only been described in merozoites. They secrete proteases like 
PfSUB1, resulting in host cell rupture (Yeoh et al., 2007). 
WD40 domain Coiled coil Low complexity region
820 aa, 95.8 kD
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Fig. 1.10: Schematic of a merozoite of P. falciparum depicting the most important organelles 
and cellular structures (Cowman and Crabb, 2006). 
Like other Apicomplexan parasites all stages of P. falciparum except microgametes 
possess an apicoplast (Okamoto et al., 2009). This organelle is a relict of a chloroplast, 
which was achieved via endosymbiosis of a red or green algae (Köhler et al., 1997; 
McFadden and Waller, 1997; Blanchard and Hicks, 1999; Fast et al., 2001; Funes et al., 
2002; Waller et al., 2003). The apicoplast is surrounded by four plasma membranes and 
possess a circular genome (Lemgruber et al., 2013). The apicoplast genome encodes 
genes involved in fatty acid and isoprenoid precursor synthesis and is thus indispensable 
for parasite replication (reviewed in Ralph et al., 2004; McFadden, 2011). 
Furthermore, the invasive stages possess the typical eukaryotic cellular organelles, mi-
tochondrion, nucleus and ribosomes (Fig. 1.10). The ER is associated with the nucleus 
and the Golgi apparatus. Contrary to Golgi apparatuses of higher eukaryotes, in Plas-
modium spp. it is rather rudimentary consisting of only one or few membrane cisternae 
and associated vesicles (reviewed in Cooke et al., 2004). The trafficking of proteins via 
ER and Golgi ensures that secreted proteins and proteins of intracellular organelles are 
transported to their correct destinations. 
1.6.2 Motility of invasive stages is mediated by an actin-myosin motor 
complex 
Gliding on surfaces and host cell invasion are mediated by a molecular motor which is 
conserved in invasive parasite stages of Apicomplexan parasites. It has been described 
in detail in sporozoites and merozoites of Plasmodium spp. and tachzoites of T. gondii 
(Baum et al., 2006). In ookinetes only few components of the so-called glideosome 
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have been described so far. The motor complex is located underneath the parasite plas-
ma membrane where it is anchored to the inner membrane complex (IMC), the basis of 
which are the flat membrane cisternae that are part of the parasite’s pellicule. The key 
components are filamentous actin and class XIV myosin, PfMyoA. Anchoring of 
PfMyoA to the IMC is mediated by PfMTIP (myosin A tail domain interacting protein) 
and the glideosome-associated proteins PfGAP45 and PfGAP50 (Fig. 1.11) (Bergman et 
al., 2003; Baum et al., 2006; Green et al., 2006).The small transmembrane protein fami-
ly PfGAPM (glideosome-associated protein with multiple membrane spans) has been 
postulated to connect the membrane cisternae to the cytoskeleton of the parasite via 
alveolins (Gould et al., 2008; Bullen et al., 2009; Volkmann et al., 2012). The actin 
filaments are connected via Pfaldo to a transmembrane protein, referred to as invasin, 
which links the intracellular actin-myosin motor to ligands of the surface of the host cell 
(Jewett and Sibley, 2003). Several invasins have been described with stage-specific ex-
pression. Sporozoites possess both the micronemal proteins PfTRAP (TRAP-like pro-
tein) and PfTLP (TRAP-like protein) and PfTREP (TRAP-related protein) (Heiss et al., 
2008; Moreira et al., 2008; Combe et al., 2009). The respective protein in merozoites is 
PfMTRAP and in ookinetes the same role is carried out by PfCTRP (circumsporozoite 
protein and TRAP related protein) (Baum et al., 2006; Templeton et al., 2000). The 
forward moving of the parasites is caused by the interaction of MyoA with actin, similar 
to the sliding-filament model of the skeletal muscles. Upon ATP hydrolysis the head 
domain of MyoA moves the actin filament which is connected to the host cell receptor 
rearwards, thereby driving the parasite forward in respect to the host cell surface (re-
viewed in Baum et al., 2008). Select components of the actin-myosin motor complex 
are described in more detail: 
Actins and actin regulatory proteins of Plasmodium spp. 
Actin is a globular protein which can form polarized filaments upon polymerization. 
Actin filament assembly and disassembly is highly dynamic and depends both on ATP 
binding and hydrolysis as well as on actin regulatory proteins (reviewed in Engel et al., 
1977; Carlier, 1990). Several of the regulatory proteins encoded in the genome of Plas-
modium spp. are orthologous to those of other eukaryonts. Amongst these are for in-
stance the capping protein, which regulates growth of actin filaments and coronin, a 
WD40-repeat domain protein, which mediates bundling of actin filaments (Tardieux et 
al., 1998; Gardner et al., 2002; reviewed in Morrissette and Sibley, 2002; Gandhi and 
Goode, 2008; Cooper and Sept, 2008; Sattler et al., 2011). Several of classical actin 
regulating proteins are absent in Plasmodium parasites, like the Arp2/3 complex which 
enables branching of actin filaments (Gordon and Sibley, 2005; Mullins et al., 1998). 
Compared to other eukaryotic organisms actin filaments of Plasmodium spp. are rather 
short, only measuring 150 nm in length (Schmitz et al., 2005, 2010; Schüler et al., 
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2005). It has been suggested that low polymerizability and short persistence of actin 
polymers are intrinsic properties of actin proteins of Plasmodium spp. (reviewed in Satt-
ler et al., 2011). In contrast to other Apicomplexan parasites Plasmodium spp. encode 
two actin isoforms, termed actinI and actinII (Gordon and Sibley 2005; Wesseling et al., 
1988; Gardner et al., 2002). Whilst actinI is expressed in all blood stages (and all inva-
sive stages), expression of actinII is restricted to sexual parasite stages (Wesseling et al., 
1989; Rupp et al. 2010). 
Myosins of P. falciparum 
Myosin proteins are commonly comprised of three different domains, the head domain, 
which interacts with actin filaments and possess ATPase activity, a hinge domain, func-
tioning as lever arm and the tail domain. According to sequence comparisons of the 
head domain, myosins are divided into several classes (Hodge and Cope 2000; Thomp-
son and Langford 2002). Almost all Apicomplexan myosins, including all P. falciparum 
myosins have been allocated to myosin class XIV (Heintzelman and Schwartzman, 
1997; Chaparro-Olaya et al., 2005). “Conventional” myosins as found in the skeleton 
muscles of vertebrates cluster in class II. The genome of P. falciparum contains six 
myosin genes termed myoA – myoF (Chaparro-Olaya et al., 2003; reviewed in Vale, 
2003). Semi-quantitative RT-PCR showed that all six gens are expressed in asexual 
blood stages (Chaparro-Olaya et al., 2005). 
Pfaldo 
Pfaldo belongs to class I aldolases which can be found in all living organisms with the 
amino acid sequences largely conserved (reviewed in Gefflaut et al., 1995). It catalyses 
the cleavage of Fructose-1,6-diphosphate into dihydroxyacetone phosphate and glyce-
raldehyde-3-phosphat and its reverse reaction. As all aldolases Pfaldo is present as te-
tramer. Both its multimeric nature and its molecular flexibility are important features for 
its interaction with both actin and the cytoplasmatic tail of TRAP-like proteins (Bosch 
et al., 2007). Carrying out two completely unrelated functions Pfaldo can be considered 
as moonlighting protein (reviewed in Jeffery, 1999; Huberts and van der Klei, 2010). 
PfGAP50, PfGAP45 and PfMTIP 
PfGAP50 is another example for a multifunctional protein of P. falciparum. In addition 
to its structural role in the glideosome, PfGAP50 has been described as a secreted acid 
phosphatase expressed in asexual blood stages. A role in uptake of nutrients from the 
host cell upon dephosphorylation has been proposed (Müller et al., 2010). PfGAP50 
possesses an N-terminal signal peptide which leads to translation of the protein into the 
ER. The C-terminal transmembrane domain and the cytoplamatic domain are responsi-
ble for the correct localization with the IMC (Yeoman et al., 2011). PfGAP45 forms a 
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ternary complex with the myosin light chain PfMTIP and PfMyoA in the parasite cyto-
sol Fig. 1.11). PfGAP45 is acylated at its N-terminus and phosphorylated, however it 
seems to be mainly the interaction with PfGAP50 that ensures anchoring of the protein 
complex at the IMC (Rees-Channer et al., 2006; Green et al., 2008; Ridzuan et al., 
2012). 
 
Fig 1.11: Schematic depicting the molecular motor complex mediating gliding motility and 
invasion in the invasive stages of Plasmodium spp. The right panel illustrates the location of the 
magnified schematic of the left panel within a merozoite. APR, apical polar rings, IMC, inner 
membrane complex, MT, subpellicular microtubules, NUC, nucleus (modified from Baum et 
al., 2008). 
1.7 Transport across the red blood cell membrane 
1.7.1 Red blood cell-owned transporter systems 
RBCs (also known as erythrocytes) are the most abundant type of blood cells. They are 
disc-shaped, biconcave cells that mediate the transport of oxygen from lung to tissue 
cells and the transport of carbon dioxide from cells of the human body to the lung. The 
metalloprotein hemoglobin accounts for approximately 35 % of the erythrocytes mass. It 
is responsible for oxygen binding and the hem group gives the cells their red color. 
RBCs are highly deformable which allows their passage through capillaries that are 
much smaller (2 – 3 µm diameter) than the diameter of the RBC (6 – 8 µm). Flexibility is 
enabled due to the complex cytoskeleton located underneath the plasma membrane. The 
most prominent parts of the 2D meshwork are spectrin tetramers. They are connected 
via ankyrin to the band 3 protein (anion exchanger protein, AE1) or via the protein band 
4.1 to glycophorin C (GpC). Both band 3 and GpC are transmembrane proteins of the 
RBC membrane, thus mediating the attachment of the cytoskeleton meshwork to the 
plasma membrane of the RBC.  
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Despite the fact that erythrocytes lack a nucleus and cell organelles like ribosomes or 
mitochondria and despite their inability to synthesize proteins (Gronowicz et al., 1984; 
Germinard et al., 2002) they are far more than a “hapless sack of hemoglobin” (Green-
walt, 1993). They have a “sophisticated and focused metabolism” that allows to respond 
to alterations in their surroundings and that includes programmed cell death (reviewed 
in Hess and Beyer, 2006). RBCs use glycolysis for energy production. Both glucose and 
fructose are used as substrates.  
 
Fig. 1.12: Schematic of transport proteins of the RBC membrane that have been identified via 
mass spectrometry. GLT1, GLT3, GLT4, facilitated glucose transporters, AQ1, AQ3, Aquapo-
rins, LAT1, System L amino acid transporter 1, ENT1, equilibrative nucleoside transporters 
ENT-1 (Pasini et al., 2010). 
The proteome of the RBC has been studied intensively in the past years (Low et al., 
2002; Kakhniashvilli et al., 2004; Tyan et al., 2005; Pasini et al., 2006; reviewed in 
Goodman et al., 2007; Pasini et al., 2010). Mass spectrometric analyses identified 592 
RBC proteins, amongst these 252 membrane-associated proteins (Pasini et al., 2006). 
The latter include 47 proteins involved in transport responsible for osmoregulation and 
uptake of nutrients (see Fig. 1.12) (Pasini et al., 2006). The most prominent transport 
protein is the anion exchanger band 3 (Fujinaga et al., 1999) which mediates exchange 
of bicarbonate and chloride anions (Tanner, 1993; reviewed in Pasini et al., 2010). Oth-
er anions like, phosphate, phosphoenolpyruvate, and superoxide are transported less 
efficiently. A Na+/K+-ATPase and a Ca2+-ATPase maintain the concentration of these 
cations at concentrations typical for mammalian cells (Kaplan, 1989; Mercer et al., 
1989; Vincenzi et al., 1989). Examples for secondary active transport across the RBC 
membrane are a K+/Cl−-co-transporter and the Na+/H+-exchanger (Gunn et al., 1989; 
Parker and Dunham, 1989). Three proteins have been implicated to regulate the RBC 
volume in response to changes in osmolarity via transport of water: Aquaporin-1, aqua-
porin-3 and the urea transporter UT-B (Roudier et al., 1998; Agre, 2006; reviewed in 
Pasinin et al., 2010). Furthermore, the amino acid transporter protein XK has been pro-
posed to be involved in osmoregulation (reviewed in Pasinin et al., 2010). Further ami-
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no acid transporters of the RBC have been described: Member 1 and member 2 of the 
solute carrier family 43, as well as the System L amino acid transporter 1 (LAT-1), and 
a glutamate transporter (Li and Whorton, 2007; reviewed in Pasinin et al., 2010). Up-
take of glucose, the main energy source of RBCs, is mediated by the facilitated glucose 
transporters GLUT1, GLUT3 and GLUT 4 (Mueckler et al., 1985; reviewed in Thorens 
and Mueckler, 2010; Pilch, 1990). Nucleosides uridine and adenosine are supposedly 
taken up by the RBC via the equilibrative nucleoside transporters ENT-1 (reviewed in 
King et al., 2006). RBCs also possess a transporter for the uptake of nucleobases, the 
human facilitative nucleobase transporter (hFNT1) (Griffith and Jarvis, 1993; Quashie 
et al., 2010). 
1.7.2 Parasite induced modifications to the red blood cell 
Like the RBC the intra-erythrocytic parasite utilizes glucose as main energy source. 
RBC-owned transport proteins are sufficient to supply the amount of glucose metabo-
lized by the parasite (Kirk et al., 1996; Kirk und Saliba, 2006). However, nutrient re-
quirements of the parasite are much more complex as compared to those of the RBC. 
The parasite solves this problem by modifying the host cell according to its needs. A 
number of parasite-derived proteins are inserted into the RBC membrane. They are re-
ferred to as “new permeability pathways” (NPP) (Ginsburg et al., 1983; Elford et al., 
1985) and mediate uptake of amino acids, peptides, sugars, vitamins, choline and other 
molecules (reviewed in Cabantchik, 1990; Kirk, 2001; Ginsburg und Stein, 2004). As 
mature erythrocytes do not possess a secretion system for trafficking of proteins to the 
RBC membrane, the parasite itself establishes a continuous network of membranes 
within the RBC cytosol. It comprises the Maurer’s clefts, which consist of flat mem-
brane cisternae and vesicles, as well as the tubovesicular network emanating from the 
PVM into the RBC cytosol (Atkinson und Aikawa, 1990; Behari und Halder, 1994; 
Lanzer et al., 2006). These membrane structures are postulated to play an essential role 
for protein trafficking to the RBC (for review see Przyborski et al., 2003; Lanzer et al., 
2006; Epp und Deitsch, 2006). Transport to the RBC membrane via Maurer’s clefts has 
for instance been shown for the immune variant cell surface antigens PfEMP1, RIFIN 
(repetitive interspersed gene encoded protein) and SURFIN (surface-associated inters-
persed gene encoded protein) (Fernandez et al., 1999; Kriek et al., 2003; Haeggström et 
al., 2004; Winter et al., 2005; Khattab und Klinkert, 2006). The modifications of the 
host cell by the parasite are manifold and in great part not characterized in detail, yet. It 
is thus an important objective to further study the interface between parasite and host 
cell, as it is of great importance for parasite survival, and thus represents an attractive 
target for intervention studies. 
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1.8 Aim of the PhD thesis 
The sexual phase is a crucial and at the same time critical part of the life cycle of 
P. falciparum. Only a minor fraction of asexual blood stage parasites will develop into 
gametocytes, the precursor cells of gametes. After their uptake into the mosquito midgut 
only a small proportion of gametocytes will successfully undergo gametogenesis and 
fertilization followed by formation of an oocyst. Thus, the sexual stages are considered 
bottle neck stages presenting an attractive target for intervention strategies. During the 
sexual development processes in the mosquito midgut a number of essential intercellu-
lar interactions occur that are mediated via cell surface-expressed adhesion proteins. 
Details on the molecular interplay, however are rare and the exact function of most sex-
ual stage-specific adhesion proteins remains elusive. 
The proteins of the PfCCp protein family are expressed specifically in sexual parasite 
stages. All members of this protein family possess multiple adhesion domains. Protein-
protein interactions were described both amongst members of the protein family as well 
as between PfCCp proteins and the sexual-stage proteins Pfs25, Pfs48/45 and Pfs230. In 
view of the manifold interactions of the PfCCp proteins the formation of a multimeric 
protein complex is anticipated. Additionally, the PfCCp proteins show a co-dependent 
expression manifesting at post-translational level. The loss of one member of the protein 
family thus results in diminished or abrogated expression of the other proteins of the 
PfCCp protein family.  
The first main objective of this PhD thesis was to study expression and potential pro-
tein-protein interactions of sexual stage proteins to obtain information about protein 
function. The specific aims are described below: 
 Knock-out (KO) parasite lines expressing truncated forms of PfCCp1, PfCCp4, 
PfCCp5, PfFNPA, Pfs230, Pfs48/45 and Pfg377 were investigated, in order to 
reveal interdependencies in protein expression. Via indirect immunofluorescence 
assays (IFAs) the expression of 20 proteins was investigated in sexual parasite 
stages of the KO parasite lines. 
 A parasite line expressing a truncated version of the sexual stage-specific protein 
PfactinII as well as a parasite line expressing PfactinII as hemagglutinin (HA) 
fusion protein were generated. Mutants were studied with the aim of gaining in-
formation on the function of the protein. Indirect IFAs where carried out to in-
vestigate the expression profile of PfactinII. In addition, co-immunoprecipitation 
assays (co-IPs) and indirect IFAs where carried out to examine its relation with 
other sexual stage proteins.  
 The expression of the so far uncharacterized protein PfWLP1 was studied in 
several parasite stages via indirect IFA in order to gain information on its spatial 
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and temporal expression pattern. Both a KO mutant and a mutant expressing 
PfWLP1 fused to an HA tag were generated. 
 Via reverse transcriptase PCR (RT-PCR) and indirect IFA the expression of 
IMC proteins was investigated in gametocytes. The objective of this study was 
to better understand the composition of the subpellicular membrane complex of 
gametocytes and to compare it to the composition of the IMC of asexual para-
sites. 
The second main objective was to study the molecular background of gametocyte acti-
vation and the mode of action of XA. Inhibitor studies were carried out with both unin-
fected and gametocyte-infected RBCs in order to check for interference with XA-
induced gametocyte activation. In addition, gametocyte activation was studied on the 
ultrastructural level in order to better understand the sequential processes of gametocyte 
activation on cellular level. 
 2 Materials and Methods 
2.1 Materials 
2.1.1 Technical equipment 
Tab. 2.1: Utilized technical devices and respective manufacturer. 
Technical device Manufacturer 
Universal oven Memmert GmbH + Co. KG (Schwa-
bach) 
Bunsen burner schuett flammy S schuett-biotec GmbH (Göttingen) 
Centrifuge Avanti® J-26 XP Beckman Coulter GmbH (Krefeld) 
Clean bench HERAsafe® Heraeus Holding GmbH (Hanau) 
Confocal laser scanning microscope LSM 
510 
Carl Zeiss AG (Oberkochen) 
Confocal laser scanning microscope TCS 
SP1 
Leica Microsystems GmbH (Wetzlar) 
Developing machine CURIX 60 Agfa HealthCare GmbH (Bonn) 
Dispenser Multipette® plus Eppendorf AG (Hamburg) 
Dry block thermostats TBD-100, TDB-
120 
LAB4YOU GmbH (Berlin) 
Electrophoresis chambers MIDI, MAXI Carl Roth GmbH & Co. KG 
(Karlsruhe) 
Electrophoresis power supply Consort 
E835 
Consort via A. Hartenstein GmbH 
(Würzburg) 
Electrophoresis power supply PowerPacTM 
HC 
Bio-Rad Laboratories GmbH  
(München) 
Electroporation System Gene Pulser 
XcellTM 
Bio-Rad Laboratories GmbH  
(München) 
French® Press G. Heinemann (Schwäbisch Gmünd) 
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Tab. 2.1 (continued) 
Technical device Manufacturer 
Gel documentation system GelDocTM 
2000 
Bio-Rad Laboratories GmbH  
(München) 
Hemocytometer (Neubauer chamber) Paul Marienfeld GmbH  
(Lauda-Königshofen) 
Incubator HERAcell® Heraeus Holding GmbH (Hanau) 
Light microscope Leitz Laborlux 11 Leitz (Wetzlar) 
Light microscope Leica DMLS Leica Microsystems GmbH (Wetzlar) 
Luminescent Image Analyzer LAS-1000 Fujifilm (Vila Nova de Gaia, Portugal) 
Mini-gel drying frame Carl Roth GmbH & Co. KG 
(Karlsruhe) 
Mini-rocker shaker MR-1 LAB4YOU GmbH (Berlin) 
Mini-shaker for PSU-2T LAB4YOU GmbH (Berlin) 
Multichannel micropipette Calibra® 852 Socorex via A. Hartenstein GmbH 
(Würzburg) 
PCR thermocycler PTC-100TM MJ Research Inc. (St. Bruno, Canada) 
PCR thermocycler Primus 25 advanced® PEQLAB (Erlangen) 
pH meter inoLab® pH Level1 WTW GmbH (Weilheim) 
Pipetter accu-jet®  Brand GmbH & Co. KG (Wertheim) 
Pipette set Research® Eppendorf AG (Hamburg) 
Precision scales 440-47N and 440-33 Kern und Sohn GmbH (Balingen-
Frommern) 
Protein gel electrophoresis chamber Mini-
PROTEAN® 3  
Bio-Rad Laboratories GmbH  
(München) 
Refrigerated centrifuge Avanti® J-26 XP Beckmann (München) 
Roller mixer Karl Hecht KG (Sondheim) 
Roller mixer Labinco BV (DG Breda, The Nether-
lands) 
Slide stretching table OTS 40 Medite GmbH (Hannover) 
Spectrophotometer BioPhotometer plus Eppendorf AG (Hamburg)  
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Tab. 2.1 (continued) 
Technical device Manufacturer 
Spectrophotometer Nanodrop® 1000 PEQLAB (Erlangen) 
Thermo Scientific TKA water purification 
system 
Thermo Electron LED GmbH  
(Niederelbert) 
Transmission electron microscope EM10 Carl Zeiss AG (Oberkochen) 
Microcentrifuge Biofuge pico Heraeus Holding GmbH (Hanau) 
Ultrasound device Sonoplus HD70 Bandelin (Berlin) 
Universal shaker SM 30 A control and in-
cubation hood TH 30 
Edmund Bühler GmbH (Tübingen) 
UV Stratalinker® 1800  Stratagene (Amsterdam, The Nether-
lands) 
Vacuum blotter VacuGene XL Pharmacia Biotech (Freiburg) 
Vortex mixer Labinco BV (DG Breda, The Nether-
lands) 
Water bath WB-20 P-D Industriegesellschaft mbH  
(Wilsdruff) 
Water bath incubator WTE var 3185 Karl Hecht KG (Sondheim) 
Western Blot transfer cell Mini Trans-Blot  Bio-Rad Laboratories GmbH  
(München) 
2.1.2 Consumable supplies 
Consumable material used during this thesis was purchased from Becton Dickinson 
GmbH (Heidelberg), Sarstedt AG & Co. (Nümbrecht), Eppendorf AG (Hamburg) and 
Greiner Bio-One GmbH (Frickenhausen). Further manufacturers are listed in Tab. 2.2. 
Tab. 2.2: Utilized consumable material and the respective manufacturer. 
Consumable material Manufacturer 
Bottle top filter 0.22 µm PES membrane Biochrom AG (Berlin) 
Centrifugal filter unit Vivaspin 6  
(5 kDa cut-off) 
Sigma-Aldrich Chemie GmbH  
(München) 
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Tab. 2.2 (continued) 
Consumable material Manufacturer 
Cover slips A. Hartenstein GmbH (Würzburg) 
Disposable syringes  B. Braun Melsungen AG (Melsungen) 
Electroporation cuvette, gap width 2 mm VWR International GmbH (Darmstadt) 
Fuji Medical X-Ray Film Super X Fujifilm via A. Hartenstein GmbH 
(Würzburg) 
Hybond ECL nitrocellulose membrane GE Healthcare Europe GmbH (Frei-
burg) 
Hybond N+ nylon membrane GE Healthcare Europe GmbH (Frei-
burg) 
Syringe filter Rotilabo® (PVDF membran, 
pore size 0.22 µm) 
Carl Roth GmbH & Co. KG (Karlsruhe) 
Microscope slides, double frosted Glaswarenfabrik Karl Hecht GmbH & 
Co. KG (Sondheim) via A. Hartenstein 
GmbH (Würzburg) 
Pasteur pipettes A. Hartenstein GmbH (Würzburg) 
Pasteur pipettes with cotton-wool plug A. Hartenstein GmbH (Würzburg) 
Poly-Prep Chromatography Columns Bio-Rad Laboratories GmbH (München) 
Teflon coated diagnostic microscope 
slides 
Gerhard Menzel, Glasbearbeitungswerk 
GmbH & Co. KG (Braunschweig) via 
Carl Roth GmbH & Co. KG (Karlsruhe) 
96-well plates F96 MicroWell™ Nunc GmbH & Co. KG via A. Hartens-
tein GmbH (Würzburg) 
2.1.3 Chemicals 
Tab. 2.3: Utilized chemicals and the respective manufacturer. 
Chemical Manufacturer 
N-Acetyl-D-glucosamin (GlcNAc) Carl Roth GmbH & Co. KG (Karlsruhe) 
Acrylamid/ Bisacrylamid stock solution 
(37.5 :  1) Protogel 
Biozym Scientific GmbH (Hessisch Ol-
dendorf) 
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Tab. 2.3 (continued) 
Chemical Manufacturer 
Adenine Sigma-Aldrich Chemie GmbH  
(München) 
DifcoTMAgar BD GmbH (Heidelberg) 
Agarose NEEO ultra quality Carl Roth GmbH & Co. KG (Karlsruhe) 
Albumin fraction V (BSA) Carl Roth GmbH & Co. KG (Karlsruhe) 
para-Aminobenzoic acid Sigma-Aldrich Chemie GmbH  
(München) 
AminoLink Coupling Resin Pierce (Thermo Fisher Scientific, Bonn) 
Ammonium hydroxide (5.0 N solution) Fluka®, Sigma-Aldrich Chemie GmbH 
(München) 
Ammonium peroxodisulfate Carl Roth GmbH & Co. KG (Karlsruhe) 
Ampicillin Carl Roth GmbH & Co. KG (Karlsruhe) 
3-Acetylpyridine adenine dinucleotide 
(APAD) 
Sigma-Aldrich Chemie GmbH  
(München) 
BAPTA-AM Sigma-Aldrich Chemie GmbH  
(München) 
Blue Stain protein staining solution Pierce (Thermo Fisher Scientific, Bonn) 
BCIP/NBT tablets Sigma-Aldrich Chemie GmbH  
(München) 
Blasticidin S HCl InvitrogenTM (Life Technologies GmbH, 
Darmstadt) 
β-Mercaptoethanol Sigma-Aldrich Chemie GmbH  
(München) 
Bromophenol blue solution AppliChem GmbH (Darmstadt) 
100 x BSA  New England Biolabs GmbH (Frankfurt) 
Chloramphenicol Carl Roth GmbH & Co. KG (Karlsruhe) 
Citifluor Citifluor Ltd. (London, UK) 
Cyanoborohydride Solution Pierce (Thermo Fisher Scientific, Bonn) 
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Tab. 2.3 (continued) 
Chemical Manufacturer 
Cytochalasin B Sigma-Aldrich Chemie GmbH 
(München) 
Deoxynucleotide Set, 100 mM Sigma-Aldrich Chemie GmbH  
(München) 
Chloroform Carl Roth GmbH & Co. KG (Karlsruhe) 
Diaphorase Sigma-Aldrich Chemie GmbH  
(München) 
Diethylpyrocarbonate (DEPC) ( 97 % so-
lution) 
Carl Roth GmbH & Co. KG (Karlsruhe) 
1,4-Dithiothreitol (DTT) Carl Roth GmbH & Co. KG (Karlsruhe) 
Ethanol, p.a. Carl Roth GmbH &Co. KG (Karlsruhe) 
EDTA disodium salt x 2 H2O AppliChem GmbH (Darmstadt) 
EGTA AppliChem GmbH (Darmstadt) 
Erythromycin Kindly provided by Prof. T. Schirmeist-
er, University of Wuerzburg 
Ethanol, denatured Carl Roth GmbH &Co. KG (Karlsruhe) 
Evans Blue Sigma-Aldrich Chemie GmbH  
(München) 
Ethidium bromide (10 mg/ml solution) Carl Roth GmbH & Co. KG (Karlsruhe) 
Gentamicin (10 mg/ml) Gibco® (Life Technologies GmbH, 
Darmstadt) 
Gel Blue Stain Solution Carl Roth GmbH & Co. KG (Karlsruhe) 
Giemsa stock solution Carl Roth GmbH + Co. KG (Karlsruhe) 
D-(+) Glucose Sigma-Aldrich Chemie GmbH  
(München) 
Glutaraldehyde, 25 % Fluka®, Sigma-Aldrich Chemie GmbH 
(München) 
Glutathione sepharose GE Healthcare Europe GmbH (Freiburg) 
Glycerol, anhydrous, p.a. Carl Roth GmbH + Co. KG (Karlsruhe) 
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Tab. 2.3 (continued) 
Chemical Manufacturer 
Goat serum (Neutral goat serum) Sigma-Aldrich Chemie GmbH  
(München) 
HEPES Carl Roth GmbH + Co. KG (Karlsruhe) 
HCl 32 %, p.a. AppliChem GmbH (Darmstadt) 
HCl 37 % fuming, p.a. AppliChem GmbH (Darmstadt) 
Hoechst stain 33342 Molecular Probes® (Life Technologies 
GmbH, Darmstadt) 
Hypoxanthine Sigma-Aldrich Chemie GmbH  
(München) 
Immersion oil  Carl Roth GmbH + Co. KG (Karlsruhe) 
Isopropanol, p.a. Carl Roth GmbH + Co. KG (Karlsruhe) 
Isopropyl-β-D-thiogalactopyranoside 
(IPTG) 
InvitrogenTM (Life Technologies GmbH, 
Darmstadt) 
KCl Carl Roth GmbH + Co. KG (Karlsruhe) 
Ketamine Sigma-Aldrich Chemie GmbH  
(München) 
K2HPO4 AppliChem GmbH (Darmstadt) 
Kynurenic acid Sigma-Aldrich Chemie GmbH (Mün-
chen) 
DL-Lactic acid sodium solution 60 % Sigma-Aldrich Chemie GmbH  
(München) 
L(+)-Lactic acid Sigma-Aldrich Chemie GmbH  
(München) 
L-Leucine Carl Roth GmbH + Co. KG (Karlsruhe) 
Maleic acid Carl Roth GmbH + Co. KG (Karlsruhe) 
MgCl2 x 6 H2O Carl Roth GmbH + Co. KG (Karlsruhe) 
MgSO4 x 7 H2O AppliChem GmbH (Darmstadt) 
Methanol, p.a. Carl Roth GmbH + Co. KG (Karlsruhe) 
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Tab. 2.3 (continued) 
Chemical Manufacturer 
Milk powder, blotting grade Carl Roth GmbH + Co. KG (Karlsruhe) 
NaCl Carl Roth GmbH + Co. KG (Karlsruhe) 
Na2HPO4, anhydrous AppliChem GmbH (Darmstadt) 
NaH2PO4 x 2 H20 Carl Roth GmbH + Co. KG (Karlsruhe) 
NaOH Carl Roth GmbH + Co. KG (Karlsruhe) 
NBTI (NBMPR) Sigma-Aldrich Chemie GmbH  
(München) 
Nigericin Sigma-Aldrich Chemie GmbH  
(München) 
Nitroblue tetrazolium (NBT) Carl Roth GmbH + Co. KG (Karlsruhe) 
Nonidet® P-40 (NP-40) Fluka®, Sigma-Aldrich Chemie GmbH 
(München) 
Paraformaldehyde Sigma-Aldrich Chemie GmbH  
(München) 
Percoll® Sigma-Aldrich Chemie GmbH  
(München) 
Phenol Carl Roth GmbH + Co. KG (Karlsruhe) 
L-Phenylalanine  Carl Roth GmbH + Co. KG (Karlsruhe) 
Poly-L-Lysine Sigma-Aldrich Chemie GmbH  
(München) 
Potassium hexacyanoferrate (III) Sigma-Aldrich Chemie GmbH  
(München) 
Propylene oxide Sigma-Aldrich Chemie GmbH  
(München) 
Protein G PLUS-Agarose Santa Cruz Biotechnology, Inc.  
(Heidelberg) 
Pyrimethamine Sigma-Aldrich Chemie GmbH  
(München) 
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Tab. 2.3 (continued) 
Chemical Manufacturer 
Rifampicin DUCHEFA Biochemie B.V. (Haarlem, 
Netherlands) 
RPMI 1640 medium (containing 25 mM 
HEPES, 2.05 mM L-Glutamine, Phenol Red) 
Gibco®, Life Technologies GmbH, 
Darmstadt 
RPMI 1640 powder Gibco®, Life Technologies GmbH, 
Darmstadt 
Saponin from quillaja bark  
 
Sigma-Aldrich Chemie GmbH (Mün-
chen) 
Sea salt Alnatura GmbH (Bickenbach) 
Sodium hypochlorite solution 13 % AppliChem GmbH (Darmstadt) 
D(–)-Sorbitol AppliChem GmbH (Darmstadt) 
SDS, ultra pure for electrophoresis Carl Roth GmbH + Co. KG (Karlsruhe) 
TEMED for electrophoresis Carl Roth GmbH + Co. KG (Karlsruhe) 
Tris PUFFERAN® ultra quality Carl Roth GmbH + Co. KG (Karlsruhe) 
Triton® X-100 Carl Roth GmbH + Co. KG (Karlsruhe) 
TRIzol® Reagent Life Technologies GmbH (Darmstadt) 
Trypton/pepton from casein Carl Roth GmbH + Co. KG (Karlsruhe) 
L-Tryptophan  Carl Roth GmbH + Co. KG (Karlsruhe) 
Tween® 20 Carl Roth GmbH + Co. KG (Karlsruhe) 
Valinomycin Sigma-Aldrich Chemie GmbH (Mün-
chen) 
Water, double-distilled (ddH2O) for cell 
culture 
Carl Roth GmbH + Co. KG (Karlsruhe) 
Yeast extract, pulverized, for bacteriology Carl Roth GmbH + Co. KG (Karlsruhe) 
Xanthurenic acid Fluka®, Sigma-Aldrich Chemie GmbH 
(Munich) 
Xylazine Sigma-Aldrich Chemie GmbH (Mün-
chen) 
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2.1.4 Enzymes and Kits 
Tab. 2.4: Enzymes used and the respective manufacturer. 
Enzyme Manufacturer 
Antarctic Phosphatase NEB GmbH (Frankfurt/Main) 
Calve Intestinal Phosphatase (CIP) NEB GmbH (Frankfurt/Main) 
Chymotrypsin Sigma-Aldrich Chemie GmbH (München) 
DNaseI QUIAGEN GmbH (Hilden) 
GoTaq® DNA Polymerase Promega GmbH (Mannheim) 
Phusion® High-Fidelity DNA Polyme-
rase 
New England Biolabs GmbH (NEB) 
(Frankfurt/Main) 
Polynucleotide Kinase NEB GmbH (Frankfurt/Main) 
Proteinase K Sigma-Aldrich Chemie GmbH (München) 
Restriction endonucleases NEB GmbH (Frankfurt/Main) 
T4 DNA Ligase NEB GmbH (Frankfurt/Main) 
Tab. 2.4 summarizes enzymes that were used. The following laboratory kits were uti-
lized in the course of this work: 
 NucleoSpin® Plasmid kit (Macherey & Nagel GmbH & Co. KG, Düren) 
 Midi kit NucleoBond® Xtra Midi (Macherey & Nagel) 
 NucleoSpin® Gel and PCR Clean-up kit (Macherey & Nagel) 
 NucleoSpin ® Blood kit (Macherey & Nagel) 
 innuPREP RNA Mini Kit (Analytik Jena AG) 
 BigDye™ Terminator Cycle Sequencing Kit (Applied BiosystemsTM, Life 
Technologies GmbH, Darmstadt) 
 SuperScript® III First-Strand Synthesis System for RT-PCR (Life Technologies 
GmbH, formerly Invitrogen GmbH, Darmstadt) 
 DIG High Prime DNA Labeling and Detection Starter Kit II (Roche Diagnostics 
Deutschland GmbH, Mannheim) 
 MasterPureTM DNA Purification Kit (Epicentre®, via Biozym Scientific 
GmbH, Hessisch Oldendorf) 
 Epoxy Embedding Medium Kit (Sigma-Aldrich Chemie GmbH, München) 
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2.1.5 Media and buffers for cell biological methods 
All solutions were prepared using Milli-Q water (MQH2O). Solutions and media used 
for culturing of P. falciparum were prepared from cell culture-grade ddH2O and were 
sterile filtered using syringe filter or a bottle-top filter. 
2000 x Blasticidin S stock solution 
 5 mg/ml Blasticidin S dissolved in ddH2O, stored in aliquots at 20°C 
Cytomix buffer (Wu et al. 1995) 
120 mM  KCl 
0.15 mM CaCl2 
2 mM  EGTA 
5 mM  MgCl2 
10 mM  K2HPO4/ KH2PO4 
25 mM  HEPES 
ddH2O ad 500 ml, pH 7.6 
Erythrocyte concentrate (Hematocrit 50 %) 
 purchased erythrocyte concentrate (blood type A Rh+, Bavarian Red Cross, Augs-
burg) was mixed 1:1 with RPMI incomplete medium, centrifuged at 3220 x g for 
10 min 
 supernatant was removed, cells were washed two more times with RPMI incom-
plete medium 
 storage of cells in RPMI incomplete medium at 50 % hematocrit at 4°C for up to 
four weeks 
Fresh erythrocytes for transfection experiments 
 16 ml of human whole blood (blood type A Rh+) were taken into a syringe contain-
ing 4 ml 106 mM disodium citrate 
 inversion of syringe, blood was centrifuged 
 serum and buffy coat were removed 
 red blood cells were washed three times with RPMI incomplete medium, stored at a 
hematocrit of 50 %, used within one week 
10 x Giemsa buffer 
51.4 mM  KH2PO4 
37.3 mM  Na2HPO4 
Glycerolyte 
13.33 g  DL-Lactic acid sodium (60 % solution, final concentration 1.6 %) 
285 g  Glycerol (45 % [v/v]) 
4 mM  KCl 
3.77 mM  NaH2PO4 
8.75 mM  Na2HPO4 
ddH2O ad 500 ml 
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Human serum (blood type A Rh+) 
 sera from different donors (Bavarian Red Cross, Würzburg) were pooled 
 sterile filtered, aliquoted and heat-inactivated at 55°C for 50 min 
 storage at –20°C 
1000 x Hypoxanthine stock solution 
 50 mg/ml in 1 M NaOH 
IFA incubation solution 
0.5 %  BSA 
0.01 %  Saponin 
in 1 x PBS, pH 7.4 
Malstat reagent 
0.5 ml  10 % Triton X-100 solution 
0.5 g  L-Lactic acid 
0.165 g  Tris-Base 
 Dissolved in ddH2O, cooled 
0.0165 g  APAD  
 Dissolved, ddH2O ad 50 ml, pH 9.0 
10 x PBS (Phosphate-buffered saline) 
75 mM Na2HPO4 
75 mM NaH2PO4 
1.45 M NaCl 
MQH2O ad 1 l, pH 7.4 
4 % PFA/ PBS 
 heating of 90 ml dH2O to 60°C 
 addition of 4 g paraformaldehyde, covering of glass beaker, maintained at 60°C 
 addition of ~50 µl of 2 M NaOH, solution will clear 
 addition of 10 ml 10 x PBS, pH to 7.2 
 filtered and kept on ice 
 storage light-protected in aliquots at –20°C 
250 x Pyrimethamine stock solution 
 15 mg/ml dissolved in DMSO at 37°C 
 diluted in RPMI incomplete medium to a final concentration of 125 µg/ml 
RPMI 1640 complete A+ medium (RPMI complete medium) 
500 ml  RPMI 1640  
50 ml  Humane serum A Rh+ 
550 µl  1000 x Hypoxanthine 
550 µl  1000 x Gentamicin 
RPMI 1640 complete GlcNAc (N-Acetyl glucosamin) medium 
 6.08 g of GlcNAc were dissolved in 550 ml RPMI 1640 complete A+ medium (final 
concentration of 50 mM) followed filtration through a bottle-top filter to sterilize 
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RPMI 1640 complete pyrimethamine medium 
 2.2 ml of the 250 x Pyrimethamine stock solution were added to 550 ml of RPMI 
1640 complete A+ medium 
RPMI 1640 complete blasticidin medium 
 275 µl of the 2000 x Blasticidin S stock solution were added to 550 ml of RPMI 
1640 complete A+ medium  
1 x RPMI 1640 incomplete medium (ICM) 
 0.05 g hypoxanthine (final concentration 0.36 mM) were heated 2 x 2 min in 200 ml 
ddH2O until dissolved 
 5.94 g HEPES (final concentration 25 mM) were added and stirred for 30 min 
 1 package RPMI 1640 powder (10.43 g) was added followed by stirring for 30 min 
 ddH2O added to a volume of 1 l, sterile filtered 
10 x RPMI 1640 incomplete medium 
 preparation as for 1 x RPMI 1640 incomplete medium 
 ddH2O added to a final volume of 100 ml 
1 mM Xanthurenic acid 
 25 mg/ml dissolved in 0.5 M NH4OH 
 diluted in MQH2O to final concentration 
2.1.6 Media and buffers for molecular biological methods 
Buffers and stock solutions were prepared with deionised water (dH2O) from the on-site 
desalting plant. Buffers and solutions for Southern blot were prepared with MQH2O. 
1000 x Ampicillin 
 100 mg/ml dissolved in dH2O, shelf life at 4°C: four weeks 
 Long term storage of aliquots at –20°C 
Bacteria freezing solution 
65 % (v/v)  glycerol 
100 mM  MgSO4 
25 mM  Tris-HCl pH 8.0 
 autoclaved to sterilize 
Blocking buffer Southern Blot 
 10 x Blocking solution (vial 6, DIG High Prime DNA Labeling and Detection Start-
er Kit II, Roche) in Maleic acid buffer 
Chloramphenicol 
 50 mg/ml dissolved in Ethanol, storage at –20°C 
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DEPC-H2O 
 0.1 % (v/v) DEPC in MQH2O, stirring 
 incubation at 37°C overnight  
 autoclaved to inactivate DEPC 
10 mM dNTP mix 
 10 ml each of 100 mM dATP, dCTP, dGTP and dTTP 
 sterile MQH2O ad 100 µl  
Detection buffer Southern Blot 
100 mM  Tris-HCl, pH9.5 
100 mM  NaCl 
LB medium 
10 g/l  Tryptone 
5 g/l  Yeast extract 
5 g/l  NaCl 
LB agar 
10 g/l  Tryptone 
5 g/l  Yeast extract 
5 g/l  NaCl 
15 g/l Agar 
Maleic acid buffer 
100 mM  Maleic acid 
150 mM  NaCl 
adjust pH to 7.5 with solid NaOH 
Plasmid DNA isolation resuspension buffer P1 
50 mM Tris-HCl pH 8.0 
10 mM EDTA 
100 µg/ml  RNase A 
Plasmid DNA isolation lysis buffer P2 
200 mM NaOH 
1 %  SDS 
SOC medium 
20 g/l  Tryptone 
5 g/l  Yeast extract 
0.5 g/l  NaCl 
10 ml  250 mM KCl 
5 ml  2 M MgCl2 
20 ml  1 M Glucose 
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20 x SSC 
300 mM  Trisodium citrate 2 x H2O 
3.0 M  NaCl 
50 x TAE (Tris-acetate-EDTA) buffer  
2.0 M Tris 
2.0 M  Acetic acid 
50 mM  EDTA (100 ml 0.5 M EDTA, pH 8.0) 
dH2O ad 1 l 
TSE buffer 
20 mM Tris, pH 8.0 
100 mM  NaCl 
50 mM  EDTA 
Washing buffer Southern Blot 
 3 % Tween 20 in Maleic acid buffer 
2.1.7 Media and buffers for protein biochemical methods 
Blocking solution Western Blot 
1 x TBS 
5 % (w/v) Milk powder 
1 % (w/v) BSA 
Co-immunoprecipitation (Co-IP) lysis buffer 
0.2 %  Saponin 
0.8 %  NP-40 
1 %  Protease inhibitor cocktail (PIC) 
5 µM  EDTA 
in 1 x PBS, pH 7.4 
Detergent buffer inclusion bodies 
20 mM   Tris-Base 
2 mM  EDTA  
0.20 M NaCl  
1 % (w/v) Deoxycholic acid  
1 % (v/v) NP-40 
pH 7.5 
Equilibration buffer Western Blot 
100 mM Tris 
100 mM NaCl 
110 mM MgCl2 
dH2O ad 1 l, pH 9.5 
Materials and Methods  43 
 
GST Elution buffer 
50 mM Tris 
10 mM glutathione 
pH 8.0 
Lysis buffer inclusion bodies  
50 mM Tris-Base 
0.25 % (w/v) Sucrose 
1 mM EDTA 
pH8.0 
10 x SDS-PAGE running buffer 
240 mM Tris 
1.92 M Glycine 
1 % (w/v) SDS 
dH2O ad 1 l 
5 % SDS Polyacrylamide stacking gel (for 2 mini gels) 
0.6 ml  30 % Acrylamid 
1 ml  500 mM Tris pH 6.8 
12 µl  10 % SDS 
30 µl  10 % APS 
4 µl  TEMED 
2.4 ml  dH2O 
12 % SDS Polyacrylamide separating gel (for 2 mini gels) 
4 ml  30 % Acrylamid 
2.5 ml  1.5 M Tris pH 8.8 
100 µl  10 % SDS 
100 µl  10 % APS 
4 µl  TEMED 
3.3 ml  dH2O 
2 x SDS-PAGE sample buffer 
2.5 ml  500 mM Tris pH 6.8 
2 ml  Glycerine 
4 ml  10 % SDS 
0.5 ml  0.1 % Bromophenol blue 
dH20 ad 10 ml 
Stop buffer Western Blot 
10 mM Tris 
1.4 mM EDTA 
dH2O ad 1 l, pH 8.0 
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10 x TBS (Tris-buffered saline) 
100 mM Tris 
1.49 M NaCl 
dH2O ad 1 l, pH 7.5 
Transfer buffer Western Blot 
25 mM Tris 
192 mM Glycin 
20 % (v/v)  Methanol 
dH20 ad 1 l 
TBSM 
1 x TBS 
3 % (w/v) Milk powder 
Washing buffer 
0.5 %  Triton X-100 
1 mM  EDTA 
2.1.8 Bacteria strains and cell lines 
The following E. coli strains were used for recombinant DNA techniques: 
E. coli Nova Blue (originally from Life Technologies GmbH, Darmstadt): chemical 
competent cells (generation according to Inoue et al. 1990) 
E. coli BL21 CodonPlus®(DE3)-RIL-Zellen (Agilent Technologies Sales & Services 
GmbH & Co.KG, Waldbronn) competent cells for protein expression 
P. falciparum strains and KO cell lines investigated in this work are listed in Tab. 2.5. 
Tab. 2.5: P. falciparum cell lines and clones investigated. Plasmids used for genetically mani-
pulation of parasites and the respective selection marker are listed. 
Cell line Clones Plasmid 
Selection 
marker 
Reference 
Wild-type NF54 - - - - 
3D7 (clone of 
NF54) 
F12 - - Alano et al., 
1995 
NF54, PfCCp1-KO 5YE2 pHHT-TK Pyrimethamine Simon et 
al., 2009 
NF54, PfCCp4-KO L4C pDT.Tg23 Pyrimethamine Scholz et 
al., 2008 
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Tab. 2.5 (continued) 
Cell line Clones Plasmid 
Selection 
marker 
Reference 
NF54, PfFNPA-
KO 
1H4 pCAM-BSD Blasdicidin S Simon et 
al., 2009 
NF54, Pfs230-
KOd1 
12-1 pDT.Tg23 Pyrimethamine Eksi et al., 
2002 
NF54, Pfs230-
KOd2 
15-4 pDT.Tg23 Pyrimethamine Eksi et al., 
2002 
NF54, Pfs48/45-
KO 
 pDT.Tg23 Pyrimethamine van Dijk et 
al., 2001 
3D7, Pfg377-KO E4 pHH1 WR99210 de Koning-
Ward et al., 
2008 
 
2.1.9 Antibodies and antisera 
Antibodies and antisera used for this work are listed in Tab. 2.6. Antisera generated in 
the Pradel laboratory are polyclonal antisera derived from female NMRI mice (Charles 
River Laboratories Germany GmbH, Sulzfeld). Some of the non-commercially obtained 
antisera were friendly provided by Dr. Jude Przyborski (Marburg), Prof. Kim William-
son (Chicago, USA), Dr. Pietro Alano (Rome, Italy) und Prof. Tom Templeton (New 
York, USA). 
Tab. 2.6: Primary and secondary antibodies and antisera utilized. 
Antibody/Antiserum 
Animal of 
origin 
Dilution 
Source 
Western Blot IFA 
Primary antibodies/ antisera 
anti-Glycophorin A mouse 1:500 – Sigma-Aldrich 
(clone E4, G7900) 
anti-MYO1C (hu-
man) 
rabbit – 1:50–1:100 Sigma-Aldrich 
(SAB2104382) 
anti-PfactinI rp1 mouse – 1:100 Pradel Lab 
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Tab. 2.6 (continued) 
Antibody/Antiserum 
Animal of 
origin 
Dilution 
Source 
Western Blot IFA 
anti-PfactinII rp1 mouse 1:50 – 1:200 1:50 – 1:200 Pradel Lab 
anti-PfCCp1 rp1 mouse – 1:100 Pradel Lab 
anti-PfCCp2 rp3 mouse 1:100 1:50 Pradel Lab 
anti-PfCCp3 rp3 mouse – 1:50 Pradel Lab 
anti-PfCCp3 SR1 mouse – 1:50 Tom Templeton 
anti-PfCCp4 rp1 mouse – 1:25 – 1:50 Pradel Lab 
anti-PfCCp5 rp4 mouse 1:200 1:50 Pradel Lab 
anti-PfFNPA rp2 mouse – 1:50 Pradel Lab 
anti-PfFNPA rp1 mouse 1:200 – Pradel Lab 
anti-PfExp-1 rabbit – 1:50 Jude Przyborski 
anti-Pfg377 rat – 1:50 Pietro Alano 
anti-PfGAP50 rp1 mouse – 1:50 Pradel Lab 
anti-PfMR5 mouse – 1:50 Pradel Lab 
anti-Pfpeg3 rat – 1:50 Pietro Alano 
anti-Pfpeg4 rat – 1:50 Pietro Alano 
anti-Pfs16 
mouse – 1:200 Pradel Lab 
(Plasmid by Kim 
Williamson) 
anti-Pfs16 
rabbit – 1:100 Biogenes (Plas-
mid by Kim Wil-
liamson) 
anti-Pfs25 rabbit 1:200 1:500 – 1:1000 ATCC (Manas-
sas, USA) 
anti-Pfs28 rabbit – 1:100 ATCC (MRA-18) 
(Manassas, USA) 
anti-Pfs230-C 
mouse 1:500 1:100 – 1:200 Pradel Lab 
(Plasmid by Kim 
Williamson) 
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Tab. 2.6 (continued) 
Antibody/Antiserum 
Animal of 
origin 
Dilution 
Source 
Western Blot IFA 
anti-Pfs230-C 
rabbit – 1:100 – 1:200 Biogenes (Plas-
mid by Kim Wil-
liamson) 
anti-Pfs47.1 rat – 1:50 Robert 
Sauerwein 
anti-Tubulin (Stron-
gylcentrotus purpura-
tus) 
mouse – 1:100 Sigma-Aldrich 
(T5168) 
anti-α-tubulin II rp1 mouse – 1:20 Pradel Lab 
anti-α-tubulin II rabbit – 1:500 ATCC (Manas-
sas, USA) 
anti-Pf39 (PfERC) mouse 1:100 – Pradel Lab 
anti-PfMSP1 rabbit – 1:1000 ATCC (Manas-
sas, USA) 
anti-PfWLP1 rp2  mouse – 1:50 Pradel Lab 
anti-HA tag  mouse 1:1000 – Roche 
(11583816001) 
anti-HA tag  mouse 1:100 1:50 Santa Cruz  
(sc-805) 
anti-PfCCp1-1rp1 mouse 1:200 1:100 AG Pradel 
anti-PfCCp1-1rp5 mouse 1:200 1:100 AG Pradel 
anti-PfCCp2-2rp3 mouse 1:200 1:100 AG Pradel 
anti-PfCCp3-SR1 mouse 1:100 1:100 Tom Templeton 
anti-PfCCp4-4rp1 mouse – 1:50 AG Pradel 
Secondary antibodies 
anti-mouse alkaline 
phosphatase conju-
gated antibody 
goat 1:6000 – Molecular 
Probes, Invitro-
gen, Karlsruhe 
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Tab. 2.6 (continued) 
Antibody/Antiserum 
Animal of 
origin 
Dilution 
Source 
Western Blot IFA 
anti-rabbit alkaline 
phosphatase conju-
gated antibody 
goat 1:6000 – Molecular 
Probes, Invitro-
gen, Karlsruhe 
anti-mouse Alexa 
Fluor® 488 antibody 
goat – 1:1000 Sigma-Aldrich  
anti-rabbit Alexa 
Fluor® 488 antibody 
goat – 1:1000 Sigma-Aldrich  
anti-rat Alexa Fluor® 
488 antibody 
goat – 1:1000 Sigma-Aldrich  
anti-mouse Alexa 
Fluor® 594 antibody 
goat – 1:1000 Sigma-Aldrich  
anti-rabbit Alexa 
Fluor® 594 antibody 
goat – 1:1000 Sigma-Aldrich  
2.1.10 Oligonucleotides 
Oligonucleotides used in this work were purchased from biomers.net (Ulm). Oligonuc-
leotides used for the generation of transfection plasmids are listed in Tab. 2.7, oligonuc-
leotides employed in diagnostic PCRs investigating manipulated gene loci of transfected 
parasites are listed in Tab. 2.8. All other oligonucleotides are listed in Tab. 2.9. 
Tab. 2.7: Sequence of oligonucleotides (5’ – 3’ orientation) used for generation of genetically 
modified parasites. Recognition sites of restriction endonucleases are shown as capitals, stop 
codons are underlined.  
Oligonucleotide Sequence 
Product 
length 
CCp5-KO-S atGGATCCggttcgcgcgattgggat 
507 bp 
CCp5-KO-AS taGCGGCCGCttattctaatggtcctctact 
CCp5-HA1-S atCTGCAGctccaataattaatccaaac 
569 bp 
CCp5-HA-AS taGGATCCaattttcaatatttgaagtgcc 
CCp5-HA2-S atCTGCAGccaaatagttattccattgta 
525 bp 
CCp5-HA-AS taGGATCCaattttcaatatttgaagtgcc 
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Tab. 2.7 (continued) 
Oligonucleotide Sequence 
Product 
length 
FNPA-KO-S atGGATCCggggtacatgcatttatg 
568 bp 
FNPA-KO-AS taGCGGCCGCttacgtattgacccagtgatt 
PfactinII-HA-S1 atCTGCAGgaacattcagatgaaatagaaga 
435 bp 
PfactinII-HA-AS1 taGGATCCgaaacattttctatgaacaatactag 
PfactinII-KO2-S1 atGGATCCgtgaagtctggtttggctgga 
381 bp 
PfactinII-KO2-AS1 taGCGGCCGCttaatatagggataagatggcttgtat 
PfWLP1-HA-S1 atCTGCAGtatgtcaaatcatactttaaccat 
417 bp 
PfWLP1-HA-AS1 taGGATCCaaaagccacaaacgccca 
PfWLP1-KO-S1 atGGATCCccgatataaataacataagctac 
404 bp 
PfWLP1-KO-AS1 taCGGCCGCttacatattatcactctctgaacagtt 
PfSR1-KO-S1 atGGATCCccaatttttaatgatggtaatgtt 
489 bp 
PfSR1-KO-AS1 taGCGGCCGCttacctctttgttatcacaaccgt 
PFE1265w-KO-S1 atGGATCCaaagaaagaaagaatagtattacc 
513 bp PFE1265w-KO-
AS1 
taGCGGCCGCttattccttttgattcttcggtgt 
Tab. 2.8: Primer pair combinations used for diagnostic PCR investigating the genotype of trans-
fected parasites and the expected lengths of PCR products. 5’ integr - 5’ region of gene locus 
modified by vector integration, 3’ integr. - 3’ region of modified locus, episome - detection of 
transfection plasmid, WT - detection of WT gene locus. 
Region of 
interest 
Oligonucleotid Sequence 
Product 
length 
PfCCp5-KO 
5’ integr. 
CCp5-KO-Integ5-S ggtgttatgtcgaagttcaatt 
598 bp 
pCAM-BSD/R caattaaccctcactaaag 
3’ integr. 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
656 bp 
CCp5-KO-Integ3-AS atacccttcataacgaataga 
Episome 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 773 bp 
pCAM-BSD/R caattaaccctcactaaag 
WT 
CCp5-KO-Integ5-S ggtgttatgtcgaagttcaatt 581 bp 
CCp5-KO-Integ3-AS atacccttcataacgaataga 
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Tab. 2.8 (continued) 
Region of 
interest 
Oligonucleotid Sequence 
Product 
length 
PfCCp5-HA1 
5’ integr. 
CCp5-HA-Integ5-S gcttctattcatgcaggt 
821 bp 
pCAM-comp-AS2 aacattaagctgccatatcc 
3’ integr. 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
748 bp 
CCp5-HA-Integ3-AS ttctatatgacgttggtg 
Episome 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 760 bp 
pCAM-comp-AS2 aacattaagctgccatatcc 
WT 
CCp5-HA-Integ5-S gcttctattcatgcaggt 815 bp 
CCp5-HA-Integ3-AS ttctatatgacgttggtg 
PfCCp5-HA2 
5’ integr. 
CCp5-HA-Integ5-S gcttctattcatgcaggt 
821 bp 
pCAM-comp-AS2 aacattaagctgccatatcc 
3’ integr. 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
703 bp 
CCp5-HA-Integ3-AS ttctatatgacgttggtg 
Episome 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 715 bp 
pCAM-comp-AS2 aacattaagctgccatatcc 
WT 
CCp5-HA-Integ5-S gcttctattcatgcaggt 
815 bp 
CCp5-HA-Integ3-AS ttctatatgacgttggtg 
PfFNPA-KO 
5’ integr. 
FNPA-KO-Integ5-S ggtaatgtatctacgcct 
699 bp 
pCAM-BSD/R caattaaccctcactaaag 
3’ integr. 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
828 bp 
FNPA-KO-Integ3-AS aatgatgatgcccaggag 
Episome 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
734 bp 
pCAM-BSD/R caattaaccctcactaaag 
WT 
FNPA-KO-Integ5-S ggtaatgtatctacgcct 
792 bp 
FNPA-KO-Integ3-AS aatgatgatgcccaggag 
 
Materials and Methods  51 
 
Tab. 2.8 (continued) 
Region of 
interest 
Oligonucleotid Sequence 
Product 
length 
PfactII-KO 
5’ integr. 
actIIKO-Integ5-S aatgtataaatactatggtagattt 
833 bp 
pCAM-BSD/R caattaaccctcactaaag 
3’ integr. 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
509 bp 
actIIKO-Integ3-AS acctgttgttcttcctgatg 
Episome 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
547 bp 
pCAM-BSD/R caattaaccctcactaaag 
WT 
actIIKO-Integ5-S aatgtataaatactatggtagattt 
795 bp 
actIIKO-Integ3-AS acctgttgttcttcctgatg 
PfactII-HA 
5’ integr. 
actIIHA-Integ5-S tttgcatgatttaattttatctga 
830 bp 
pCAM-comp-AS2 aacattaagctgccatatcc 
3’ integr. 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
614 bp 
actIIHA-Integ3-AS aacatgaattagccaaatatac 
Episome 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
625 bp 
pCAM-comp-AS2 aacattaagctgccatatcc 
WT 
actIIHA-Integ5-S tttgcatgatttaattttatctga 
819 bp 
actIIHA-Integ3-AS aacatgaattagccaaatatac 
PfWLP1-KO 
5’ integr. 
PfWLP1-KO-Integ5-S gggttccaagaagtacatcaa 
693 bp 
pCAM-BSD/R caattaaccctcactaaag 
3’ integr. 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
813 bp 
PfWLP1-KO-Integ3-AS acaccatctcctccacctga 
Episome 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
570 bp 
pCAM-BSD/R caattaaccctcactaaag 
WT 
PfWLP1-KO-Integ5-S gggttccaagaagtacatcaa 
939 bp 
PfWLP1-KO-Integ3-AS acaccatctcctccacctga 
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Tab. 2.8 (continued) 
Region of 
interest 
Oligonucleotid Sequence 
Product 
length 
PfWLP1-HA 
5’ integr. 
PfWLP1-HA-Integ5-S aacaaattagaacccacatggtc 
614 bp 
pCAM-comp-AS2 aacattaagctgccatatcc 
3’ integr. 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
875 bp 
PfWLP1-HA-Integ3-AS ttccaggaggaactccagtg 
Episome 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
607 bp 
pCAM-comp-AS2 aacattaagctgccatatcc 
WT 
PfWLP1-HA-Integ5-S aacaaattagaacccacatggtc 
822 bp 
PfWLP1-HA-Integ3-AS ttccaggaggaactccagtg 
PfSR1-KO 
5’ integr. 
SR1-KO-Integ5-S acatacacagatttgccttg 
650 bp 
pCAM-BSD/R caattaaccctcactaaag 
3’ integr. 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
746 bp 
SR1-KO-Integ3-AS ctcttcctcctcttcc 
Episome 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
655 bp 
pCAM-BSD/R caattaaccctcactaaag 
WT 
SR1-KO-Integ5-S acatacacagatttgccttg 
784 bp 
SR1-KO-Integ3-AS ctcttcctcctcttcc 
PFE1265w-KO 
5’ integr. 
1265wKO-Integ5-S tctttacgatgggtgatg 
838 bp 
pCAM-BSD/R caattaaccctcactaaag 
3’ integr. 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
1218 bp 
1265wKO-Integ3-AS gagctgggaaatagactagat 
Episome 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
679 bp 
pCAM-BSD/R caattaaccctcactaaag 
WT 
1265wKO-Integ5-S tctttacgatgggtgat 
1377 bp 
1265wKO-Integ3-AS gagctgggaaatagactagat 
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Tab. 2.9: Sequence of oligonucleotides (5’ – 3’ orientation). Recognition sites of restriction 
endonucleases are shown as capitals, stop codons are underlined. 
Oligonucleotide Sequence 
Oligonucleotides for generation of recombinant proteins 
PfWLP1-rp2-S1 atGGATCCatgatagacctaaattatgttaaattg 
PfWLP1-rp2-Not-AS taGCGGCCGCttatcgtattagtggtttgtttaagca 
PfWLP1-rp2-Pst-AS taCTGCAGttatcgtattagtggtttgtttaagca 
Oligonucleotides for RT-PCR 
PfactinI-RT2-S aatgtaaaagcaggagttgca 
PfactinI-RT2-AS catcctctcacgatttccttttgg 
PfactinII-RT2-S gcatcaggaagaacaacag 
PfactinII-RT2-AS atttcttctatttcatctgaatg 
PfCCp1-RT3-S ctggtatggaccattatgttggg 
PfCCp1-RT3-AS cgaaattacagaagaatcaacaccatg 
PfCCp2-RT2-S tcggatggagaatccgtt 
PfCCp2-RT2-AS gtatcccatgtcttgtga 
PfCCp3-RT2-S gccctcatgaaacacatgatg 
PfCCp3-RT2-AS cacatctcctgttgtcgc 
PfCCp4-RT1-S atgcccgaacaaatcatt 
PfCCp4-RT1-AS tgctgaggcgcatatact 
PfCCp5-RT1-S ggttcgcgcgattgggat 
PfCCp5-RT1-AS ttttccgcacacagaatc 
PfFNPA-RT3-S cgctggattcagtggtaataacc 
PfFNPA-RT3-AS ccgtattggtctttattggag 
Pf39-RTPCR-1S cttgaacaccatgatgta 
Pf39-RTPCR-1AS tccactttcatgagcagg 
Pfmyo-A-RT1-S cgtattcagacagcaataatggc* 
Pfmyo-A-RT1-AS tcctccttctggttcaattcttg* 
Pfmyo-B-RT1-S gggtggtaaatctaattgtagt*g 
Pfmyo-B-RT1-AS ctgattcaattataattccttcc* 
PfmyoC-RT1-S ggtaataatacgcatgatgatc*c 
PfmyoC-RT1-AS gagtaacaacttattcgacatcg* 
PfmyoD-RT1-S agcacaacaaggttcagggtattag 
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Tab. 2.9 (continued) 
Oligonucleotide Sequence 
PfmyoD-RT1-AS gtttatacttaattttgttccttcc 
PfmyoE-RT1-S atatctataagcaagaaggattgg 
PfmyoE-RT1-AS ttcccatttgtatcataatcataag 
PfmyoF-RT1-S aaatataataaattcggcaaagt 
PfmyoF-RT1-AS ttacattgtttggtcctatcac 
GAP45-RT1-S attatgcaactcaagaaaataaatc 
GAP45-RT1-AS tcaataaaggtgtatcggataaatc 
GAP50-RT1-S taaggatacaaaaggtcagatattg 
GAP50-RT1-AS ggtccacttgatactgtaaaatg 
Pfaldo-RT1-S tagatggattagcagaaagatgc 
Pfaldo-RT1-AS agaaaccaacatcttgagtagtgg 
MTIP-RT1-S tagtggtgggaaaataagtatagac 
MTIP-RT1-AS aaggcattaagagcatctatgg 
PfAMA1-RT-1S ggattatgggtcgatgga 
PfAMA1-RT-1AS gatcatactagcgttctt 
Oligonucleodites for generation of Southern blot probes 
CCp5-SB-S atCTGCAGccaaatagttattccattgta 
CCp5-SB-AS atCTGCAGccaaatagttattccattgta 
FNPA-SB-S gcaacatctctaagtgatactgg 
FNPA-SB-AS tggtatccctgtgtccca 
Vector-specific oligonucleotides 
pGEX-S tggacccaatgtgcctgg 
pGEX-AS acgtgactgggtcatggc 
pIH-S ggtcgtcagactgtcgatgaagcc 
pIH-AS2 cctcttcgctattacgccagc 
pCAM-BSD/F tattcctaatcatgtaaatcttaaa 
pCAM-BSD/R caattaaccctcactaaag 
pCAM-comp-AS2 aacattaagctgccatatcc 
*Oligonucleotides as in Chaparro-Olaya et al. 2005 
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2.1.11 PlasmoDB gene identifiers 
The proteins investigated in this work as well as the identifiers of the encoding genes 
according to the PlasmoDB database are listed in Tab. 2.10. 
Tab. 2.10: Gene products investigated in this work and their gene identifiers of the database 
PlasmoDB (http://plasmodb.org/plasmo/). 
Name of encoded protein Gene ID Previous Gene ID 
PfactinI PF3D7_1246200 PFL2215w  
PfactinII PF3D7_1412500 PF14_0124  
PfAMA1 PF3D7_1133400 PF11_0344 
PfCCp1 PF3D7_1475500 PF14_0723 
PfCCp2 PF3D7_1455800 PF14_0532 
PfCCp3 PF3D7_1407000 PF14_0067 
PfCCp4 PF3D7_0903800 PFI0185w 
PfCCp5 PF3D7_0109100 PFA0445w 
PfFNPA PF3D7_1451600 PF14_0491 
PfEXP-1 (CRA) PF3D7_1121600 PF11_0224 
Pfg377 PF3D7_1250100 PFL2405c 
PfGAP50 PF3D7_0918000 PFI0880c  
PfMR5 (Pfs230p) PF3D7_0208900 PFB0400w 
Pfpeg3 (MDV1) PF3D7_1216500 PFL0795c 
Pfpeg4 (ETRAMP10.3) PF3D7_1016900 PF10_0164 
Pfs16 PF3D7_0406200 PFD0310w 
Pfs25 PF3D7_1031000 PF10_0303 
Pfs28 PF3D7_1030900 PF10_0302 
Pfs230 PF3D7_0209000 PFB0405w 
Pfs47 PF3D7_1346800 PF13_0248 
Pfs48/45 PF3D7_1346700 PF13_0247 
α-tubulin II PF3D7_0422300 PFD1050w 
Pf39 (PfERC) PF3D7_1108600 PF11_0098 
PfWLP1 PF3D7_1443400 PF14_0412 
PfSR1 PF3D7_1131100 PF11_0321 
G-protein coupled receptor, puta-
tive 
PF3D7_0525400 
PFE1265w 
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2.1.12 Plasmids 
For the generation of gene disruptant mutants of 
was employed. In order to obtain parasites expressing a gene of interest fused to the 
sequence encoding a double hemagglutinin (HA) tag, parasites were transfected with the 
pCAM-BSD-HA plasmid. These plasmids contain the 
that encodes a blasticidin S deaminase conferring resistance to Blasticidine S (Mamoun 
et al., 1999). Both pCAM
Christian Doerig (Melbourne, Australia). For the generation of antisera via 
tion of mice with inclusion bodies or recombinant protein, the expression vectors 
pGEX-4T-1 and pIH902 (the latter kindly provided by Prof. Kim Williamson, Chicago) 
were used. Before insertion into the final vector, PCR products were subcloned into
pGEM-T-Easy vector. Maps of the vector backbones are listed in appendix
 8.4.  
2.1.13 DNA- and protein ladders
The protein molecular weight standards Page Ruler
Page RulerTM Plus Prestained Protein Ladder (
Scientific GmbH (Schwerte, formerly Fermentas GmbH)
ladder were applied per gel lan
the Spectra™ Multicolor High Range Protein Ladder
dard (Fisher Scientific GmbH, Schwerte
Fig. 2.1: The protein molecula
(http://www.thermoscientificbio.com/nucleic
ladders, accessed 11 May 11, 2013).
As DNA marker the 1kb DNA Ladder and 100
furt/Main) were used (Fig. 
ladder were applied.  
 
P. falciparum the pCAM
BSD gene of 
-BSD and pCAM-BSD-HA were kindly provided by Prof. 
 
TM Prestained Protein Ladder and 
Fig. 2.1) were purchased from Fisher 
. 5 µl of the respective protein 
e. For high molecular weight proteins 10
 served as molecular weight sta
). 
r weight standards used for SDS
-acid-purification-and-electrophoresis/protein-electrophoresis/protein
 
 bp DNA Ladder by NEB GmbH (Fran
2.2). Depending on the size of the gel pockets 4
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-BSD vector 
Aspergillus terreus 
immuniza-
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, Fig. 8.1 –
 µl per lane of 
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-PAGE. 
-
k-
-10 µl of the 
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Fig. 2.2: The 1 kb DNA Ladder (
furt/Main) which were used for agarose gel electrophoresis (NEB) 
ducts/n3232-1-kb-dna-ladder, https://www.neb.com/products/N3231
2013). 
2.1.14 Computer programs and online tools
 CorelDraw® Graphics Suite X4
 BioEdit sequence alignment editor version 7.1.
 NCBI BLAST (http://blast.ncbi.nlm.nih.gov/) 
 GraphPad Prism 5
 Zeiss LSM Image Browser Version 4,2,0,121
 ImageJ 1.45  
 Melting Temperature (T
 Tm Calculator Phusion polymerase 
(http://www.finnzymes.fi/tm_determination.html)
 Primer3 version 0.4.0 (http://frodo.wi.mit.edu/)
 PlasmoDB (http://plasmodb.org/plasmo/)
 SMART (http://smart.embl
 Microsoft® Office 2002, Microsoft® Office 2007
2.2 Cell biological methods
2.2.1 Culturing of Plasmodium falciparum
Continuous cultures 
Culturing of P. falciparum
Vanderberg (1981). Continuous parasite cultures were maintained in small cell culture 
flasks (25 cm²) in 5 ml pre
dium was changed daily followed by gassing the culture with 5
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A) and 100 bp DNA Ladder (B) by NEB GmbH (Fran
(https://www.neb.com/pro
-100-bp-DNA-Ladder, accessed 11 May 11, 
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(Westfalen AG, Münster) for 10 sec. When a parasitemia of approximately 2 % was 
reached, continuous cultures were diluted in order to avoid density stress that can lead 
to growth inhibition or formation of sexual parasite stages (Stephens and Christophers, 
1908). Dilution was carried out at a ratio of 1:5 to 1:12 by transferring the infected cul-
ture to a new cell culture flask filled with fresh medium and human RBCs. At the day 
after passaging no medium exchange was carried out. Instead flasks were shaken care-
fully in order to redistribute cells. Wild-type parasites were grown in RPMI medium 
containing heat-inactivated human serum of the blood type A+. Media for culturing KO 
parasites were supplemented with the respective substance which has been used for se-
lection of transfected parasites. 
Gametocyte cultures 
Gametocyte cultures were set up by adding 2 – 4 ml of a continuous culture to a 75 cm² 
cell culture flask filled with 20 ml of medium and RBCs at a hematocrit of 5 %. As for 
the continuous cultures at the day after passaging, instead of changing medium, flasks 
were shaken to redistribute cells. Spent medium was aspirated daily and replaced with 
15 – 20 ml fresh medium. To avoid gamete formation upon cooling, gametocyte cultures 
were kept at 37°C on a slide stretching table and only medium pre-warmed to 37°C was 
used for these cultures. Induction of gametocyte formation was induced by applying 
stress to a culture of a parasitemia > 5 % containing mainly ring stages. As described by 
Fivelman et al. (2007) spent medium was removed only partially and replaced by an 
accordant amount of fresh medium. Alternatively, gametocytogenesis was induced by 
applying stress by low hematocrit as described by Buchholz et al., 2011. In order to 
obtain gametocyte cultures devoid of asexual blood stages, cultures containing gameto-
cytes of stage II – III were grown in medium containing 50 mM GlcNAc for two to three 
days. GlcNAc has been reported to kill trophozoites and schizonts (Ponnudurai et al., 
1982). 
Cryopreservation of cultures  
Only cultures of a parasitemia > 2 % with > 50 % ring stages were frozen for long term 
storage because other parasite stages would be harmed by the freezing and thawing pro-
cedures. A 5 ml culture was transferred to a 15 ml reaction tube and pelleted by centrifu-
gation at 470 x g for 5 min. The cell pellet was resuspended in 1.2 ml glycerolyte solu-
tion, shifted to a 2 ml cryotube and incubated for 5 min at RT. The culture then was fro-
zen at 80°C for long-term storage. 
Thawing cultures 
The frozen parasite culture was rapidly thawed and subsequently transferred to a 15  ml 
reaction tube. The following solutions were added slowly in order to avoid an osmotic 
shock of the cells when incubating in decreasing salt concentrations. Centrifugation 
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steps were carried out at 470 x g for 5 min. Firstly, 200 µl of a 12 % NaCl solution were 
added dropwise followed by incubation for 5 min at RT. The cell suspension was then 
dropwise supplemented with 10 ml of a 1.6 % NaCl solution. After centrifugation the 
supernatant was removed and the cell pellet was cautiously resuspended in 10 ml of 
0.2 % Glucose/ 0.9 % NaCl solution. Cells were pelleted by centrifugation and the su-
pernatant was aspirated. Lastly, the cell pellet was resuspended in 5 ml RPMI 1640 
complete A+ medium, transferred to a 25 cm² cell culture flask and cultivated as above. 
From day 3 after thawing on, growth of parasites was monitored by preparing blood 
smears. As soon as the parasitemia was sufficient, 1 – 2 vials of the culture were frozen 
to maintain the stock of cryopreserved cultures. KO cultures carrying a blasticidin-
resistance gene were immediately taken up in blasticidin medium, whilst other KO pa-
rasite lines were kept in A+ medium after thawing. Drug pressure was only started when 
a parasitemia of ≥ 2 % was reached. 
Synchronization 
To obtain synchronized parasite cultures, a culture containing young ring stages at > 5 % 
was pelleted and subsequently dissolved in 5 % sorbitol/ ICM. The cell suspension was 
kept for 10 min at room temperature. After centrifugation (470 x g, 5 min) the cells were 
washed once with RPMI complete medium. Thereafter, cells were resuspended in com-
plete medium and transferred to a fresh culturing flask. After sorbitol treatment the cul-
ture almost exclusively contained ring stages (Lambros and Vanderberg, 1979). If a 
highly synchronized culture was required as for isolation of schizonts, the procedure 
was repeated after 4 h. 
2.2.2 Monitoring parasite growth via Giemsa-stained blood smears and 
test for exflagellation 
Parasitemia and condition of continuous parasite cultures was controlled thrice per week 
via thin blood smears. Approximately 100 µl of the culture were pelleted by centrifuga-
tion at 3 400 x g. Upon removal of the supernatant the pellet was resuspended in an equal 
volume of medium as compared to pellet size. A small drop of the cell suspension was 
transferred onto a glass microscope slide and spread with a second glass slide held in a 
45° angle by a single smooth movement. The thin film was allowed to air-dry and fixed 
with methanol. The slide was air-dried again followed by staining in Giemsa dye bath 
for 15 min which was prepared by 1:25 dilution of the Giemsa stock solution in Giemsa 
buffer. By rinsing the slide with dH2O residual staining solution was removed. Blood 
smears were viewed at 1 000 x magnification using an oil immersion objective.  
The stage of maturation of gametocyte cultures was examined twice a week via Giemsa-
stained thin blood smears. The ability of mature gametocyte cultures to undergo game-
togenesis was tested via induction of exflagellation of male gametocytes. Depending on 
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culture density, 100 – 500 µl of the culture were taken off and xanthurenic acid was add-
ed to a final concentration of 20 µM. After incubation at RT for 15 min the sample was 
placed onto a microscope slide and covered with a cover slip. Exflagellation was moni-
tored light microscopically at 400 x magnification. 
2.2.3 Gametocyte purification 
Gametocytes were isolated via density gradient centrifugation with Percoll, a sol of sili-
ca particles coated with polyvinylpyrrolidone (Pertoft et al., 1978). The gradient was 
prepared as described by Kariuki et al. (1998), with the exception that it only consisted 
of three layers. A 15 ml reaction tube was filled with 2 ml of 65 % and 50 % and 4 ml of 
35 % Percoll dilutions, respectively. All solutions and disposable material used during 
gametocyte purification were preheated to 37°C. Furthermore, gametocytes were kept at 
37°C during purification process in order to avoid early gamete formation. Firstly, ga-
metocyte cultures were pelleted (1 000 x g for 5 min) and washed once in 10 ml ICM. 
The cell pellet then was resuspended in 1.2 ml ICM and layered on top of the Percoll 
gradient. Cells were separated via centrifugation at 470 x g for 10 min. Gametocytes 
were collected from the 35 %/ 50 % Percoll interface and transferred to a new test tube. 
After one more washing step, gametocytes were frozen at 20°C either as cell pellet or 
in an appropriate buffer. If necessary for downstream applications, the number of iso-
lated gametocytes was determined using a Neubauer chamber and a thin smear was pre-
pared to assess maturation level and composition of isolated parasite material.  
2.2.4 Transfection of Plasmodium falciparum 
P. falciparum parasites were transfected with plasmid constructs based on pCAM-BSD-
KO and pCAM-BSD-2 x HA vectors in order to generate either gene-disruptant parasite 
lines or parasite lines with the gene of interest fused to the DNA sequence encoding a 
double HA-tag (see 2.1.12, appendix, Fig. 8.4). The KO plasmids constructs were gen-
erated by introducing a fragment homologous to the 5’ region of the respective gene, 
omitting the start codon, into the multiple cloning site of the pCAM-BSD-KO vector. 
Plasmids used for generation of HA-fusion proteins contained a region homologous to 
the 3’ end of the gene of interest omitting the stop codon. Oligonucleotides used for 
amplification of gene fragments and sizes of PCR products are listed in Tab. 2.7. 
The transfection protocol was adapted from Wu, 2008 and Cowman et al., 2008. A syn-
chronized culture was split two days before transfection and freshly isolated human 
erythrocytes of blood group A+ were added. The culture was kept under slow agitation 
until the day of transfection to avoid double infections of red blood cells. Only cultures 
at a parasitaemia of ≥ 5 % with mainly ring stages were used for transfection. Parasite 
cultures were supplied with fresh medium and allowed to rest for at least one hour. Then 
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4 – 5 ml the culture was pelleted at 4°C and washed once with cold cytomix buffer (Wu 
et al., 1995). 60 µg of plasmid DNA were resuspended in cold cytomix buffer to a final 
volume of 400 µl. The plasmid solution was added to the pellet. The resuspended in-
fected RBCs were transferred to a pre-cooled 0.2 cm electroporation cuvette. Cells were 
electroporated at a voltage of 0.310 kV and a capacity of 950 µF, with a time constant 
between 10 – 13 msec. Immediately 500 µl of medium were added and the cuvette was 
kept on ice for 5 min. Next, the infected RBCs were transferred to a 25 cm³ cell culture 
flask supplied with 5 ml complete medium and erythrocyte concentrate at a hematocrit 
of 5 % for cultivation. Approximately 4 – 6 h after transfection drug pressure was in-
itiated by adding blasticidin medium. Thereby only parasites carrying the transfection 
plasmid containing the blasticidin resistance cassette will survive selection process. As a 
control parasites were electroporated after addition of cytomix buffer devoid of plasmid 
DNA. This control culture was split 4 – 6 h after transfection into two cultures, of which 
one was exposed to drug pressure, the other one was further cultivated in complete me-
dium lacking blasticidin. From the day after the transfection onwards medium was ex-
changed daily and 50 µl of RBC concentrate was added once per week. Growth of trans-
fectants was monitored via Giemsa-stained blood smears. Approximately 3 days after 
transfections no parasites were visible. First parasites resurged after 2 – 10 weeks. Once 
a parasitemia of 2 % was reached, cultures were split. Aliquots were frozen for cryopre-
servation regularly. Genomic DNA was isolated on a regular basis in order to examine 
integration of the plasmid into the gene locus of interest (see 2.3.15). Stably transfected 
parasites were observed after 5 – 31 weeks post transfection. 
2.2.5 Obtaining clones via limiting dilution and detection of clones by 
Malstat assay 
Cultures of transfectants were split and incubated under agitation two days before dilu-
tional cloning. Total cell number per ml was determined using a Neubauer chamber. 
After determination of the parasitemia the number of infected RBCs per ml was calcu-
lated. The culture was diluted in 25 ml of ICM in three sequential steps to obtain a para-
site concentration of 50 – 200 parasites per ml. A last dilution was carried out to obtain 
12 parasites in 38.4 ml complete BSD medium containing 5 % RBCs. 200 µl of the sus-
pension were transferred to each well of a 96-well plate, thus distributing 12 parasite-
infected RBCs per 96-well plate. For each transfectant 2 96-well plates were set up. 
Every other day medium was exchanged. Gassing of the incubation chamber with 5  % 
CO2/ 5 % O2/ N2 was carried out daily. Every third time of medium change 1 % RBC 
concentrate was added. 
After approximately three weeks the presences of parasite clones was tested by means 
of Malstat assay. This assay measures the activity of the Plasmodium lactate dehydro-
genase and can detect parasites at a parasitemia as low as 0.2 % (Makler et al., 1998). 
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20 µl cell suspension per well were transferred into a new 96-well plate and 100 µl of 
the Malstat reagent were added per well. Then, 20 µl of a mixture of diaphorase and 
NBT (0.5 mg/ml each) was pipetted into each well. After 30 – 50 min under agitation 
medium of wells containing parasites turned purple due to the reduction of NBT. For 
detection of parasite clones at low parasitemia that did not result of in an obvious color 
change optical density was determined spectrophotometrically at a wavelength of 
630 nm. Cells from wells tested positive were transferred into 25 cm² cell culture flasks 
and cultivated as described above (see 2.2.1). Once a parasitemia of 2 % was reached, 
cultures were split and aliquots were frozen for cryopreservation. Genomic DNA was 
isolated in order to confirm absence of parasites with WT genotype (see 2.3.15). 
2.2.6 Indirect Immunofluorescence Assay 
Methanol fixation 
Indirect immunofluorescence assays (IFAs) were carried out to investigate presence and 
subcellular localization of proteins of interest by means of antisera. Blood stage para-
sites, gametes and zygotes resuspended in cell culture medium were applied to the wells 
of teflon coated microscope slides resulting in a single layer of cells. To obtain gametes 
and zygotes, cultures of mature gametocytes were activated by addition of XA at a final 
concentration of 20 µM. Gametes were applied to teflon coated slides 30 min post acti-
vation, zygotes after approximately 16 h. For ookinete preparations mosquito midguts 
were isolated 24 h after a bloodmeal on gametocyte-infected RBCs via membrane feeds 
(see 2.5.2). Midguts were resuspended in PBS and applied to teflon coated slides. Para-
site preparations were air dried followed by fixation in methanol for 10 min at 80°C. 
Slides were stored at 20°C or processed directly after fixation. Samples were incubated 
for 30 min in 0.5 % BSA/ 0.01 % saponin/ PBS followed by a 30 min incubation in 
0.5 % BSA/ 0.01 % saponin/ PBS containing 1 % neutral goat serum in order to permea-
bilize cells and to block unspecific antisera binding sites. Subsequently the primary an-
tiserum in 0.5 % BSA/ 0.01 % saponin/ PBS was added and incubated for 1.5 h at 37°C. 
After washing of the slides with 0.5 % BSA/ 0.01 % saponin/ PBS for 2 x 5 min the sam-
ples were incubated with secondary antibodies in 0.5 % BSA/ 0.01 % saponin/ PBS for 
1 h at 37°C. During this step and further steps slides were incubated protected from light 
due to the light sensitivity of the fluorochrome coupled secondary antibody. After wash-
ing in PBS for 2 x 5 min erythrocytes were counterstained with 0.01 % Evans Blue in 
PBS for 1 min except when using Alexa Fluor 594 coupled secondary antibody. After 
two further washing steps (2 x 10 min in PBS) parasites DNA was stained with Hoechst 
nuclear stain (1:5000 in PBS) for 1 min. The slides were washed once and anti-fading 
medium was added to the wells. Preparations were covered with a cover slip, which was 
sealed with nail polish. Slides were examined with the confocal laser scanning micro-
scope LSM 510 by Zeiss. For storage slides were kept at 4°C. 
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Paraformaldehyde fixation 
Paraformaldehyde (PFA) fixation method was employed to achieve a better preservation 
of cellular structures, as needed for protein co-localization studies. 1 ml of a gametocyte 
culture was centrifuged (2 min at 1 600 x g). The cell pellet was resupended in 4 % 
PFA/ PBS and fixation was carried out overnight at 4°C. Cells were washed twice with 
sterile-filtered PBS and either processed directly or stored up to several days at 4°C. 
The following incubation steps were carried out with minor modifications according to 
Tonkin et al., 2004. Incubation was carried out in 1.5 ml reaction tubes under rotating 
conditions at room temperature. Cells were centrifuged at 1 500 x g for 1 min between 
incubation steps. Firstly, cells were permeabilized for 10 min in 0.1 % Triton X-
100/ PBS. After washing twice, cells were blocked 30 min in 3 % BSA/ PBS and further 
30 min in 3 % BSA/ PBS containing 1 % neutral goat serum. Incubation with primary 
antibody in 3 % BSA/ PBS was carried out for 2 h. After washing (3 x 10 min), iRBCs 
were incubated for 1 h with the secondary antibody in a 1:1 000 dilution in 3 % 
BSA/ PBS. Subsequently, cells were washed (3 x 10 min) and stained with a 1:2 500 di-
lution of Hoechst in PBS. After rinsing of cells in PBS for 5 min, cells were pelleted, 
resuspended in PBS and the suspension was applied to poly-L-lysine coated slides in a 
single cell layer. Slides were dried at 37°C and subsequently covered with anti-fading 
mounting medium. A cover slip was placed on the slide and sealed with nail polish. 
Slides were examined with the confocal laser scanning microscope TCS SP1 by Leica. 
Slides were kept at 4°C for long term storage. 
2.2.7 Transmission electron microscopy 
For the investigation of the ultrastructure of gametocytes parasite samples were embed-
ded in epoxy resin (Epon) which allowed the preparation of ultra-thin sections. Pelleted 
parasites were fixed with 1 % glutaraldehyde/ 4 % PFA in PBS for 1 – 16 h at 4 °C. Spe-
cimens were washed 2 x 30 min with PBS at room temperature and subsequently post-
fixed and contrasted in 1 % OsO4/ 1.5 % K3Fe(CN)6/ PBS for 2 h. After washing twice 
with MQH2O cells were incubated in 0.5 % uranyl acetate for 1 h at room temperature. 
After two further washing steps samples were dehydrated by applying increasing con-
centrations of ethanol. In detail, 2 x 15 min of incubation were carried out in 70 %, 80 %, 
95 % and 100 % of ethanol, respectively. The samples were incubated in propylene 
oxide for 2 x 30 min. Propylene oxide then was replaced by a 1:1 mixture of propylene 
oxide and Epon. After 1 h of incubation the mixture was removed after centrifugation 
and Epon was added. Epon was exchanged after 16 h followed by polymerization for 
two days at 60°C. Cutting of ultra-thin sections and post-contrastation were carried out 
by the electron microscopy team of Prof. Georg Krohne at the Biocenter of the Univer-
sity of Würzburg. Specimens were examined and documented by means of a Zeiss 
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EM10 transmission electron microscope. Scanned images were processed using Corel 
PHOTO-PAINT X4. 
2.2.8 Exflagellation assays 
The effects of potential inhibitors or activators of gametogenesis were investigated via 
exflagellation assays. In these in vitro bioassays the formation of male gametes via ex-
flagellation was studied. Depending on the cell density 100 – 500 µl of a gametocyte cul-
ture were used per sample investigated. In most cases gametocytes were incubated with 
potentially inhibiting substances prior to induction of gametogenesis for 15  min at 37°C. 
Inhibitors were added directly into the cell culture medium. Alternatively, the culture 
aliquot was centrifuged (3 000 x g, 15 – 30 s) and the substance of interest dissolved in 
ICM, pH7.4 was added. After pre-incubation the sample was centrifuged (3 000 x g, 15 –
 30 s) and the cell pellet was resuspended in 10 – 20 µl of the substance in PBS or ICM, 
pH 7.4 and 10 µM XA followed by incubation at room temperature for 15 min. 10 – 15µl 
of the sample were transferred to a microscopic slide, covered with a cover slip and eva-
luated microscopically at 400 x magnification. For each sample the number of exflagel-
lation centers for 30 visual fields was determined. For each test condition three inde-
pendent samples were investigated, if not otherwise indicated. Samples were taken off 
individually, gassing the gametocyte culture after each withdrawal of a sample. Alterna-
tively, samples for each test condition were taken off at once and samples were stored at 
37°C until used. In this case, a positive control was tested before and after all additional 
samples to confirm stable condition of the parasites. 
Preparation of RBC homogenate 
To investigate the uptake of XA by non-infected RBCs the latter were incubated with 
XA under different conditions. 1.5 ml of RBC concentrate per sample were centrifuged, 
the supernatant was removed and cells were resuspended in 4 ml PBS containing the 
substances to be investigated, e. g. XA at different concentrations or XA combined with 
potential inhibitors. Pre-incubation with inhibitors was carried out at 37°C. After incu-
bation with XA at room temperature the incubation solution was diluted with ice-cold 
PBS ad 50 ml and centrifuged (1 260 x g, 5 min, at 4°C). The RBC pellet was washed 4 
times with PBS to remove residual extracellular XA. The pellet was finally resuspended 
in 750 µl PBS. The cell suspension (referred to as XA-RBCH, homogenated of XA-
incubated RBCs) was sonicated (2 min 50 % intensity; 50 % duty cycle) on ice. Cell de-
bris was pelleted by centrifugation (5 min, 15 500 x g) and the cell lysate was further 
cleared by filtration through a 0.22 µm syringe (referred to as XA-RBCF). The ability of 
XA-RBCF to induce gametogenesis was investigated via exflagellation assays. 10 – 20 
µl of the XA-RBCF were added to the pelleted gametocyte culture and incubated for 
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15 min at room temperature. Handling of gametocyte culture and microscopically evalu-
ation were carried out as described above. 
The composition of stock solutions, working concentrations and literature values for 
working concentrations of published inhibitors of transport proteins are listed in 
Tab. 8.1 (Appendix). Data for other substances used in the study of gametocyte activa-
tion/ XA uptake by RBCs are listed in Tab. 8.2 (Appendix). 
When producing XA-RBCH for ultracentrifugation cells were ruptured via three freez-
ing/thawing cycles and passaging through a 26 g injection needle. Samples were centri-
fuged to remove debris. Thereafter the lysate was centrifuged 25 min at 50 000 rpm. The 
pellet fraction was washed two times with PBS (50 000 rpm, 30 min). 
2.3 Molecular biological methods 
2.3.1 Polymerase chain reaction 
The polymerase chain reaction (PCR) was used for to amplify DNA fragments of genes 
of interest, which subsequently were cloned into an appropriate DNA plasmid for 
downstream applications such as production of inclusion bodies and recombinant pro-
teins or the generation of transfection plasmids. For these purposes the Phusion High 
Fidelity DNA Polymerase was chosen due to its high proofreading capacity as well as 
its high fidelity. Genomic DNA obtained from mixed asexual parasite stages served as 
template (see 2.3.15). 
Tab. 2.11: Composition of PCRs using Phusion polymerase. 
Component Final concentration Volume 
5 x Phusion HF Buffer 1 x 10 µl 
dNTPs (10 mM) 200 µM 1 µl 
Sense primer (100 µM) 1 µM 0.5 µl 
Antisense primer(100 µM)  1 µM 0.5 µl 
DNA template (100 ng/µl) 2 ng/µl 1 µl 
Phusion DNA Polymerase 0.2 U/µl 0.5 µl 
Autoclaved MQH2O  36.5 µl 
Total volume 50 µl 
The primer annealing temperature was calculated as suggested by the internet-based 
tool provided by the manufacturer. The annealing temperature for Phusion PCRs is 
about 5°C higher than that determined for other polymerases. As recommended by the 
manufacturer for primers > 20 nucleotides an annealing temperature of Tm + 3°C of the 
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lower Tm of both primers was used. For primers ≤ 20 nucleotides an annealing tempera-
ture equal to the lowest calculated Tm was used. The composition of ingredients of the 
PCR is listed in Tab. 2.11. The program used for amplification of DNA fragments em-
ploying fusion polymerase is depicted in Tab. 2.12.  
Tab. 2.12: PCR program for Phusion polymerase. 
Reaction step Temperature Duration Number of cycles 
Initial denaturation 98°C 30 s 1 
Denaturation 98°C 10 s 
33 Annealing as calculated 30 s  
Elongation 72°C 30 s/ kb 
Final elongation 72°C 5 min 1 
Storage 12°C ∞ – 
For diagnostic PCRs aiming at investigation of modified gene loci (see 2.2.4) as well as 
for colony PCRs (see 2.3.8) the GoTaq polymerase was used. The following reaction 
composition and PCR program was applied (Tab. 2.13, Tab. 2.14). For difficult PCR 
primer combinations which did not result in any PCR product a modified version of the 
L60 PCR program (Kim Williamson, Chicago) was used. In this program a lower tem-
perature for primer extension is used which improves amplification of templates with 
high A + T content (Tab. 2.15, Su et al., 1996). 
Tab. 2.13: Composition of PCRs using GoTaq DNA polymerase. 
Component Final concentration Volume 
5 x GoTaq Flexi Green Buffer 1 x 10 µl 
MgCl2 (25 mM) 2 mM 4 µl 
dNTPs (10 mM) 200 µM 1 µl 
Sense primer (100 µM) 1 µM 0.5 µl 
Antisense primer(100 µM)  1 µM 0.5 µl 
DNA template (100 ng) 2 ng/µl XY µl 
GoTaq DNA polymerase (5 U/µl) 0.025 U/µl 0.25 µl 
autoclaved MQH2O - ad 50 µl 
The annealing temperature for the primers of the PCR reaction was determined from the 
melting temperature (Tm) of the respective oligonucleotides which was obtained from 
the internet-based tool “Melting Temperature (Tm) Calculation”. The annealing temper-
ature was chosen approximately 3°C below the calculated melting temperature in order 
to ensure efficient hybridization of the primers to the PCR template. Only the part of the 
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primer sequence which was complementary to the gene of interest was used for the cal-
culations omitting additional nucleotides like restriction sites. Amplification of the de-
sired PCR product was examined via agarose gel electrophoresis (see 2.3.2). Prior to 
further usage the PCR amplified DNA fragments were purified as described in 2.3.4. 
Tab. 2.14: PCR program for GoTaq polymerase. 
Reaction step Temperature Duration Number of cycles 
Initial denaturation 95°C 2 min 1 
Denaturation 95°C 40 s 
33 Annealing as calculated 50 s  
Elongation 72°C 1 min/ kb  
Final elongation 72°C 5 min 1 
Storage 12°C ∞ – 
 
Tab. 2.15: Modified version of L60 PCR program for GoTaq polymerase. 
Reaction step Temperature Duration Number of cycles 
Initial denaturation 94°C 5 min 1 
Denaturation 94°C 40 s 
35 Annealing 40°C 50 s  
Elongation 60°C 3 min  
Storage 12°C ∞ – 
2.3.2 Agarose gel electrophoresis 
Agarose gel electrophoresis allows the separation of DNA fragments of a size ranging 
from 0.5 – 25 kb. Depending on the size of the PCR products that were to be analyzed 
0.8 – 2 % agarose in TAE buffer was prepared. The voltage applied was 5 – 7 V/cm (dis-
tance between electrodes). Approximately 10 µl of GoTaq amplified PCR products were 
loaded directly into the gel slots, since the reaction buffer already contained loading 
buffer. Phusion polymerase amplified PCR products were diluted in MQH2O and sup-
plied with 6 x loading dye. After separation of DNA fragments agarose gels were 
stained in ethidium bromide solution (0.5 µg/ml) for 15 min. After rinsing, gels were 
examined and documented with a UV transilluminator. Alternatively, ethidium bromide 
stain was added directly to agarose solution (0.3 µg/ml) prior to casting the agarose gel. 
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2.3.3 Subcloning of PCR products 
In most cases PCR products were subcloned into the shuttle vector pGEM-T Easy prior 
to insertion into the destination vector. Thereby, complete digestion of PCR products 
restriction endonucleases is ensured. The 3’ overhangs of the commercially available 
pGEM-T Easy vector (Promega) were removed and the vector was ligated to allow rep-
lication. The circular plasmid was kindly provided by the laboratory of Prof. Ute Hent-
schel, Würzburg. The plasmid was linearized by digestion with EcoRV thereby enabling 
blunt end ligation with PCR products. The vector was dephosphorylated with antarctic 
phosphatase or calve intestinal phosphatase (CIP, see 2.3.5) to prevent religation of vec-
tor backbone not containing an insert. The PCR products were phosphorylated by means 
of a polynucleotide kinase (PNK). Composition of the reaction mix is depicted in Tab. 
2.16. Firstly, a dilution of the purified PCR product in MQH2O containing the PNK 
reaction buffer was denaturated by incubation at 70°C for 10 min. After incubation on 
ice for 2 min, dATP and the PNK were added, followed by incubation at 37°C for 
30 min. The enzyme was heat inactivated by incubation at 65°C for 20 min. The phos-
phorylated PCR product was purified as described in 2.3.4. 
Tab. 2.16: Composition of phosphorylation reactions. 
Component Concentration Amount 
Purified PCR product 12.5 ng/µl 500 ng 
PNK Buffer 4 10 x 4 µl 
ATP 0.2 mM 1 µl 
T4 PNK 10 U/ µl 2 µl 
MQH2O – ad 40 µl 
2.3.4 Purification of PCR products and gel purification of vectors 
Purification of PCR products was carried out using the NucleoSpin Gel and PCR Clean 
up kit (Macherey-Nagel). The columns provided with the kit contain a silica membrane. 
The purification is based on the binding of DNA to the silica membrane in the presence 
of chaotropic salts. During washing steps PCR components that might interfere with 
following application (e.g. dNTPs, enzymes) are removed. The same kit was used for 
the gel elution of DNA bands cut out from agarose gels. Gel purification was used for 
purification of vectors after digestion with restriction endonucleases or to isolate PCR 
fragments ligated into pGEM-T easy vector after digestion with restriction enzymes. For 
purification of both PCR products and vectors 30 – 50 µl MQH2O was used for elution 
of DNA. The eluate was loaded a second time onto the silica membrane and a second 
elution was performed when high DNA concentrations were required. All other steps 
were carried out as described in the manufacturer’s protocol. 
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2.3.5 Preparative restriction digest 
Destination vectors and PCR products beforehand cloned into pGEM-T-Easy vector 
were digested with restriction enzymes to provide sticky ends for subsequent ligation. 
Digest was carried out as a 50 µl reaction containing 3 – 5 µg of plasmid DNA and 36 U 
of each restriction enzyme. Double digests and addition of BSA was performed as 
suggested by the manufacturer. The reaction was performed for at least 3 h at 37°C. One 
hour before stopping the reaction antarctic phosphatase and the 10 x antarctic 
phosphatase reaction buffer were added when digesting the destination vector. Due to 
hydrolysis of terminal phosphate residues a religation of cut vector can be avoided. 
Where applicable the restriction enzymes were heat-inactivated. The restriction digested 
vectors and PCR products were separated via agarose gel electrophoresis and 
subsequently purified with the NucleoSpin Gel and PCR Clean up Kit (see 2.3.4). 
Beside the isolation of restriction fragments of interest this procedure also ensures the 
removal of not inactivated restriction enzymes which might interfere with further 
reactions. 
2.3.6 Ligation 
The ligation of PCR product and vector were mediated by T4 DNA Ligase. For blunt 
end ligation reactions PCR product and vector were used in a molar ratio of 5:1, for 
sticky end ligations a molar ration of 3:1 was used. The following equation was used to 
determine the amount of PCR product needed for sticky end reactions: 
Mass Fragment [ng] = 3 x Mass Vector [ng] x Length Fragment [bp] / Length Vector [bp] 
A mass of 50 ng of the respective vector was used. The volumes of the components of 
the reaction are listed in Tab. 2.17. Blunt end ligations were incubated at 4°C overnight. 
Sticky end ligations were incubated at least for 1 h at room temperature. For extended 
ligation reaction longer than 1 h, the reaction tubes were stored at 4°C. 
Tab. 2.17: Composition of ligation reactions. 
Component Concentration Volume 
Vector  X µl 
PCR product  Y µl 
T4 DNA Ligase Buffer 10 x 10 µl 
T4 DNA Ligase  400 U/µl 1 µl 
MQH2O – ad 20 µl 
2.3.7 Transformation of E. coli  
Both E. coli NovaBlue and BL21 CodonPlus®(DE3)-RIL were transformed via heat 
shock. 20 µl of competent E. coli cells were thawed on ice. Of a ligation reaction a vo-
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lume of 2 µl were added to the E. coli cells, of a plasmid preparation 1 µl was added 
followed by incubation on ice for 30 min. Heat shock was applied for 30 s at 42°C. The 
bacteria were returned to ice immediately for 2 min. After addition of 200 µl SOC me-
dium cells were incubated under rotation for 1 h. For the transformation of E. coli No-
vaBlue cells with a ligated plasmid the entire bacteria suspension was streaked onto LB 
agar plates with the appropriate antibiotic for selection of successfully transformed bac-
teria. Only 100 µl of the bacteria suspension were distributed onto LB agar plates con-
taining the respective antibiotic when transforming E. coli BL21CodonPlus® (DE3)-
RIL cells with a plasmid. Plates were incubated at 37°C overnight. 
2.3.8 Analysis of transformants 
Bacteria clones obtained after transformation of ligated plasmid constructs were ana-
lyzed via colony PCR or via diagnostic restriction digest. For colony PCR clones were 
picked, streaked on a master LB agar plate and resuspended in 25 µl MQH2O. 2 µl of 
this suspension was then used in a diagnostic PCR as described above (see 2.3.1) using 
primers complementary to the region of the vector flanking the insert. Alternatively, 
bacteria clones carrying a plasmid with the DNA fragment of interest inserted correctly 
were identified via restriction digest. Overnight cultures were set up and plasmid DNA 
was isolated via a column-free method as described (see 2.3.9). A small scale digest 
reaction was used (Tab. 2.18) and the reaction was incubated for a minimum of one 
hour at 37°C.  
Tab. 2.18: Composition of diagnostic restriction digests. 
Component Concentration Volume 
Plasmid DNA  2 µl 
Enzyme 1 20 U/µl 0.5 µl 
Enzyme 2 20 U/µl 0.5 µl 
Buffer 4 10 x 1 µl 
BSA (if applica-
ble) 
10 x 1 µl 
MQH2O – ad 10 µl 
2.3.9 Isolation of plasmid DNA 
Plasmid DNA isolation with commercially available kits 
Plasmid DNA for sequencing, for transfection and expression of recombinant proteins 
was isolated using the NucleoSpin® Plasmid kit (Macherey-Nagel) allowing isolation 
of up to 40 µg plasmid DNA from a 1 – 5 ml overnight culture. The kit was used accord-
ing to the manufacturer’s description. Usually 4 ml of a 5 ml overnight culture were 
used. For elution of the plasmid DNA bound the silica membrane of the columns pro-
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vided MQH2O was used. The eluate was applied to the silica membrane and a second 
eluation was carried out if a high yield of plasmid DNA was required. For isolation of 
larger amounts of plasmid DNA the NucleoBond® Xtra Midi kit (Macherey-Nagel) was 
used as indicated by the manufacturer, which allows isolation of up to 250 µg plasmid 
DNA from a 200 ml overnight culture.  
Column-free protocol for plasmid DNA isolation 
When plasmid DNA was isolated to screen plasmids for the presence of the PCR prod-
uct inserted into a vector an alternative column-free protocol based on alkaline lysis of 
the bacteria was applied (“Dirty mini”). 4 ml of an overnight bacteria culture were cen-
trifuged at 9 500 x g for 1 min. The resulting pellet was resuspended in 100 µl of buffer 
P1 and incubated on ice for 10 min. Subsequently, 200 µl of the lysis buffer P2 were 
added. After mixing by inversion of reaction tubes, samples were incubated on ice for 
further 5 min. After addition of 150 µl cold 3 M potassium acetate (pH 4.8) the suspen-
sion was again incubated on ice for 10 min. This step results in precipitation of genomic 
DNA, proteins and cell debris. 450 µl of 5 M LiCl were added to precipitate RNA. After 
cautious mixing of the samples contaminants were pelleted by centrifugation at 
15 500 x g for 15 min. The supernatant was transferred into a new reaction tube and 
plasmid DNA was precipitated by addition of 600 µl isopropanol. After mixing the reac-
tion tubes were centrifuged for 10 min at 15 500 x g. The pellet was washed with 70 % 
ethanol and centrifuged again. Finally, the pellet was air-dried and resuspended in 30 µl 
MQH2O.  
2.3.10 Determination of DNA concentration 
DNA concentration was determined via spectrophotometer or via Nanodrop® spectro-
photometer. In both cases optical density of the DNA solution at a wavelength of 
260 nm was measured and the concentration was calculated with the following equation: 
c [µg/ml] = OD260 x D x F 
D represents the dilution factor and F the multiplication factor, 50 for dsDNA and 40 for 
RNA. The quotient of OD260 und OD280 allows estimation of purity of the DNA solu-
tion. A solution devoid of protein contaminations exhibits a quotient between 1.8 and 
2.0. When measuring the DNA concentration with the Nanodrop® spectrophotometer 
1 µl of the solution was applied without further dilution. For measurements with the 
spectrophotometer 2 µl of DNA solution were diluted in 68 µl MQH2O. 
2.3.11 DNA Sequencing 
The sequencing method used is based on the principle of the chain-termination method 
(Sanger et al., 1977). Beside deoxynucleotides fluorescently labeled dideoxynucleotides 
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are utilized during the sequencing PCR. These do not exhibit a hydroxyl group at their 
3’ C atom, which results in termination of DNA strand synthesis and PCR products of 
different lengths are produced. During the separation of these chain-termination prod-
ucts the fluorescent dyes are excited and the resulting fluorescence signal is detected, 
analyzed and depicted as chromatogram.  
Sequencing of plasmid constructs was performed at the Institute for Virology of the 
University of Würzburg on a fee for service basis. The sequencing PCR was carried out 
as listed in Tab. 2.19 using the BigDye™ Terminator Cycle Sequencing Kit (Applied 
BiosystemsTM). The ready to use sequencing mix contained the AmpliTaq® DNA 
polymerase, FS, deoxynucleotides, fluorescently labeled dideoxynucleotides und 
MgCl2. The primers used for sequencing of the different vectors used are listed in Tab. 
2.9. A standard program was used for all plasmids sequenced (Tab. 2.20). 
Tab. 2.19: Composition of sequencing PCRs using the Big Dye® Terminator Cycle Sequencing 
Kit. 
Component Amount 
5 x sequencing mix 2 µl 
5 x Buffer 2 µl 
Template 0.1 – 0.4 µg 
Primer  15 – 50 pmol 
ddH2O  ad 10 µl 
Tab. 2.20: PCR program for sequencing PCRs. 
Reaction step Temperature Duration Number of cycles 
Initial denaturation 95°C 4 min 1 
Denaturation 96°C 30 s 
30 Annealing 50°C 30 s  
Elongation 62°C 4 min 
Final elongation 72°C 3 min 1 
Storage 12°C ∞ - 
The PCR products were purified via DNA precipitation. Reagents were added to the 
PCR product as listed in Tab. 2.21. After mixing of all components the samples were 
centrifuged for 15 min at 15 500 x g. The resulting pellet was washed with 70 % ethanol. 
After further centrifugation 15 min at 15 500 x g) the supernatant was removed and the 
pellet was air-dried. Finally the precipitated plasmid DNA was resolved in 25 µl HiDi 
formamide. 
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Tab. 2.21: Components used for purification of sequencing PCR reactions. 
Component Amount 
PCR reaction 10 µl 
ddH2O 90 µl 
3 M NaAc pH 4.6 10 µl 
100 % ethanol 250 µl 
2.3.12 RNA isolation 
Column-free protocol for RNA purification 
RNA isolation was performed using the reagent TRIzol, a monophasic solution of phe-
nol and guanidine isothiocyanate as described (Kyes, 2008). For isolation of gametocyte 
RNA the gametocytes were isolated via Percoll gradient (see 2.2.3) omitting all washing 
steps except the washing of parasites after aspirating the gametocyte-containing inter-
phase between 50 % and 65 % Percoll. When isolating RNA of asexual parasite stages 
no saponin lysis was performed. Instead, the parasite pellet was resuspended directly in 
20 pellet volumes of prewarmed TRIzol followed by incubation at 37°C for 5 min. If not 
processed immediately suspensions were stored at 80°C. Next, 0.2 TRIzol volumes of 
chloroform were added and samples were mixed by rotation. Reaction tubes were cen-
trifuged (9 000 x g for 1.5 ml reaction tubes, 1 400 x g for 15 ml reaction tubes) for 30 min 
at 4°C. The aqueous layer which located to the top layer was transferred to a new col-
lection tube avoiding carrying over of interface containing DNA. Subsequently, 0.5 vo-
lumes of isopropanol were added and tubes were inverted several times. Samples were 
precipitated for a minimum of 2 h at 4°C up to several days. After centrifugation for 
3 min at 4°C (15 500 x g) supernatant was removed and the RNA pellet was washed in 
750 µl of 75 % ethanol. Subsequently, the pellet was air-dried at room temperature for 
5 min. 50 µl DEPC-H2O were added and samples were heated at 60°C for 10 min. Final-
ly the pellet was dissolved by resuspension. RNA concentration was determined and 
aliquots were prepared for storage at -80°C as repeated freezing-thawing cycles destroys 
RNA stored in DEPC-H2O. 
DNase treatment 
In order to remove potential contaminations of RNA with genomic DNA a DNase 
treatment was carried out for 10 min at RT as recommended by the manufacturer of the 
enzyme (QIAGEN, see Tab. 2.22). DNase treated RNA was purified via phenol-
chloroform extraction. 250 µl of DEPC-H2O, 150 µl phenol and 150 µl chloroform were 
added after DNase treatment and mixed well. After incubation at room temperature for 
3 min samples were centrifuged for 10 min at 10 000 x g at 4°C. The aqueous top phase 
was transferred to a new tube, 300 µl chloroform were added and samples were mixed 
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by agitation. After 5 min of incubation at RT samples were centrifuged for 10 min at 
10 000 x g at 4°C. The aqueous top phase again was transferred to a new collection tube 
and RNA was precipitated by adding 0.1 volumes of cold 3 M NaAc (pH 4.8-5.2, 
DEPC-treated) and 2.5 volumes of cold 100 % ethanol. After incubation at 4°C for 
30 min to 24 h samples were centrifuged for 30 min at 15 500 x g at 4°C. The pellet was 
washed with 1 ml of ice-cold RNase-free 75 % ethanol. After vortexing the pellet was 
centrifuged at 4°C (10 min, 15 500 x g). The RNA pellet was air-dried for 5 min at RT. 
Resolving and storage of RNA was performed as mentioned above for RNA isolation. 
Tab. 2.22: Components and respective amounts used for DNase treatment. 
Component Amount 
RNA in DEPC-H2O up to 87.5 µl 
Buffer RDD 10 µl 
DNase I (2.73 Kunitz U/ µl) 2.5 µl 
DEPC-H2O ad 100 µl 
RNA isolation with commercially available kits 
RNA of wild-type gametocytes was mainly obtained by means of the innuPREP RNA 
Mini Kit (Analytik Jena AG). This approach was chosen due to the very low yields ob-
tained when RNA of gametocytes was isolated via the Trizol-based method. The kit 
contains a genomic DNA-binding column, which allows removal of the major part of 
genomic DNA from the samples. Additionally, an on-column DNase treatment was ap-
plied to the RNA bound by the second column. RNA was eluted with RNase-free water 
and elution was carried out twice in order to increase the yield of isolated RNA. The 
RNA samples were stored as described above. 
2.3.13 cDNA synthesis and RT-PCR 
Synthesis of cDNA was performed by means of the Superscript III First Strand Synthe-
sis Kit II for RT-PCR (Invitrogen). The reaction was set up as recommended by the 
manufacturer (Tab. 2.23).  
Tab. 2.23: Components used for preparing RNA for cDNA synthesis. 
Component Amount 
RNA  up to 5 µg 
Random hexamers (50 ng/µl) 1 µl 
dNTP mix (10 mM) 2.5 µl 
DEPC-H2O ad 10 µl 
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The reaction mix was incubated at 65°C for 5 min and subsequently incubated on ice for 
at least 1 min. The cDNA synthesis continued by adding the reagents necessary for re-
verse transcription as listed in Tab. 2.24.  
10 µl of the reverse transcription mix (Tab. 2.14) was added to the RNA primer mix. For 
each RNA preparation one control reaction was carried out where instead of the Super-
Script III RT DEPC-H2O was added (RT control). This control served as negative 
control to confirm absence of genomic DNA. After mixing, samples were incubated at 
room temperature for 10 min followed by incubation at 50°C for 50 min. The reaction 
was terminated by incubation at 80°C for 5 min and subsequently incubated on ice. Fi-
nally, 1 µl of RNase H was added to each reaction and incubated at 37°C for 20 min. 
Tab. 2.24: Components and respective amounts used for cDNA synthesis. 
Component Amount 
10x RT buffer  2 µl 
25 mM MgCl2 4 µl 
0.1 M DTT 2 µl 
RNase OUT  1 µl 
SuperScript III RT 1 µl 
The final concentration was calculated according to the amount of RNA used for cDNA 
synthesis. 125 ng of cDNA were used per RT-PCR reaction. The reaction was prepared 
as described for PCRs employing GoTaq polymerase (see 2.3.1). The PCR program was 
altered for RT-PCRs as listed in Tab. 2.25. 
Tab. 2.25: PCR program for RT-PCR using GoTaq polymerase. 
Reaction step Temperature Duration Number of cycles 
Initial denaturation 95°C 4 min 1 
Denaturation 95°C 30 s 
25 Annealing as calculated 30 s  
Elongation 72°C 1.5 min  
Final elongation 72°C 5 min 1 
Storage 12°C ∞ – 
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2.3.14 Southern Blot 
DNA digest, separation, transfer 
Southern blot analysis was carried out in order to confirm mutated gene loci of parasites 
transfected with pCAM-BSD vector or pCAM-BSD-HA vector. Concentration of iso-
lated genomic DNA was determined spectrophotometrically and confirmed by separa-
tion of 0.5 µg DNA via agarose gel electrophoresis. 3 µg of DNA were digested with 
restriction endonucleases. Reactions were prepared in a total volume of 20 µl and incu-
bated for 6 – 16 h. Restriction digested DNA (3 µg per lane) was separated via a 0.8 % 
agarose gel at low voltage (e.g. 2 V/cm electrode distance for 15 min and 1 V/cm over-
night) to ensure high resolution of separation. After electrophoresis the gel was incu-
bated in 0.25 M HCl under agitation for 30 min in order to achieve depurination of 
fragments > 5 kb. After rinsing the gel briefly in MQH2O the gel was incubated in 0.5 M 
NaOH/ 1.5 M NaCl for 30 min to denature DNA. The gel was rinsed in MQH2O again 
and neutralized by incubation in 0.5 M Tris-HCl/ 1.5 M NaCl for 3 x 15 min. The DNA 
was transferred via capillary transfer onto a nylon membrane. Three layers of whatman 
paper were soaked with 20 x SSC and placed onto a sponge lying in a tray filled with 
20 x SSC. The nylon membrane was firstly soaked in MQH2O, secondly in 20 x SSC for 
5 min and then placed onto the gel. The membrane was covered by three layers of 
whatman paper soaked in 2 x SSC. Air bubbles between the different layers were re-
moved. Finally a stack of paper towels were placed on top and transfer was carried out 
for approximately 16 h. The efficiency of transfer was controlled after staining of the 
agarose gel with ethidium bromide. The damp membrane was UV crosslinked placed on 
a sheet of whatman paper soaked with 10 x SSC. The membrane was rinsed in MQH2O 
briefly. When not proceeding with hybridization immediately the membrane was air-
dried and stored at 4°C. Alternatively to the capillary transfer DNA was transferred via 
electro blot from the gel to the nylon membrane. In this case, the gel and the nylon 
membrane soaked in MQH2O and 20 x SSC were placed onto the vacuum blot appara-
tus. Depurination, denaturation and neutralization were carried out with the solutions 
mentioned above for 15 min each with the vacuum pump set to 0.05 bar. The transfer 
was carried out for 90 min with 20 x SSC. The DNA was fixed via UV crosslinking as 
described above. 
Preparation of probe 
A DNA fragment of 100 – 1000 bp (primers see Tab. 2.9) was amplified via PCR by 5 
reactions of 50 µl each. The PCR products were pooled and purified via gel purification 
(see 2.3.4).1 µg of the probe was diluted in 16 µl mQH2O and denatured by incubation at 
95°C for 3 min and immediate cooling on ice. The labeling of the probe was carried out 
using the DIG High Prime DNA Labeling and Detection Starter Kit II (Roche) as de-
scribed in the manual. Subsequently 4 µl of DIG High Prime was added and incubated 
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for 20 h at 37°C. Thereby a digoxigenin (DIG)-label was transferred to the DNA probe. 
The labeling reaction was terminated by addition of 2 µl 0.2 M EDTA or heat inactiva-
tion for 10 min at 65°C. 
Hybridization and detection of DNA probe 
Hybridization and detection were carried out as recommended by the kit’s manufactur-
er. The optimal hybridization temperature (Topt) was calculated with the following equa-
tion: 
Tm = 49.82 + 0.41 (% G+C) – (600/ length of hybrid in bp) 
Topt = Tm –20 to 25°C 
The DIG Easy Hyb granules were dissolved as described and preheated to Topt. 10 ml 
per 100 cm² membrane (at least 20 ml) were added to the membrane placed into a hybri-
dization tube. The membrane was incubated for 30 min to 1 h under rotation to prepare it 
for hybridization. The DIG-labeled probe was denatured by heating to 95°C for 5 min 
followed by rapid cooling. The probe was added to preheated DIG Easy Hyb to achieve 
a final concentration of 25 ng/ml. 3.5 ml/ 100 cm² of the probe solution (at least 20 ml) 
was added to the membrane after removal of prehybridization solution and the hybridi-
zation process was carried out overnight at Topt under rotation. 
The membrane then was washed twice in 2 x SSC/ 0.1 % SDS for 10 min at room tem-
perature and 2 x 30 min in prewarmed 0.5 x SSC/ 0.1 % SDS at 54°C. The membrane 
was washed in Southern blot washing buffer for 3 min shaking, then the membrane was 
incubated for 30 min in 100 ml blocking solution under rotation at room temperature. 
Anti-DIG alkaline phosphatase-conjugated antibody supplied with the detection kit was 
centrifuged for 5 min at 10 000 x g and an aliquot was taken from the top of the antibody 
solution. The membrane was incubated with anti-DIG antibody diluted 1:10 000 in 
blocking buffer. After washing twice with washing buffer for 15 min each, the mem-
brane was incubated for 2 x 5 min in equilibration buffer. The nitrocellulose membrane 
was placed into a plastic folder and CSPD solution was added, followed by a 5 min of 
incubation at room temperature. After further incubation at 37°C for 10 min the lumi-
nescence signal was detected either by exposure on an X-ray film or by a luminescence 
image analyzer. Exposure times ranged from 15 – 45 min. 
If the membrane was to be reused it was not allowed to dry out. After rinsing the mem-
brane thoroughly in MQH2O it was washed 3 x 15 min at 37°C in 0.2 M NaOH/ 0.1 % 
SDS. Then it was rinsed thoroughly in 2 x SSC and stored in either 2 x SSC or Maleic 
acid at 4°C. DIG Easy Hyb containing DIG-labeled probe was stored at 20°C if reused 
for a second hybridization. Prior to use it was then denatured by incubation at 68°C for 
10 min. 
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2.3.15 Isolation of genomic DNA 
Genomic DNA isolation with commercially available kits 
The isolation of genomic DNA for investigation of the genotype of mutated parasites 
via PCR was carried out by means of the NucleoSpin ® Blood kit (Macherey-Nagel). 
5 – 10 ml of a parasite culture of a parasitemia of ≤ 5% were supplied with 10 % sapo-
nin/ PBS to a final concentration of 0.2 % saponin. After 10 min of incubation at RT the 
lysed culture was centrifuged (5 min, 3 200 x g). After washing with 10 ml PBS the sam-
ple was centrifuged again at 3 200 x g for 5 min. The resulting pellet was stored at -20°C 
or processed directly as described in the manual of the kit. 
For investigation of the genotype of mutated parasites via Southern blot the MasterPu-
reTM DNA Purification Kit (Epicenter®) was employed. At least 20 ml of an asexual 
culture (parasitemia of ≤ 5 %) were saponin-treated as described above. The pellets were 
treated as recommended by the manufacturer. 
Column-free protocol for isolation of genomic DNA 
Genomic DNA as template for cloning PCRs was obtained via phenol-chloroform ex-
traction. A 20 ml culture of asexual parasites of a parasitemia of ≤ 5 % was pelleted and 
lysed by adding 0.15 % saponin in PBS (5 min, RT). Parasites were pelleted and washed 
twice with PBS. The pellet was taken up in 500 µl TSE buffer, 100 µl 10 % SDS and 
50 µl of 6 M NaClO4. The suspension was incubated overnight under agitation at room 
temperature. Then, an equal volume of phenol was added and the samples were incu-
bated for 5 min under agitation. After centrifugation (15 500 x g, 5 min) the colorless 
aqueous top phase was transferred to a clean tube. 0.5 volumes each of phenol and chlo-
roform were added followed by 5 min of incubation and centrifugation (15 500 x g, 
5 min). Again the top phase was transferred to a new reaction tube and 1 volume of 
chloroform was added, incubated under agitation and centrifuged. Subsequently, 2 vo-
lumes of ethanol were added and the samples were incubated under gentle agitation for 
5 min. After centrifugation the pellet was washed with ice-cold 70 % ethanol and air-
dried. Finally, the pellet was dissolved in 40 µl of MQH2O by incubation at 55 – 60°C. 
2.3.16 Cultivation and storage of bacteria 
E. coli bacteria cells were cultivated in LB medium containing the antibiotic required 
for selection of bacteria cells of interest. Overnight cultures were incubated 14 – 18 h at 
37°C in Kapsenberg tubes at 225 rpm. Larger volumes cultivated in Erlenmeyer flask 
were incubated at 150 rpm. Bacteria suspensions streaked onto LB agar plates were in-
cubated at 37°C for 14 – 18 h. For long-term conservation of bacteria 1 ml of a 3 – 5 ml 
overnight culture was resuspended with 1 ml bacteria freezing solution containing gly-
cerol, transferred to cryotubes and stored at 80°C. 
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2.4 Protein biochemical Methods 
2.4.1 Expression of recombinant proteins 
For expression of recombinant proteins the E. coli expression strain BL21 Codon-
Plus®(DE3)-RIL (Agilent Technologies) was used. It possesses the following genotype: 
E. coli B F– ompT hsdS (rB– mB–) dcm+ Tetr gal λ(DE3) endA Hte [argU ileY leuW 
Camr]. These cells contain additional copies of tRNA genes that are common in organ-
isms with AT-rich genomes. They are encoded by a plasmid conferring chlorampheni-
col resistance. The expression vectors used possess the tac promoter, which is a strong 
promoter that can be repressed by the LacI protein, repressor of the lac operon. 
Small scale protein expression  
Expression in a small scale culturing volume was carried out as a first test to investigate 
whether the synthesized recombinant protein possesses the correct size and is expressed 
in sufficient amounts. After transformation of BL21-CodonPlus®-(DE3)-RIL cells with 
the respective plasmid as described (see 2.3.7) 5 ml overnight cultures were prepared. 
LB medium contained the antibiotic required for selection of bacteria possessing the 
expression plasmid as well as chloramphenicol which prevents loss of the plasmid en-
coding additional tRNAs. After the overnight incubation, two tubes with 1:5 dilutions of 
the original cultures were set up and incubated at 37°C until an OD of 0.5 was reached. 
Then protein expression was induced in one of the samples by addition of 0.75 mM 
IPTG (Isopropyl-β-D-thiogalactopyranosid) whilst the other culture served as non-
induced control. Both cultures were incubated under shaking conditions at 30°C for 
2 - 3 h. 30 µl of each culture were mixed with SDS sample buffer and subjected to SDS-
PAGE (2.4.3).  
Large scale protein expression and purification of GST-fusion proteins 
A 20 ml starter culture of BL21-CodonPlus®-(DE3)-RIL cells transformed with the 
respective expression plasmid was set up in LB medium containing ampicillin and chlo-
ramphenicol. After overnight incubation the culture volume was increased to 1 l and was 
incubated for 1.5 h at 37°C. The temperature was then decreased to room temperature. 
Protein expression was induced by adding IPTG to a final concentration of 0.75 mM. 
After 4 - 5 h of incubation cells were pelleted by centrifugation for 10 min at 5 000 x g. 
All following steps were carried out on ice. Firstly, the pellet was resuspended in 20 ml 
50 mM Tris, pH 8.0 and 10 % glycerol. Then lysis buffer components were added to 
result in final concentrations of 350 mM NaCl, 10 mM Imidazol, 20 % IGEPAL and 
1 mM ß-Mercaptoethanol. The mixture was incubated rotating for 1 h at 4°C. Further 
cell lysis was achieved by pressure cell disruption on ice (3 x 1000 psi) and sonication 
(2 min 50 % intensity, 50 % duty cycle). The samples were centrifuged for 1 h at 
30 000 x g at 4ºC. The supernatant was filtered through a 0.2 µm syringe filter. Subse-
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quently 500 µl of glutathione sepharose (washed 3 x with PBS) were added and the mix-
ture was incubated overnight rotating at 4°C. The samples were applied to chromato-
graphy columns and glutathione sepharose was washed 5 x with PBS. Bound recombi-
nant protein was eluted with 4 ml elution buffer. 8 fractions were collected which sub-
sequently were analyzed via sodiumdodecylsulfat polyacrylamid gel electrophoresis 
(SDS-PAGE) and staining of the gel. To concentrate protein and for replacing the elu-
tion buffer with 5 % glycerol/ PBS centrifugal filter units with an appropriate molecular 
weight cut-off were used. 
Large scale protein expression and purification of MBP-fusion proteins 
BL21-CodonPlus®-(DE3)-RIL cells were transformed with the respective plasmid 
based on the vector pIH902. A 5vml starter culture in 0.1 % glucose/ LB medium was 
set up. Cultivation in large volume, induction of protein expression and harvesting of 
cells was carried out as described for GST-tag fusion proteins. Per gram pellet 3 ml 
MBP lysis buffer, 80 µl lysozyme and 30 µl PMSF were used to resuspend the pellet. 
After 20 min of incubation on ice the cells were disrupted via pressure cell disruption 
(3 x 1000 psi) and sonication (2 min 50 % intensity, 50 % duty cycle). Per ml of suspen-
sion 6 µl 1 M MgCl2 and 0.08 g NaCl were added and incubated under rotation for 1 h at 
4°C. After centrifugation for 20 min at 20 000 – 30 000 x g the supernatant was filtrated if 
necessary. 1 ml amylase resin was washed with MBP column buffer and resuspended in 
2.5 ml TE buffer (pH 7.5). The supernatant containing the recombinant protein was in-
cubated with the amylase resin under rotation at 4°C overnight. Subsequently, the sus-
pension was transferred to a chromatography column. After several washing steps the 
MBP-tagged protein was eluted via addition of MBP column buffer containing maltose. 
2.4.2 Isolation of inclusion bodies 
When then the purification of recombinant proteins only resulted in a low yield of pro-
tein, inclusion bodies formed within the bacteria cytosol were isolated. These then were 
used for the immunization of mice to obtain antisera reactive against the recombinant 
protein enclosed in inclusion bodies (see 2.4.6). A 100 ml starter culture of BL21-
CodonPlus®-(DE3)-RIL cells transformed with the respective expression plasmid was 
set up in LB medium containing ampicillin and chloramphenicol. After overnight incu-
bation the starter culture was added to 1.5 l LB medium containing ampicillin and chlo-
ramphenicol followed by incubation for 1 h at 37°C. The bacteria culture was then 
cooled down to 30°C and induced with 0.75 mM IPTG when an optical density of 0.5 –
 0.8 was reached. After 5 h of incubation the cells were pelleted (3 000 x g for 5 min) and 
resuspended in 100 ml ice-cold lysis buffer. After addition of lysozyme (2 mg/ml final 
concentration) the suspension was incubated on ice for 10 min. Further cell disruption 
was achieved by sonication on ice for 10 min (50 % intensity, 50 % duty cycle). Subse-
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quently, 200 ml of detergent buffer was added and the mixture was centrifuged 
(6 000 x g for 10 min). The supernatant was removed carefully and the pellet was resus-
pended in 250 ml washing buffer. Several washing steps were carried out until a tight 
pellet was obtained. Then the pellet was washed with 250 ml 75 % ethanol by thorough-
ly resuspending it. After centrifugation (6 000 x g for 10 min) the pellet was air-dried on 
ice to avoid carry-over of ethanol. Finally the pellet was taken up in 2 – 5 ml sterile PBS 
and was sonicated shortly to obtain a homogenous suspension. The concentration of the 
protein of interest was estimated by subjecting serial dilutions to SDS-PAGE.  
2.4.3 SDS-PAGE 
The SDS-PAGE enables the analysis of proteins by separation of the proteins of a pro-
tein mixture according to their mass. The discontinuous PAGE is comprised of a resolv-
ing gel and a 5 % stacking gel. Depending on the mass of proteins of interest an acryla-
mid concentration of 8 – 15 % was chosen for the resolving gel. Protein solutions or pa-
rasite lysates were resuspended in 2 x SDS sample buffer containing 2.5 mM DTT and 
denatured by heating for 8 min for 95 min. After loading the samples onto the gel a vol-
tage of 80 V was applied for 20 – 30 min until the samples had entered the resolving gel. 
Subsequently, voltage was increased to 120 V for up to 2 h. After protein separation gels 
were either used for Western blot (see 2.4.5) or gels were stained to visualize proteins. 
Staining of gels 
Gels were washed in dH2O for 3 x 10 min under agitation. DH2O was replaced by Gel 
Blue Stain Solution and gels were stained for 1 h under agitation. Subsequently gels 
were incubated in dH2O to remove residual staining solution. 
2.4.4 Co-immunoprecipitation 
Co-immunoprecipitation (CoIP) assays were carried out to investigate protein-protein 
interactions. In this assay a protein mixture is incubated with antibodies directed against 
the protein of interest. The antibodies are covalently bound to agarose beads. The result-
ing complex comprising agarose beads, antibody and the protein of interest bound to its 
interaction partners can thus be isolated.  
The AminoLink Coupling Resin (Pierce/ThermoScientific) was washed in PBS and 
subsequently incubated with the respective antiserum and cyanoborohydride at a final 
concentration of 50 mM at 4°C overnight. The activated agarose support contains alde-
hyde functional groups that react with primary amines of the antibodies under formation 
of a Schiff base bond. Upon incubation with cyanoborohydride these bonds are reduced 
resulting in a stable secondary amine bond. The agarose beads were washed 3 x with 
PBS to remove unbound antiserum. After two washing steps with 1 M Tris/HCl pH7.4 
beads were incubated under rotation for 30 min at room temperature with 1 M Tris/HCl 
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pH7.4 containing cyanoborohydrid at a final concentration of 50 mM. Thereby, remain-
ing active sites were blocked. 
The entire preparation of samples was carried out on ice or at 4°C. Pellets of enriched 
gametocytes were combined and resuspended in Co-IP lysis buffer. Further disruption 
of cells was achieved by means of ultrasound homogenization for 1 min at 50 % intensi-
ty/ 50 cycles. The homogenate was centrifuged at 14 200 x g for 1 min and the resulting 
pellet containing cell debris was discarded. The supernatant was incubated with 8  µl of 
normal mouse serum per 2 gametocyte cultures being processed. After 30 min of incu-
bation under rotation approximately 20 µl of protein G agarose beads were added and 
incubated for further 30 min. The protein G agarose was centrifuged (225 x g, 5 min) and 
the resulting pellet was discarded, thereby avoiding unspecific interactions of mouse 
sera with the proteins of interest. The supernatant was transferred to a new reaction tube 
and the antiserum bound to AminoLink Coupling Resin was added. Incubation was car-
ried out overnight under rotation. After centrifugation (225 x g, 5 min) the agarose bead 
pellet was washed twice with Co-IP lysis buffer and two further times with PBS con-
taining 1 % PIC and 0.5 mM EDTA (centrifugation at 225 x g, 5 min). The pellet was 
resuspended in PBS and 2 x SDS-PAGE sample buffer containing 25 mM DTT. The 
samples then were denatured by incubation at 95°C for 8 min. The samples were centri-
fuged once more, to remove the antisera bound to agarose beads prior to loading the 
samples to a protein gel. SDS-PAGE was carried out as described in 2.4.3 and detection 
of interaction partners of the protein of interest was proven by detection of the suspected 
proteins via Western blot (see 2.4.5). 
2.4.5 Western Blot analysis 
In order to detect a specific protein of interest within mixture of proteins that was sepa-
rated via SDS-PAGE proteins were transferred to a nitrocellulose membrane via elec-
troblotting. Binding of proteins to the membrane is based on hydrophobic interactions. 
The SDS polyacrylamid gels were placed onto two layers of whatman paper soaked in 
transfer buffer lying on a foam pad, likewise soaked with transfer buffer. The membrane 
was also wetted with transfer buffer, put on top of the gel and covered by additional two 
sheets of pre-soaked whatman paper. The stack was covered by a second foam pad. Air 
bubbles residing between the single layers were excluded and the stack was enclosed by 
a cassette of the blotting device. The cassette was placed into the blotting chamber with 
the membrane facing to the anode resulting in the negatively charged proteins to be 
transferred from gel to membrane. Transfer was usually carried out overnight at a vol-
tage of 15 V or, alternatively at 25 V for 2 h. 
After the transfer the membrane was briefly rinsed in TBS buffer followed by blocking 
of free binding sites by incubation with 5 % TBSM/ 1 % BSA for 1 h at room tempera-
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ture or 4°C overnight. After rinsing the membrane for 2 x 5 min in TBS the primary 
antibody diluted in 3 % TBSM was added (for dilution see Tab. 2.6) and incubated for 
2 h at room temperature. After incubation of the membrane with primary antibody the 
membrane was washed four times. Firstly, the membrane was rinsed in 3 % TBSM, fol-
lowed by two washing steps for 10 min each in 0.1 % Tween/ 3 % TBSM. After washing 
once more with 3 % TBSM, the secondary alkaline phosphatase-conjugated antibody 
was added in a concentration of 1:6 000 in 3 % TBSM. Incubation of secondary antibo-
dy was for 2 h at room temperature. After four washing steps (TBS, 2 x 0.1 % 
Tween/ TBS, TBS) of 10 min each the membrane was incubated in equilibration buffer 
for 3 min. Finally, the NBT/BCIP substrate tablet dissolved in dH2O was added which is 
converted into a violet precipitate by the alkaline phosphatase. Once a sufficient grade 
of coloration of protein bands was reached the reaction was stopped by addition of stop-
ping buffer. After 30 min of incubation the membrane was air-dried. 
2.4.6 Generation of antisera via immunization of mice 
Antisera were generated via immunization of six week old female NMRI mice. 100 µg of 
solutions containing recombinant proteins or emulsions containing or inclusion bodies were 
diluted in 200 µl sterile PBS. 200 µl Freund’s incomplete adjuvant were added and the mix-
ture was injected subcutaneously. After four week a second dose of either 50 µg inclu-
sion bodies or 100 µg recombinant protein was administered. After 10 days mice were 
anesthesized by intraperitoneal injection of ketamine and xylazine according to protocol 
of the manufacturer (Sigma-Aldrich). Whole blood of mice was obtained via heart 
puncture. Sera from naïve mice served as negative controls. 
2.5 Entomological methods 
2.5.1 Rearing of Anopheles stephensi 
Anopheles stephensi mosquitoes were reared in an insectary at 26 ± 0.5°C with a humidity 
of 80 ± 2 % and a light/dark cycle of 12 h each. Alimentation of mosquitoes that were used 
for colony maintenance was by means of sterile 5 % saccharose/ 0.1 % sea salt solution con-
taining 0.05 % para-aminobenzoic acid. Once per week egg production was induced by ali-
mentation with mouse blood. After four days eggs were collected in a small glass beaker 
containing a solution of 0.1 % sea salt. With maturation of larvae, density of larvae per tray 
was reduced resulting in a density of approximately 300 larvae per 3 l of 0.1 % sea salt solu-
tion. Larvae were fed with fodder pellets. Pupae were transferred into a small glass beaker 
residing within a new mosquito cage.  
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2.5.2 Infection of Anopheles stephensi 
Mosquitoes which were reared for infection by P. falciparum were fed with 5 % saccha-
rose/ 0.1 % sea salt solution containing 0.05 % para-aminobenzoic acid and 40 µg/ml genta-
micin (Beier et al., 1994). One day prior to infection female mosquitoes were starved. Per-
coll-purified gametocytes were mixed with an equal volume of freshly drawn human eryt-
hrocytes. The combined pellet was mixed with an equal volume of prewarmed heat-
inactivated human serum. The mixture was transferred to a glass feeder that was kept at 
37°C. The mosquitoes were allowed to feed for 20 min in the dark. Only mosquitoes with 
fully engorged midguts were kept. After 24 h mosquito midguts were isolated and prepared 
for indirect IFA as described above (see 2.2.6). 
2.6 Mass spectrometry 
Sample preparation 
2 ml of RBC concentrate per sample were centrifuged, the supernatant was removed and 
cells were resuspended in 8 ml PBS containing the substances to be investigated, i.e. XA 
at different concentrations or XA combined with potential inhibitors. After incubation at 
room temperature the incubation solution was diluted with ice-cold PBS to 50 ml and 
centrifuged (1260 x g, 5 min, at 4°C). The RBC pellet was washed 4 x with PBS to re-
move residual extracellular XA. The cell suspension was sonicated (2 min 50 % intensi-
ty; 50 % duty cycle) on ice. Cell debris was pelleted by centrifugation (5 min, 15 500 x g) 
and the cell lysate was further cleared by filtration through a 0.22 µm syringe filter and a 
centrifuge filter unit with 5 kDa cut-off. 
LC/ESI/MS/MS analysis 
LC/ESI/MS/MS (Liquid chromatography/ electrospray injection/ tandem mass spectro-
metry) analyses to quantify XA in the RBC samples were kindly carried out by Michael 
Völker of the laboratory of PD Dr. Matthias Unger at the Institute for Pharmacy and 
Food Chemistry, University of Würzburg. Briefly, samples were injected into a HPLC 
(high performance liquid chromatography) system (Agilent 1200, Agilent Technolo-
gies) and separated via a reverse phase HPLC column (Synergi MAX-RP 50 x 2.0 mm 
4 µm, Phenomenex®). Subsequently the eluate was ionized via electrospray ionization 
(ESI) and ions were transferred to the triple quadrupole mass analyzer which was oper-
ated in the multi-reaction monitoring mode (MRM). The system was calibrated by ana-
lyzing solutions containing different concentrations of the analyte (1 - 250 ng/ml XA. 
Parameters for HPLC and MS are listed in Tab. 8.3 -8.4 (Appendix). 
 
3 Results 
3.1 Reverse genetics studies on PfCCp5 and PfFNPA 
The gene loci encoding two PfCCp family proteins, PfCCp5 and PfFNPA, were dis-
rupted in order to gain information on the potential roles of the proteins by studying the 
phenotype of the KO parasites. Two parasite lines possessing disrupted pfccp5 loci and 
one parasite line with disrupted pffnpa gene locus were constructed by Dr. Marie-
Adrienne Dude (Dude, 2009). Additionally, she generated two parasite lines in which 
the pfccp5 loci were modified by adding the sequence encoding a double HA-tag to the 
3’ end of the gene upstream of the stop codon.  
3.1.1 Verification of modified gene loci 
Diagnostic PCR 
As Dr. Dude did not observe growth of parasites after transfection with the PfCCp5-KO 
plasmid, two new vials of parasites were thawed that had been cryopreserved directly 
after transfection. In contrary to the observations of Dr. Dude the transfected parasites 
started to grow within few weeks. Thus, it was possible to isolate genomic DNA of the 
above mentioned five parasite lines.  
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Fig. 3.1: A. Schematic depicting the pfccp5 gene locus and the modified KO locus resulting 
from homologous recombination. Regions used for discrimination between wild-type (WT) and 
KO locus by means of diagnostic PCR are marked with A – D. B. Diagnostic PCR on genomic 
DNA of WT parasites and five PfCCp5-KO clones. Clone 2A4 clearly shows absence of the 
WT locus. Gel lanes are labeled according to panel A. 
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The site-specific integration of the respective transfection plasmid was then confirmed 
by diagnostic PCR. Limiting dilution was carried out to obtain clonal lines devoid of 
parasites carrying a wild-type locus of the respective gene of interest. Only for one of 
the two independently transfected PfCCp5-KO parasite lines clones were detectable. 
The obtained clones were isolated and the genotypes of five of the clones were investi-
gated via diagnostic PCR. For the clone PfCCp5-KO-2A4 absence of the wild-type 
pfccp5 locus was clearly confirmed. The other four clones, however, showed a band 
corresponding to the wild-type pfccp5 locus and were thus excluded from further stu-
dies (Fig. 3.1). 
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Fig. 3.2: A. Schematic depicting the pfccp5 gene locus and the modified HA locus resulting 
from homologous recombination. Regions used for discrimination between wild-type (WT) and 
HA locus via diagnostic PCR are marked with A – D. Restriction enzyme recognition sites used 
for examination of the genotype via Southern blot are shown and resulting fragments are 
marked in green. Binding site of the Southern blot probe is indicated with a dashed line. B. Di-
agnostic PCR on genomic DNA of WT parasites and four PfCCp5-HA clones. All clones 
showed bands representing the modified pfccp5 locus after vector integration. Gel lanes are 
labeled according to panel A. 
After limiting dilution of the two individually transfected PfCCp5-HA parasite lines 
seven clones were isolated in total. For the four clones further investigated, PfCCp5-
HA1-4E2, PfCCp5-HA2-5D1, PfCCp5-HA2-6A1 and PfCCp5-HA2-6A9 absence of 
parasites possessing wild-type pfccp5 locus was confirmed by means of diagnostic PCR 
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(Fig. 3.2). Of the PfFNPA-KO line eight clones were obtained after dilutional cloning. 
The genotype of six clones was investigated via diagnostic PCR and clearly showed 
absence of wild-type pffnpa locus for the clones PfFNPA-KO-1H4, PfFNPA-KO-2D2 
and PfFNPA-KO-2F1 (Fig. 3.3). 
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Fig. 3.3: A. Schematic depicting the pffnpa gene locus and the modified KO locus resulting 
from homologous recombination. Regions used for discrimination between wild-type (WT) and 
KO locus by means of diagnostic PCR are marked with A – D. Restriction enzyme recognition 
sites used for examination of the genotype via Southern blot are shown and resulting fragments 
are marked in green. Binding site of the Southern blot probe is indicated with a dashed line. B. 
Diagnostic PCR on genomic DNA of WT parasites and six PfFNPA-KO clones. All clones 
showed bands representing the pffnpa locus after vector integration. Gel lanes are labeled ac-
cording to panel A. 
Southern Blot 
The modification of the pfccp5 locus in the clones PfCCp5-HA-5D1 and PfCCp5-HA-
6A1 was investigated via Southern blot by Dipl.-Biol. Maike Gieseke. Genomic DNA 
of the two genetically modified parasite lines and of wild-type parasites was digested 
with either PacI and AclI or PacI and PstI. Analysis of the products of the restriction 
digest by means of Southern blot showed that both clones were devoid of the wild-type 
pfccp5 locus (Gieseke, 2010). Clone PfCCp5-HA-5D1 showed bands corresponding to 
restriction digested episomal pfccp5/pCAM-HA plasmid in addition to bands characte-
ristic for the disrupted pfccp5 locus (Fig. 3.4 A). 
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B 
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Fig. 3.4: Southern blot confirming the modification of gene loci and absence of (wild-type) WT 
locus of the respective gene of interest. A. Genomic DNA of WT and PfCCp5-HA clones 5D1 
and 6A1 was restriction digested with PacI and AclI (1) or PacI and PstI (2). Location and 
lengths of the resulting restriction fragments are marked in Fig. 3.2 A. In contrast to clone 6A1, 
clone 5D1 shows bands corresponding to the episomal transfection plasmid (Figure from Gie-
seke, 2010). B. Genomic DNA of (wild-type) WT and PfFNPA-KO clones 1H4 was restriction 
digested with NdeI (1), MfeI and NcoI (2) or BsaHI and BamHI (3). Location and lengths of the 
resulting restriction fragments are marked in Fig. 3.3 A. 
Integration of the transfected plasmid into the pffnpa locus was also investigated via 
Southern blot analysis. Genomic DNA of clone 1H4 of the FNPA-KO parasite line and 
of wild-type parasites was either restriction digested with NdeI only, with MfeI and 
NcoI or with BsaHI and BamHI. A DIG-labeled probe complementary to a region up-
stream of the integration site of the transfection plasmid was used to detect the DNA 
fragments obtained after the restriction digest (Fig. 3.3 A). For either combination of 
restriction enzymes used the disruption of the pffnpa gene was verified and absence of 
parasites carrying the wild-type pffnpa locus was proven Fig. 3.4 B). For the most re-
cently isolated clone PfCCp5-KO-2A4 Southern blot analysis still is to be carried out. 
3.1.2 Phenotype analyses of genetically modified parasites 
Indirect IFAs and Western Blots 
After the modifications of the gene loci of interest had been confirmed, the absence of 
the respective gene product was examined at the protein level. The absence of PfCCp5 
was confirmed in the PfCCp5-KO-2A4 parasite line via Western blot and indirect IFA 
using anti-PfCCp5 antisera (Fig. 3.5). Likewise, no PfFNPA protein was detected in 
PfFNPA-KO-1H4 parasites in Western Blot and indirect IFA (Fig. 3.6). The expression 
of the PfCCp5-HA fusion protein by the parasite line PfCCp5-HA-6A1 was confirmed 
B A 
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via Western blot probed with anti-HA antibody (Fig. 3.7). The protein band obtained 
with the anti-HA antibody was of approximately the same molecular weight as the pro-
tein band obtained using anti- PfCCp5 antisera. It was not possible to detect the fusion 
protein in indirect IFAs (data not shown). 
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Fig. 3.5: A. Western blot analysis of gametocyte lysate of PfCCp5-KO clone 2A4 showed ab-
sence of PfCCp5 (118.6 kDa). PfactII (42.6 kDa) served as loading control. B. Indirect IFA con-
firmed absence of PfCCp5 in PfCCp5-KO-2A4 gametocytes. Scale bar - 2 µm. 
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Fig. 3.6: A. Western blot analysis of gametocyte lysate of PfFNPA-KO clone 1H4 showed ab-
sence of PfFNPA (100.1 kDa). Pf39 (39.4 kDa) served as loading control. B. Indirect IFA con-
firmed absence of PfFNPA (green) in PfFNPA-KO-1H4 gametocytes. Erythrocytes were coun-
terstained with Evans Blue, scale bar - 2 µm, WT - wild-type. 
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Fig. 3.7: Western blot analysis of gametocyte lysate of PfCCp5-HA clone 6A1 showed a band 
at approximately 120 kDa when probed with anti-HA antibody (HA), whilst no band was ob-
served in wild-type (WT) gametocyte lysate. For both lysates a band at approximately 120 kDa 
was observed when probing with anti-PfCCp5 antiserum. Probing with anti-CCp5 antiserum 
served as loading control and demonstrated that in the parasite lysate of the mutant less PfCCp5 
protein was present as compared to WT parasite lysate. 
Gametocyte formation, gametogenesis and fertilization 
Both asexual parasite replication and gametocytes development of PfCCp5-KO and 
PfFNPA-KO mutants did not show obvious alterations as compared to wild-type para-
sites. The formation of gametes and zygotes of the gene-disruptant mutants was induced 
in vitro by triggering gametogenesis with XA and incubation of the parasite cultures at 
RT. For the investigation of ookinete development PfFNPA-KO gametocytes were fed 
to female An. stephensi mosquitos. After 24 h the mosquito midguts were isolated and 
investigated for the present of retort stages, an intermediate stage between zygote and 
ookinete, and the presence of ookinetes. The different development stages were detected 
via indirect IFA using antisera directed against stage-specific proteins (Fig. 3.8).  
 
Fig. 3.8: Indirect IFA showed that development of PfCCp5-KO-2A4 and PfFNPA-KO-1H4 
parasites throughout the sexual phase is not affected by absence of the respective protein. Pro-
teins expressed in the respective life cycle stage are shown in green. Erythrocytes were coun-
terstained with Evans Blue. Macrogc - macrogametocyte, Microgc - microgametocyte, Ma-
crogm - macrogamete, scale bar - 2 µm. 
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The formation of microgametocytes was investigated light-microscopically after induc-
ing gametogenesis with XA. Neither PfCCp5-KO nor PfFNPA-KO parasites showed 
alterations in gamete formation or zygote formation. The development of PfFNPA-KO 
parasites into ookinetes was not affected by absence of PfFNPA. Investigation of ooki-
nete development of PfCCp5-KO parasites was not achieved due to time limitations. 
For the PfCCp5-HA parasite lines a reduced gametocyte formation was observed as it is 
often the case for parasites undergoing periods of extended cultivation. Further studies 
on the generated KO parasite lines are described below (3.2.1). 
3.2 Co-dependent expression of sexual stage-specific 
proteins 
Amongst the members of the PfCCp protein family the phenomenon of co-dependent 
expression has been observed. It manifests in the absence or reduced abundance of all 
proteins if only one of the six PfCCp proteins is not expressed due to disruption of its 
gene locus (Pradel et al., 2006; Simon et al., 2009). In the present work ten mutants, 
lacking one sexual stage-specific protein each, were screened for the expression of 20 
proteins expressed in sexual stage parasites. The study aimed at discovering further in-
terdependencies of protein expression and protein localization. 
3.2.1 Analysis of co-dependent expression via indirect IFA 
In accordance with previous studies the results of indirect IFAs showed co-dependent 
expression amongst PfCCp proteins. Thus, all PfCCp proteins were absent or present in 
only reduced amount in PfCCp1-KO, PfCCp4-KO, PfCCp5-KO and PfFNPA-KO. The 
decrease in protein abundance was less prominent for PfCCp4 as compared to the other 
five PfCCp proteins. In PfCCp5-KO and PfFNPA-KO parasites the reduced expression 
of some PfCCp proteins was less prominent than in the PfCCp1-KO. Expression of all 
other proteins investigated was not altered in the absence of PfCCp1, PfCCp4, PfCCp5 
or PfFNPA (see Tab. 3.1, Appendix Fig. 8.5). As PfCCp5 is expressed already in the 
schizont stage, its expression was additionally investigated in this parasite stage via in-
direct IFA. Whilst in PfCCp1-KO gametocytes only very low amounts of PfCCp5 were 
detectable, the expression of PfCCp5 was not altered in schizonts of the PfCCp1-KO 
parasite line (Fig. 3.9). Amongst the 200 combinations of mutants and proteins screened 
for interdependencies of protein expression via indirect IFA, one pair of proteins 
showed to be expressed co-dependently, beside the co-dependently expressed PfCCp 
proteins. In both mutants expressing only truncated versions of Pfs230, Pfs230-KOd1 
and Pfs230-KOd2, PfactinII did not localize homogeneously to the periphery of game-
tocytes as in wild-type parasites. Instead, in Pfs230-KOd1 parasites, expressing only a 
fragment of Pfs230  
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Tab. 3.1: Summary of results of indirect IFAs investigating the expression of sexual stage pro-
teins in eight KO parasite lines. Localization of all proteins was investigated in gametocytes 
except that of Pfs25 (macrogametes) and Pfs28 (zygotes). For IFA images see Appendix 
Fig. 8.5. 
 
CCp1-
KO 
CCp4-
KO 
CCp5-
KO 
FNPA-
KO 
Pfs230-
KOd1 
Pfs230-
KOd2 
Pfs48/45
-KO 
Pfg377-
KO 
PfCCp1 + +/ + + ++ ++ ++ ++ 
PfCCp2 +/ + + + ++ + ++ ++ 
PfCCp3 +/ + + + ++ + ++ ++ 
PfCCp4 + +/ ++ ++ ++ ++ ++ ++ 
PfCCp5 +/a) +/++ +/ ++ ++ ++ ++ ++ 
PfFNPA +/ +/++ +/  ++ ++ ++ ++ 
Pfpeg3 ++ ++ ++ ++ ++ ++ ++ ++ 
Pfs16 ++ + ++ ++ ++ ++ ++ ++ 
PfGAP5
0 
++ ++ ++ ++ ++ ++ ++ ++ 
PfWLP1 ++ ++ ++ ++ ++ ++ ++ + 
MYO1C
/ 
PfmyoA 
++b) ++c) ++b) +c) +c) ++c) ++c) ++c) 
Pfs230 ++ ++ ++ ++ d) +/, #e) ++f) ++ 
PfMR5 ++ ++ ++ ++ +, #g) +, #g) ++ ++ 
Pfs47 + ++ ++ ++ ++ ++ ++ ++ 
Pfs25 ++ ++ ++ ++ + ++ ++ ++ 
Pfs28 + ++ ++ ++ ++ ++ ++ ++ 
PfactinI ++ ++ ++ ++ ++ ++ ++ ++ 
PfactinII ++ ++ ++ ++  +/, # + ++ 
alpha-
tubII ++ ++ nd ++ + ++ ++ ++ 
Tubulin ++ ++ ++ ++ ++ ++ ++ ++ 
 
 
Expression on protein level: 
++ = as wild-type 
+ = reduced 
+/ = low expression 
 = absent 
# = altered localization  
nd = not determined 
 
a) expression in schizonts as in wild-type 
b) PfMyoA 
c) MYO1C 
d) small fragment still detectable with certain antibody, altered localization 
e) fragment only 
f) expression altered in macrogametes: reduced and altered localization 
g) in KO rather punctuate expression, in wild-type homogenous 
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(452 aa instead of full length protein of 3135 aa), PfactinII was not detectable in indirect 
IFAs. In Pfs230-KOd2 parasites, expressing a longer fragment of Pf230 than Pfs230-
KOd1 mutants (950 aa), labeling with antiserum directed against PfactinII showed dis-
tribution of PfactinII in a spotted pattern in contrast to the homogenous expression in 
wild-type parasites. Further experiments investigating the co-dependent expression of 
the two proteins are described in section 3.4.2. All other combinations of mutants and 
sexual stage proteins investigated did not show an expression differing from that in 
wild-type parasites in a pronounced way (Tab. 3.1, Appendix Fig. 8.5). 
 
Fig. 3.9: Indirect IFA showed that expression of PfCCp5 is not altered in PfCCp1-KO schi-
zonts. In contrast, in PfCCp1-KO gametocytes only very low amounts of PfCCp5 (green) were 
detectable. Erythrocytes were counterstained with Evans Blue. BF - bright field, WT - wild-type, 
scale bar - 2 µm. 
3.2.2 Analysis of co-dependent expression via RT-PCR 
 
Fig. 3.10: RT-PCR on cDNA of PfFNPA-KO, clone 1H4 and wild-type (WT), showed presence 
of transcripts of the pfccp genes. Primers detecting Pf39 were used as control. RT-PCR carried 
out without adding reverse transcriptase (RT–) served as control for presence of genomic DNA. 
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Co-dependent expression was investigated at transcript level for clone 1H4 of the 
FNPA-KO parasite line. In accordance with previous reports on PfCCp gene-disruptant 
parasite lines, transcripts of all pfccp genes were detected employing RT-PCR (Fig. 
3.10). In the current analysis of clone 1H4 of the PfFNPA-KO, however, the band for 
pfccp3 was very faint. For pffnpa also a faint band was observed. Similar results had 
been obtained for the other PfCCp gene-disruptant parasite lines so far investigated, as 
well. In each case, low level residual expression of the disrupted gene was observed 
(Simon et al., 2009). 
3.3 Studies on the IMC of P. falciparum gametocytes 
Although well studied in asexual malaria parasites, the presence and composition of the 
IMC of P. falciparum had not been studied in gametocytes. Hence, we investigated the 
expression of select genes encoding IMC components on transcript and protein level. 
Furthermore, EM studies were carried out to gain information on the composition of the 
membranes surrounding the gametocyte.  
3.3.1 Transcript analysis of genes encoding components of the IMC 
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Fig. 3.11: RT-PCR on cDNA obtained from asexual parasites of F12 strain as well as of wild-
type NF54 parasite culture containing mainly gametocytes showed expression of six myosin 
genes as well as of several genes encoding IMC components. Pfama1 and pfccp2 served as 
stage-specific controls. The negative control to which no reverse transcriptase (RT) was added, 
confirmed absence of genomic DNA (Tews, 2011; Simon et al., 2012). 
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Beside the components of the IMC, the six myosin isoforms encoded in the genome of 
P. falciparum had not been described in gametocytes until now, either. We therefore 
included the six myosins expressed in Plasmodium spp. in the transcript analyses. To 
ensure functionality of the oligonucleotides used in RT-PCRs, the transcript of the 
genes was firstly detected in asexual parasites of the gametocyte-less subclone F12, 
where expression of all 14 genes investigated was observed, with the exception of 
pfmyoD, pfmyoF and pfccp2. The latter served as control for the presence of gameto-
cytes. In gametocytes, transcripts of all 14 genes were detected, except that of pfmyoE. 
A faint band for pfama1 which served as control for the presence of cDNA of asexual 
parasites was detected. The RT-PCRs were carried out in great part by undergraduate 
student Sabrina Tews, BSc in the course of her bachelor thesis (Tews, 2011). Taken 
together the results of this study showed that the components of the IMC known from 
invasive stages of the malaria parasite are expressed in gametocytes. The six myosins on 
the other hand seem to be expressed differentially in asexual blood stages and in game-
tocytes (Fig. 3.11). 
3.3.2 Ultrastructural study on IMC composition 
In addition to studying the expression of IMC components via RT-PCR, the IMC was 
investigated at ultrastructural level. Both in wild-type gametocytes as well as gameto-
cytes of three KO mutants were prepared for transmission electron microscopical analy-
sis. Gametocytes of the mutants Pfs230-KOd2 and Pfs48/45-KO exhibited the typical 
trilamelar membrane structure comprised of cisternae of the IMC, parasite plasma 
membrane  and  PVM.  However, in  Pfs230-KOd1  gametocytes  only two  membranes 
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Fig. 3.12: Electron micrographs showing the membrane structure of gametocytes of WT para-
sites and of KO strains Pfs230-KOd1, Pfs230-KOd2 and Pfs48/45-KO. In gametocytes of strain 
Pfs230-KOd1 only two membranes were visible at the periphery of gametocytes, in contrast to 
gametocytes of the other strains exhibiting three membranes as observed in WT gametocytes. 
IMC - inner membrane complex, PPM - parasite plasma membrane, RBCM - RBC membrane. 
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were visible (Fig. 3.12). The number of membranes surrounding the gametocytes was 
quantified in 15 gametocytes of each parasite strain. According to the quantification, 
both mutants expressing truncated versions of Pfs230 showed altered membrane com-
position in comparison to wild-type gametocytes. As listed in Tab. 3.2 in Pfs230-KOd1 
gametocytes only one of the 15 gametocytes investigated showed the typical membrane 
composition, whilst in the Pfs230-KOd2 parasite line only four gametocytes of 15 
showed the trilamelar membrane composition as observed in wild-type parasites. 
Tab. 3.2: Investigation of the membrane structure of WT gametocytes and the three KO parasite 
lines Pfs230-KOd1, Pfs230-KOd2 and Pfs48/45-KO was investigated at the ultrastructural lev-
el. Quantification of presence of the three membranes surrounding the gametocytes showed 
obvious differences in KO parasite lines Pfs230-KOd1 and Pfs230-KOd2 (n=15).  
No. of membranes WT Pfs230d1 Pfs230d2 Pfs48/45-KO 
3  15 1 4 12 
2  0 10 6 2 
partially 2  0 4 5 1 
3.3.3 Generation of anti-PfmyoA antiserum 
To investigate the expression of the IMC protein PfmyoA in gametocytes, an antiserum 
directed against a fragment of the protein was generated. A 750 bp region of the protein 
(corresponding to amino acids 227 – 476) was chosen for amplification as previously 
published by Pinder et al. (1998). The PCR product was cloned into the expression vec-
tor pGEX-4T-1. The recombinant protein was expressed in E. coli BL21 CodonPlus® 
(DE3)-RIL cells fused to an N-terminal GST tag (26.1 kDa).  
 
Fig. 3.13: A. SDS-PAGE after expression of recombinant protein of PfmyoA (28.2 kDa) by 
E .coli BL21 CodonPlus® (DE3)-RIL. After induction of transcription (+ IPTG) a band of 
54.3 kDa was observed for the recombinant protein PfmyoArp1 fused to GST tag (arrow). Two 
clones (1, 2) are depicted. For comparison, the lysate of control bacteria (–, no IPTG added) is 
shown. B. Different volumes (µl) of recombinant protein PfmyoA-rp1 were applied to SDS-
PAGE after isolation via inclusion bodies for estimation of protein concentration. 
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The expected molecular weight including the GST tag was approximately 54.3 kDa. 
The IPTG-induced expression was first carried out in small scale and the obtained re-
combinant protein was analyzed via SDS-PAGE. An aliquot of the bacteria culture was 
isolated before induction of protein expression to discriminated endogenous bacterial 
proteins from the recombinant protein of PfmyoA. The two bacteria clones investigated 
showed a band at the expected molecular weight of 54.3 kDa, whilst the control bacteria 
did not show a band of the same size (Fig. 3.13). The recombinant protein was isolated 
within inclusion bodies of the bacteria. The inclusion bodies were used for immuniza-
tion of mice in order to obtain a polyclonal antiserum directed against PfmyoA. 
 
Fig. 3.14: A. Western Blot using anti-PfmyoA antiserum showed a band of the expected size 
(92.3 kDa, arrow) in both schizont and gametocyte lysate. B. Indirect IFAs detecting PfmyoA 
(Alexa-488, green) in a stage V gametocyte. The rabbit antiserum directed against human 
MYO1C showed a similar fluorescence pattern. Erythrocytes were counterstained with Evans 
Blue. Scale bar - 2 µm. 
The PfmyoA antiserum was tested in Western Blot and indirect IFA (Fig. 3.14). In both 
schizont lysate and gametocyte lysate a band of the expected molecular weight of 
92.3 kDa was detected with anti-PfmyoA antiserum. In indirect IFA on gametocytes the 
antiserum show a similar fluorescence pattern as anti-MYO1C antiserum. This antise-
rum is directed against the human myosin isoform MYO1C. The sequence of the cor-
responding immunogen exhibits 62 % identitity and 75 % similarity to PfmyoC and 
58 % identity and 80 % similarity to PfmyoA. 
3.3.4 Indirect IFAs investing presence of PV and IMC 
After observing alterations of the trilaminar pellicule in gametocyte of the mutants 
Pfs230-KOd1 and Pfs230-KOd2, the presence of both PVM and IMC was investigated 
in these parasites via indirect IFAs. The antisera applied were directed against proteins 
associated with one of the two membranes. Both Pfs16 and PfEXP-1, proteins of the 
PVM, were expressed in gametocytes of the Pfs230-deficient mutants similar as in wild-
type gametocytes. Expression of PfSERP, a soluble protein of the PV, was also not al-
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tered in the absence of full-length Pfs230. The IMC proteins PfGAP50 and PfmyoA 
(detected by means of anti-MYO1C antiserum) were expressed in the mutants compara-
bly to wild-type parasites (Fig. 3.15). Since the PPM is essential for gametocyte surviv-
al, the presence of this membrane was not investigated in detail, however in earlier ex-
periments expression of several proteins associated with the PPM had been shown (e.g. 
PfCCp1, see Tab. 3.1). Thus, it was concluded that although only two membranes sur-
rounding the parasite were observed via electron microscopy, all three membranes were 
present in the mutant parasite lines. Most likely the space between two of the mem-
branes was reduced dramatically and therefore was beneath solution limit.  
PfExp-1
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Pf230-KOd2
Pfs16 PfSERP PfGAP50 MYO1C/
PfmyoA
 
Fig. 3.15: Indirect IFAs investigating the expression of proteins of the PV or PVM Pfs16, 
PfEXP-1 and PfSERP as well as IMC-associated proteins PfGAP50 and PfmyoA in gameto-
cytes. All five proteins (Alexa Fluor-488 labeled, shown in green) were expressed in the two 
mutant parasite strains similarly as in wild-type (WT) gametocytes. Anti-MYO1C antiserum 
was used to detect PfmyoA. Erythrocytes were counterstained with Evans Blue. Scale bar -
 2 µm. 
3.4 Characterization of PfactinII 
Plasmodium spp. represent the only genus of the Apicomplexan clade that expresses 
two isoforms of actin. Although PfactinII had already been described to be specifically 
expressed in sexual parasite stages (Wesseling et al., 1989), its role remained unknown. 
In order to gain more information on PfactinII, its expression as well as interactions 
with other proteins were investigated. 
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3.4.1 Expression of PfactinII throughout the life cycle of P. falciparum 
A recombinant protein corresponding to amino acids 169 – 345 of PfactinII had been 
generated in our laboratory (see Fig. 3.24). E. coli inclusion bodies containing the re-
combinant protein were injected in mice and antiserum directed against PfactinII was 
obtained. Specificity of the antiserum was confirmed in WB analyses. The antiserum 
was employed in indirect IFAs to examine the expression of PfactinII in different life-
cycle stages. For comparison the expression pattern of PfactinI was also investigated. 
 
Fig. 3.16: Indirect IFAs investigating the expression of PfactinII in different parasite stages. 
A. PfactinII is not expressed in asexual blood stages, whilst PfactinI was detected in ring, tro-
phozoite and schizont stage. B. PfactinI and PfactinII are expressed in Stage I – V gametocytes. 
PfactinI and PfactinII are labeled with Alexa Fluor-488 (green), other proteins are labeled with 
Alexa Fluor-594 (red). BF - bright field, scale bar - 2 µm. 
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PfactinII was not detected in asexual blood stages, whilst PfactinI was present in ring 
stage parasites, in trophozoites and in schizonts (Fig. 3.16 A). The labeling of PfactinI 
was located within that of PfExp-1, a protein localizing to the PVM. Both PfactinII and 
PfactinI were detected in gametocytes stage I – V. The signal for PfactinII increased 
with gametocyte maturation (Fig. 3.16 B). In macrogametes the protein was still ex-
pressed intensely, whilst in zygotes the signal ceased. In retort stages only very weak 
expression was seen in the residual body. PfactinII was detected neither in the develop-
ing microgametes nor in the residual body of the microgametocyte. In all stages in 
which PfactinII was detectable, the protein localized predominantly to the cell peri-
phery. In contrast, PfactinI showed a rather diffuse distribution within the parasite cell. 
 
Fig. 3.17: Indirect IFAs investigating the expression of PfactinII in different parasite stages. 
PfactinII is expressed in macrogametes and zygotes. PfactinII was labeled with Alexa Fluor-488 
(green), other proteins were labeled with Alexa Fluor-594 (red). Scale bar - 2 µm. 
 
Fig. 3.18: A. Western blot analysis using anti-PfactinI antiserum showed expression of PfactinI 
(41.9 kDa) in gametocytes (Gc), activated gametocytes (aGc) and mixed blood stages of the 
gametocyte-less strain F12. A faint band detected in RBC lysate at 42 kDa resulted from a 
neighboring band (Western blot kindly provided by L. Sologub). B. Western blot analysis using 
anti-PfactinII antiserum showed expression of PfactinII (42.6 kDa) in Gc and aGc. A faint pro-
tein band was observed for the gametocyte-less strain F12. No protein band was observed in 
uninfected RBCs (Rupp et al., 2010). 
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PfactinII expression was also investigated via Western blot using the same anti-PfactinII 
antiserum. A protein band at the expected molecular weight of 42.6 kDa was observed 
in both gametocytes and gametocytes activated to undergo gamete formation (Fig. 
3.18). A faint protein band was observed in the gametocyte-less strain F12. An addi-
tional band was observed at approximately 70 kDa and in non-activated gametocytes a 
third band at 90 kDa. The observation of a weak expression in the gametocyte-less 
strain F12 is in concordance with the faint band observed in F12 cDNA when carrying 
out RT-PCR (Fig. 3.11). PfactinI was detected in lysates of both gametocytes and acti-
vated gametocytes as well as in lysate of mixed asexual blood stages of the F12 strain. 
The Western blot results thus confirmed the results of indirect IFA that were obtained 
on expression of the two actin isoforms. 
3.4.2 Co-dependent expression of PfactinII and Pfs230 
As PfactinII was not detectable via indirect IFAs in mutants lacking full-length Pfs230 
(Tab. 3.1, Appendix Fig. 8.5) this co-dependent expression was further investigated. 
RT-PCR was carried out to see whether transcription or transcript stability was effected. 
For both mutants, Pfs230-KOd1 and Pfs230-KOd2, and for wild-type parasites RNA 
was obtained from cultures containing both asexual blood stages and gametocytes. In 
the subsequent RT-PCR using cDNA derived from both mutants as well as from wild-
type a PCR product corresponding to pfactinII transcript was detected (Fig. 3.19).  
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Fig. 3.19: RT-PCR on cDNA of wild-type (WT), Pfs230-KOd1 and Pfs230-KOd2 parasite lines 
showed presence of pfactinII transcript in both mutants. Amplification of pfama1 served as con-
trol for presence of cDNA of asexual blood stages, pfccp2 as stage-specific control for gameto-
cytes. RT-PCR carried out without adding reverse transcriptase (–RT) served as control for 
presence of genomic DNA. 
Similarly, a DNA fragment was amplified from pfactinI transcript when using the three 
cDNA samples as template. Oligonucleotides targeting pfama1 and pfccp2 were used to 
test for presence of asexual blood stage parasites and gametocytes, respectively. For the 
two mutants the signal of pfactinI was considerably stronger than that of pfactinII. This 
can be explained by the greater amount of asexual parasites in the samples as concluded 
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from the strong pfama1 signal. The intensity of the pfactinII signal was in concordance 
with that of the signal observed for pfccp2. For all cDNA samples a RT-PCR reaction 
was carried out without adding reverse transcriptase to confirm absence of genomic 
DNA. 
Next, the presence of PfactinII in the two mutants lacking wild-type Pfs230 was investi-
gated via Western blot. In both mutants a band corresponding to PfactinII was detected 
at the expected molecular weight of approximately 43 kDa as in WT gametocytes (Fig. 
3.20). As observed before (Fig. 3.18), additional bands were visible at around 70 kDa in 
wild-type and KO parasite lines and for wild-type and Pfs230-KOd2 also at approx-
imately 90 kDa. As a gametocyte loading control PfCCp2 was detected in the parasite 
lysates. The band running at the expected molecular weight of 185 kDa was comparable 
in the two mutants, the band observed in wild-type lysate was less intense. In contrast, 
the bands for PfactinII were of the same intensity in all of the three lysates. Thus, it 
seems that the amount of PfactinII is reduced in the two mutants (Fig. 3.20). In contrary 
to the observations of indirect IFAs these results suggest, that PfactinII is still present in 
Pfs230-KOd1 parasites. It is possible that is it mislocated or misfolded and thus not de-
tectable in indirect IFA. 
 
Fig. 3.20: Western Blot analysis investigating the presence of PfactinII in gametocyte lysates of 
wild-type (WT), and the two mutant strains Pfs230-KOd1 (230d1) and Pfs230-KOd2 (230d2). 
PfactinII was detected in all of the three lysates. Detection of PfCCp2 served as gametocyte 
loading control. Arrows highlight bands of the expected molecular weight. 
Observing a co-dependent expression of PfactinII and Pfs230 via indirect IFAs was 
suggestive of a protein-protein interaction, as observed for the proteins of the PfCCp 
protein family. Hence, co-immunoprecipitation assays were carried out to investigate 
this possibility. When investigating the presence of Pfs230 via Western blot after preci-
pitating PfactinI or PfactinII from gametocyte lysate, a band for Pfs230 was observed 
that pointed at an interaction between Pfs230 and PfactinII. A protein band correspond-
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ing to an interaction between PfactinI and Pfs230 was not visible. The precipitation of 
PfactinI and Pfs230 from gametocyte lysate followed by detection of PfactinII in West-
ern blot showed an interaction between PfactinII and Pfs230 but not between PfactinII 
and PfactinI. After precipitation of PfactinII and Pfs230 followed by probing with anti-
PfactinI antiserum in Western blot, bands suggestive of protein-protein interactions 
were observed both between PfactinII and PfactinI as well as between Pfs230 and Pfac-
tinI (Fig. 3.21). In regard of these observations a protein-protein interaction between 
PfactinII and Pfs230 seems to be likely. However, further investigations are needed to 
clarify the partially contradictory results on interaction of PfactinI with PfactinII and 
Pfs230. 
 
Fig. 3.21: Co-immunoprecipitations investigating the potential interaction of PfactinII and 
Pfs230. When probing with anti-Pfs230 antiserum after immunoprecipitation, interaction was 
observed between PfactinII but not with PfactinI. When precipitating PfactinI and Pfs230 from 
gametocyte lysate, interaction of PfactinII with Pfs230 was observed but not with PfactinI. 
When precipitating PfactinII or Pfs230 followed by Western blot detecting PfactinI, interactions 
between both PfactinII and Pfs230 with PfactinI were observed. Gametocyte lysate (Gc-Lys) 
was subjected to Western blot analysis to illustrate the protein bands detected by the respective 
antiserum. 
After a protein-protein interaction between PfactinII and Pfs230 had been observed in 
gametocyte lysates, the localization of both proteins was investigated in gametocytes in 
order to see whether the subcellular localization of the proteins would enable them to 
interact. Gametocytes of both wild-type and Pfs230-KOd2 strain were fixed with PFA 
to preserve the structure of the cells. Antiserum directed against Pfs230 derived from 
rabbit and antisera directed against PfactinI and PfactinII, derived from mice, respec-
tively were employed in the co-localization study. PfactinI was located intracellularly in 
homogenous distribution. It was surrounded by the signal for Pfs230 which was located 
at the cell periphery of gametocytes. No difference of PfactinI expression was observed 
between KO and wild-type gametocytes (Fig. 3.22). In Pfs230-KOd2 mutants Pfs230 
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was only visible in small patches (also see Appendix Fig. 8.5). PfactinII showed a co-
localization with Pfs230 at the periphery of gametocytes in wild-type gametocytes. In 
Pfs230-KOd2 gametocytes the two proteins also co-localized. PfactinII was distributed 
in exactly the same patchy pattern as Pfs230 in this mutant parasite line (Fig. 3.22). 
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Fig. 3.22: Indirect IFA of PFA-fixed gametocytes showed co-localization of PfactinII (Alexa-
488 labeled, green) and Pfs230 (Alexa-594, red) both in gametocytes of wild-type (WT) and of 
Pfs230-KOd2 parasites expressing a truncated version of Pfs230. For comparison PfactinI was 
detected which clearly was located within Pfs230-labeling. Scale bar - 2 µm. 
As gametes of Pfs48/45-KO parasites show dramatically reduced expression of Pfs230 
(Eksi et al., 2006), we wanted to see, whether the expression of PfactinII would also be 
affected in gametes of this parasite line. However, in contrast to Pfs230, the expression 
of PfactinII was only slightly reduced (Fig. 3.23 A). Instead of the homogenous expres-
sion of PfactinII in wild-type macrogametes, in the Pfs48/45-KO parasites PfactinII 
showed a punctuate expression. Quantification of the fluorescent signal of 30 wild-type 
and 30 Pfs48/45-KO macrogametes showed expectedly a highly significant reduction of 
Pfs230 expression in the mutant (Fig. 3.23 B). The fluorescence signal of PfactinII was 
also significantly reduced, when comparing wild-type and mutant macrogametes. How-
ever, the reduction was less strong. These results show that correct localization of Pfac-
tinII in gametes does not completely depend on presence of Pfs230 as observed in ga-
metocytes. 
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Fig. 3.23: A. Indirect IFAs showed that expression of Pfs230 was dramatically reduced and 
restricted to focal areas in Pfs48/45-KO macrogametes. Expression of PfactinI on the contrary 
did not show an obviously altered expression compared to wild-type (WT) gametes. Erythro-
cytes were counterstained with Evans Blue. Scale bar – 2 µm. B. Quantification of fluorescence 
intensity of Pfs230 or PfactinII labeling in WT and Pfs48/45-KO (48/45KO) macrogametes. 30 
gametocytes of WT and KO were investigated, respectively. Mean values and SD are depicted. 
Unpaired t test analysis showed significant differences between WT and Pf48/45-KO both for 
expression of Pfs230 and PfactinII. 
3.4.3 Modifications of the pfactinII locus via single crossing-over 
homologous recombination 
The gene locus encoding PfactinII was disrupted via plasmid integration in order to gain 
information on the potential role of the protein by studying the phenotype of the result-
ing KO parasites. In addition, a parasite line was generated in which the sequence en-
coding a double HA-tag was introduced at the 3’ end of the gene upstream of the stop 
codon. 
Diagnostic PCR 
After integration of the plasmid into the genome of the transfected parasites limiting 
dilution was carried out to obtain clonal lines devoid of parasites carrying a wild-type 
locus of the gene of interest. Several clones of the PfactinII-KO parasite line were iso-
lated. Absence of the wild-type allele was only shown for the clone PfactinII-KO-1A11  
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Fig. 3.24: A. Schematic depicting the pfactinII wild-type (WT) gene locus and the modified KO 
locus resulting from homologous recombination. Regions used for discrimination between WT 
and KO locus are marked with A – D. Location of the recombinant protein rp1 used for genera-
tion of antiserum is marked with a red line. B. Diagnostic PCR on genomic DNA of WT para-
sites and the PfactinII-KO clone 1A11 which showed absence of the WT locus. Gel lanes are 
labeled according to panel A. 
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Fig. 3.25: A. Schematic depicting the pfactinII wild-type (WT) gene locus and the modified HA 
locus resulting from homologous recombination. Regions used for discrimination between WT 
and HA locus are marked with A – D. Restriction enzyme recognition sites are shown and result-
ing fragments are marked in green. Binding site of probe is indicated with a dashed line. B. Di-
agnostic PCR on genomic DNA of WT parasites and five PfactinII-HA clones. All clones 
showed bands reflecting vector integration. All clones except PfactinII-HA-3D12 were devoid 
of WT pfactinII allele. Gel lanes are labeled according to panel A. 
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when carrying out diagnostic PCR (Fig. 3.24 B). After limiting dilution of the PfactinII-
HA parasite line several clones were isolated. For four of the five clones further investi-
gated absence of parasites possessing wild-type pfactinII locus was confirmed by diag-
nostic PCR (Fig. 3.25). 
Southern Blot 
The modification of the pfactinII locus in the clones PfactinII-HA-3A4 and PfactinII-
HA-3D4 was additionally investigated via Southern blot. Genomic DNA of both geneti-
cally modified parasite lines and of wild-type parasites was digested with either EcoRI 
and NheI or BamHI and BstBI. Analysis of the products of the restriction digest showed 
that both clones are devoid of the wild-type pfactinII locus (Fig. 3.26). 
  
Fig. 3.26: Southern blot confirming the modification of gene loci and absence of wild-type 
(WT) locus of pfactinII. A. Genomic DNA of WT and PfactinII-HA clones 3A4 and 3D4 was 
restriction digested with EcoRI and NheI (1) or BamHI and BstBI (2). Location and lengths of 
the resulting restriction fragments are marked in Fig. 3.25 A. B. Western blot investigating the 
expression of HA-tagged PfactinII in gametocytes of the uncloned PfactinII-HA parasite line. 
Both anti-HA antibody and anti-PfactinII antiserum detected the approximately 43 kDa protein 
as well as several additional bands. 
Indirect IFAs and Western Blots 
The expression of PfactinII-HA fusion protein was investigated via Western blot analy-
sis in gametocytes of the PfactinII-HA parasite line prior to obtaining clones via limit-
ing dilution. The fusion protein was detected with anti-HA antibody at the expected 
height. The band detected with anti-PfactinII antiserum from the same lysate runs at a 
slightly lower molecular weight and was weaker than the band detected by anti-HA an-
tibody (Fig. 3.26 B). The detection of the PfactinII-HA fusion protein via indirect IFA 
was not achieved.  
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The presence of PfactinII in the PfactinII-KO clone 1A11 was investigated via indirect 
IFA. The signal detected in the KO mutant was weaker than in wild-type parasites, 
however there was still quite pronounced expression of the protein observed (Fig. 3.27). 
WT
PfactII-KO
PfactII
 
Fig. 3.27: Indirect IFA showed residual expression of PfactinII (Alexa-488, green) in PfactinII-
KO clone 1A11. Erythrocytes were counterstained with Evans Blue. WT – wild-type, scale bar –
 2 µm. 
3.5 Characterization of the WD domain containing protein 
PfWLP1 
The WD40-domain containing protein PfWLP1 had been discovered due to its interac-
tion with PfCCp1 (see 1.5.2). It had so far been undescribed in the literature. Hence, the 
expression throughout the life cycle was investigated and genetically modified parasite 
lines were generated in order to gain more information about this protein. 
3.5.1 Generation of anti-PfWLP1 antiserum 
To investigate the expression of PfWLP1 throughout the parasite life cycle antiserum 
directed against a fragment of the protein was generated. An 822 bp region (correspond-
ing to amino acids 226 – 499) comprising three of the five WD40 domains was cloned 
into the expression vectors pGEX-4T-1 and pIH902 (see Fig. 3.28 and Fig. 3.35 A). The 
recombinant proteins that were expressed in E. coli BL21 CodonPlus® (DE3)-RIL cells 
had a molecular weight of 31.7 kDa and where fused to an N-terminal GST tag 
(26.2 kDa) or MBP tag (42.8 kDa), respectively. The expression of PfWLP1rp2 upon 
addition of IPTG was tested in small scale followed by analysis via SDS-PAGE. 
PfWLP1rp2 fused to a GST tag was visible as a band at a molecular weight of approx-
imately 58 kDa. The MBP fusion protein ran at a molecular weight of approximately 
72 kDa (Fig. 3.29 A). Before inducing the transcription of the gene of interest an aliquot 
of the bacteria culture was isolated. It served as control to discriminate endogenous bac-
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terial proteins from the introduced recombinant protein. In all clones investigated for the 
two constructs, the control bacteria did not show a protein band of comparable intensity 
at the respective molecular weight of the recombinant proteins. The GST-tagged recom-
binant protein was obtained from inclusion bodies, whilst the MBP-tagged version was 
isolated via protein purification employing amylose resin. The isolation of the MBP-
tagged PfWLP1 was kindly carried out by Dr. Nina Simon. Both inclusion bodies and 
purified protein were used to immunize mice in order to obtain polyclonal antisera di-
rected against PfWLP1 (Fig. 3.29 B). For indirect IFAs antiserum derived from immu-
nization with purified protein was used. For Western Blot analyses antiserum obtained 
after immunization with inclusion bodies was employed. Two further recombinant pro-
teins used for generation of antisera in mice were generated by Vanesa N. Ngongang, 
MSc (Ngongang, 2012). 
 
Fig. 3.28: Domain structure of the uncharacterized WD40 repeat-containing protein PfWLP1. 
The WD40 domains were depicted according to the SMART protein domain database 
(http://smart.embl-heidelberg.de/). The immunogenic region used for production of antiserum is 
labeled with blue line (rp2). 
 
  
Fig. 3.29: A. SDS-PAGE after expression of recombinant protein of PfWLP1 (~32 kDa) by 
E .coli BL21 CodonPlus® (DE3)-RIL. After induction of transcription (+ IPTG) a band of 
~58 kDa was observed for the recombinant protein PfWLP1rp2 fused to GST tag (pGEX, left 
panel). A protein of ~72 kDa was produced when PfWLP1rp2 was fused to MBP tag (pIH902, 
left panel). For both plasmid constructs two clones (1, 2) are depicted. For comparison, the ly-
sate of control bacteria (–, no IPTG added) is shown. B. Different volumes (µl) of recombinant 
protein PfWLP1rp2 were applied to SDS-PAGE after isolation via inclusion bodies for estima-
tion of protein concentration. 
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3.5.2 Expression of PfWLP1 throughout the life cycle of P. falciparum 
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Fig. 3.30: Indirect IFAs showed that PfWLP1 (Alexa-488, green) is expressed in asexual blood 
stages and that expression increases with maturation of parasites. Antiserum directed against 
PfExp-1 (Alexa-594, red) which locates to the PVM was used for visualization of the different 
parasite stages. BF - bright field, scale bar - 2 µm. 
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Fig. 3.31: Indirect IFAs showed that PfWLP1 (Alexa-488, green) is expressed in gametocyte 
stages II – V as well as in gametes and zygotes. Erythrocytes were counterstained with Evans 
Blue. In retort stages only a faint signal for PfWLP1 was detected in the residual body of the 
retort stage. Antiserum directed against Pfs28 (Alexa-594, red) were used for visualization of 
retort stages. Scale bar - 2 µm. 
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The investigation of the expression of PfWLP1 using the generated antiserum showed 
that PfWLP1 is expressed throughout the development of asexual blood stages. Intensity 
of the fluorescent signal increased with the maturation of parasites (Fig. 3.30). PfWLP1 
was detected in gametocytes stage II – V. In the course of gametocyte development in-
tensity of PfWLP1 expression increased. The fluorescent signal of gametocytes was 
stronger as compared to asexual blood stage parasites. The distribution was mainly ho-
mogenous with a partially spotted expression pattern. Stage I gametocytes were not in-
vestigated due to the difficulty to identify this first stage of gametocytogenesis without 
using a stage-specific marker. In macrogametes the protein was also detected in a rather 
homogenous distribution. In zygotes the fluorescent signal had decreased as compared 
to gametes. In retort stages only very faint expression was observed in the residual body 
(Fig. 3.31). Indirect IFAs were also carried out using neutral mouse serum, in order to 
rule out unspecific reaction of the immune sera with P. falciparum antigens (Fig. 3.32). 
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Fig. 3.32: Indirect IFAs were carried out with serum from naive mice. The serum (Alexa-488, 
green) did not show specific labeling of P. falciparum parasites. Stage specific proteins were 
labeled with Alexa-594 (red). Scale bar - 5 µm. Kindly provided by Dr. Nina Simon. 
The expression of PfWLP1 in different parasite stages was further investigated via 
Western blot analyses by MSc. Vanesa N. Ngongang, MSc (Ngongang, 2012). In ring 
stage lysates and schizont lysates of the gametocyte-less strain F12 and of wild-type 
NF54 parasites a band of approximately 70 kDa was observed when probing with anti-
PfWLP1 antiserum (Fig. 3.33 A). In wild-type gametocytes and gametocytes activated 
to undergo gametogenesis a band of the same molecular weight was detected, respec-
tively. As the molecular weight of PfWLP1 is 95.8 kDa it is probable that the protein 
had been processed. In a second set of Western blot analysis using the same antiserum, 
a band of approximately 90 kDa was detected in ring stages, schizonts and gametocytes 
(Fig. 3.33 B). In gametocyte lysate, additionally a band of 70 kDa was observed. In acti-
vated gametocytes, on the contrary, only the 70 kDa protein band was visible. The 
Western blot results are in accordance with the expression of PfWLP1 observed in indi-
rect IFAs. The different species of bands observed suggest that PfWLP1 is subject to 
proteolytic processing. Whilst in asexual blood stages and in gametocytes both the full 
length and the processed band occurred, it seems as if in activated gametocyte the 
processed form dominates. 
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Fig. 3.33: A. Western blot analysis using anti-PfWLP1 antiserum detected a band of approx-
imately 70 kDa in ring stage parasites (R) and schizonts (Sz) in lysates of both the gametocyte-
less strain F12 and WT NF54 parasites. The band was also observed for lysates of gametocytes 
(Gc) and gametocytes activated to undergo gametogenesis (aGc). B. In a second set of Western 
blot analysis a band of approximately 90 kDa was observed in ring stages, schizonts and game-
tocytes, while the previously detected band of 70 kDa was detected in lysates of gametocytes 
and activated gametocytes (Data from Ngongang, 2012). 
3.5.3 Modifications of the pfwlp1 locus via single crossing-over 
homologous recombination 
In order to gain information on the function of PfWLP1 the corresponding gene was 
disrupted via single crossing-over homologous recombination strategy. Using the same 
technique the sequence encoding a double HA-tag was introduced at the 3’ end of the 
gene. The thereupon expressed PfWLP1-HA fusion protein would allow further charac-
terization of the protein. Integration of the transfected plasmids into the pfwlp1 gene 
was investigated via diagnostic PCR. For the PfWLP1-HA mutant plasmid integration 
was observed 48 days after transfection of parasites and bands for both the 5’ and 3’ end 
of the integrated plasmid were detected (Fig. 3.34 B).  
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Fig. 3.34: A. Schematic depicting the pfwlp1 wild-type (WT) gene locus and the modified HA 
locus resulting from vector integration via homologous recombination. Regions used for dis-
crimination between WT and KO locus are marked with A – D. B. Diagnostic PCR on genomic 
DNA of PfWLP1-HA parasites showed bands corresponding to integration of the plasmid de-
tected at the 5’ region and at the 3’ region of the gene. Gel lanes labeled according to panel A. 
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Fig. 3.35: A. Schematic depicting the pfwlp1 wild-type (WT) gene locus and the modified KO 
locus resulting from vector integration via homologous recombination. Regions used for dis-
crimination between WT and KO locus are marked with A – D. Location of the recombinant 
protein rp2 used for generation of antisera is marked with a red line. B. Diagnostic PCR on ge-
nomic DNA of PfWLP1-KO parasites showing a band corresponding to integration of the plas-
mid detected at the 5’ region of the gene. Gel lanes are labeled according to panel A. 
On the contrary, integration of the PfWLP1-KO plasmid was only detectable after ap-
proximately seven months. A PCR product corresponding to plasmid integration was 
observed for the 5’ region of the disrupted gene only (Fig. 3.35 B). Dilutional cloning 
and further investigations of the two mutant parasite lines were carried out by Vanesa 
N. Ngongang, MSc (Ngongang, 2012). For the PfWLP1-HA mutant genomic DNA of 
five clones obtained from limiting dilution was isolated for diagnostic PCR. All of the 
five clones showed integration of the plasmid and no bands corresponding to the wild-
type pfwlp1 locus were observed. Western blot assays were carried out in order to verify 
expression of the HA fusion protein. In both investigated clones, PfWLP1-HA-1A7 and 
PfWLP1-HA-2F12 a band of approximately 110 kDa was observed in schizont lysates 
but not in gametocyte lysates when using anti-HA antibodies (Fig. 3.36 A). In WT ly-
sates no bands were observed. The detection of PfWLP1 with anti-PfWLP1 antiserum 
showed a band in gametocyte and schizont lysates of both clones, respectively (Fig. 
3.36 B). In indirect IFAs labeling with anti-HA antibodies did not result in a strong sig-
nal in asexual parasites, in gametocytes a slightly stronger signal was observed (Ngon-
gang, 2012). Thus, as observed for PfactinII-HA parasites detection of the HA-tagged 
protein of interest with anti-HA antibody was more successful in Western blot analyses 
as compared to indirect IFA. 
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Fig. 3.36: Western blot analysis investigating the expression of the PfWLP1-HA fusion proteins 
in two of the obtained clones, PfWLP1-HA-1A7 and PfWLP1-HA-2F12. A. When probing with 
anti-HA antibody, in schizont lysates of both mutants a band of approximately 110 kDa was 
observed. B. Probing lysates of the two mutants with anti-PfWLP1 antiserum resulted in a band 
at approximately 70 kDa in both gametocyte and schizont lysate (Ngongang, 2012). 
For the PfWLP1-KO parasite line 21 clones were obtained after dilutional cloning. The 
genomic DNA of 12 of the clones was isolated and diagnostic PCR was carried out in 
order to verify integration of the plasmid into the pfwlp1 gene. Only three of the clones 
showed bands corresponding to integration of the plasmid, the other clones were carry-
ing episomal plasmid only. The three clones showing plasmid integration, however also 
showed a band corresponding to the wild-type genotype (Ngongang, 2012). Thus, until 
now no PfWLP1-KO clone was isolated that was devoid of a wild-type parasite popula-
tion. Considering the band pattern of the diagnostic PCR before dilutional cloning, that 
showed a very strong band for wild-type locus, it becomes clear that the wild-typic ge-
notype dominated in the clones investigated (Fig. 3.35 B). 
3.6 Induction of gametogenesis 
The gamete formation of P. falciparum was studied on the molecular level in order to 
gain information on how the stimuli triggering this process are perceived by the para-
site. Additionally, investigations on the ultrastructural level were carried out to decipher 
the sequential processes occurring during gametogenesis. 
3.6.1 Interaction of XA with non-infected RBCs 
In previous studies I observed that XA apparently interacts with niRBCs (Kuehn, 2007). 
In detail, niRBCs were incubated with XA followed by extensive washing of the cells. 
The subsequently produced homogenate of niRBCs (in the following referred to as XA-
RBCH) induced exflagellation when added to mature male gametocytes. The XA con-
centration remaining in the supernatant after the washing steps on the contrary did not 
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lead to exflagellation. RBC homogenate incubated with PBS instead of XA likewise did 
not induce exflagellation (Fig. 3.37). 
 
Fig. 3.37: Exflagellation assay applying the homogenate of niRBCs after incubation with XA 
(XA-RBCH) exhibited an exflagellation rate comparable to that of a 100 μM XA solution in 
PBS whilst RBC homogenate after incubation in PBS (PBS-RBCH) did not induce exflagella-
tion. 10 nM XA in PBS, the concentration of XA expected after washing of the cell several 
times, did not lead to exflagellation, either. 
Upon these observations we supposed that XA might be taken up by the niRBC or inte-
ract with the RBCM. The following experiments aimed at investigating whether XA is 
taken up into the RBC cy tosol and to characterize this potentially occurring transport. 
3.6.2 Uptake of XA by non-infected RBCs 
In order to see whether XA was taken up into the RBC cytosol XA-RBCH was sub-
jected to ultracentrifugation to separate membrane and cytosol fraction. The resulting 
pellet and supernatant fractions were analyzed via Western blot. Probing with antibodies 
directed against the transmembrane protein glycophorin A (GpA) confirmed almost 
complete absence of RBC membranes from the supernatant fraction. In the pellet frac-
tion prominent bands corresponding to the GpA homodimer, GpA/GpB heterodimer and 
GpA monomer (Auffray et al. 2001) were detected (Fig. 3.38 A). The fractions obtained 
by ultracentrifugation were tested for their gametogenesis-inducing activity. Therefore 
the fractions were added to a culture of mature gametocytes and exflagellation centers 
were counted. The cytosol fraction (supernatant) induced exflagellation comparably to 
the positive control (10 µM XA) (p = 0.0745, unpaired t-test). The membrane pellet, in 
contrary, was not capable to induce exflagellation in male gametocytes (Fig. 3.38 B). 
The values obtained for the membrane pellet were comparable to the negative control 
(p = 0.3252, unpaired t-test). Upon these findings in the subsequent experiments only 
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the cytosolic fraction of XA-RBCH, in the following referred to as XA-RBCF, was 
used. XA-RBCF was obtained via ultrafiltration through a 0.22 µm syringe filter. 
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Fig. 3.38: A. Western blot analysis detected Glycophorin A (GpA) in the membrane fraction 
(MF) of homogenate of XA-RBCH after ultracentrifugation. The cytosol fraction (CF) showed 
almost complete absence of GpA. B. When applied to a mature gametocyte culture, the CF ob-
tained after ultracentrifugation of XA-RBCH induced exflagellation comparable to the positive 
control (10 µM XA), whilst the MF resulted in exflagellation events comparable to the negative 
control (10 pM XA). Combined results (Mean and SD) of two independent experiments, com-
prising six counts per sample in total, are shown in percent of positive control. P-values were 
determined by unpaired t test. 
Qualitative analysis of XA uptake  
 
Fig. 3.39: Mass spectrogram after separation of samples via HPLC. An extracted ion chromato-
gram from 205.7 - 206.7 was measured (the molecular mass of the protonated XA is 206.17). 
A Standard of 10 mg/ml XA. B. Ultrafiltrate of homogenized RBCs after incubation with 10 
µM XA followed by four washing steps. C. Ultrafiltrate of homogenized RBCs after incubation 
with PBS followed by four washing steps. Arrows highlight peaks of XA.  
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To confirm the uptake of XA by niRBCs HPLC followed by mass spectrometry analys-
es were carried out. All experiments employing HPLC and mass spectrometry were 
accomplished in the laboratory of Dr. Matthias Unger (Institute of Pharmacy and Food 
Chemistry, University of Würzburg). Firstly, we compared the mass spectrograms of 
XA-RBCF and of the homogenate of PBS-incubated RBC with that of the 10 mg/ml 
XA which served as standard. XA-RBCF showed the same characteristic peak 
representing the XA molecule as the XA standard. The mass spectrogram of the homo-
genate of PBS-incubated RBC on the contrary did not show this peak (Fig. 3.39). 
Quantitative analysis of XA uptake  
The uptake of XA by RBCs was further investigated quantitatively by detecting XA 
within the filtrate of XA-incubated RBCs via LC/ESI/MS/MS. RBCs were incubated 
with different XA concentrations at RT for 30 min. The concentration of XA detected in 
the XA-RBCF samples increased with the concentration applied during incubation and 
accounted for 11 – 14 % of the original concentration (Tab. 3.3, Fig. 3.40 A) 
Tab. 3.3: RBCs were incubated with different concentrations of XA for 30 min at RT. The XA 
concentrations present in the resulting XA-RBCFs were investigated via LC/ESI/MS/MS ana-
lyses. Detected XA concentration increased linearly with the XA concentration used for incuba-
tion. 
Incubation XA [µM] XA detected [nM] Uptake [%] 
PBS control (0.00) 0.2 – 
0.01 1.4 14.0 
0.10 11.8 11.8 
1.00 111.4 11.1 
10.00 1100.2 11.0 
 
Tab. 3.4: RBCs were incubated in 10 µM XA/ PBS and incubated for different durations. The 
XA concentrations present in the resulting XA-RBCFs were investigated via LC/ESI/MS/MS. 
Uptake of XA increased linearly with incubation time. 
Incubation time [min] XA detected [nM] Uptake [%] 
1 55.2 0.6 
5 220.6 2.2 
10 478.4 4.8 
15 668.8 6.7 
20 853.8 8.5 
25 897.2 9.0 
30 1185.0 11.9 
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Fig. 3.40: A. Concentration of XA detected via LC/ESI/MS/MS of XA-RBCF increased linear-
ly with XA concentration applied during incubation of RBCs (see Tab. 3.3). B. Concentration of 
XA detected via LC/ESI/MS/MS analysis of XA-RBCF increased linearly with duration of in-
cubation of RBCs with 10 µM XA (see Tab. 3.4). 
Furthermore, the influence of incubation time with XA was investigated. The XA con-
centration detected in the XA-RBCF increased linearly with incubation time. The dura-
tions of incubation tested ranged between 1 min and 30 min (Tab. 3.4, Fig. 3.40 B). 
Next we tested whether the XA uptake would be saturable with increasing concentra-
tions of XA. When applying different concentrations of XA ranging from 0.025 to 
7.5 mM XA a saturation of XA uptake was observed (Fig. 3.41). Thus, we were able to 
determine the Michealis Menten value (Km) for XA uptake. The Km value showed to be 
1.74 ± 0.12 mM, whilst Vmax was 178.2 ± 4.69 µM. 
Km = 1.74 ± 0.12 mM
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Fig. 3.41: With increasing XA concentration a saturation of XA uptake occurs (incubation for 
30 min). A Km value of 1.74 ± 0.12 mM for XA uptake was determined. Vmax was calculated as 
178.2 ± 4.69 µM. 
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3.6.3 Inhibitors of RBC transport pathways 
After demonstrating that XA is taken up by niRBCs we wanted to identify the transport 
mechanism of the RBC membrane that might be responsible for XA uptake. Therefore, 
inhibitor studies using previously described inhibitors of transport proteins were carried 
out. The inhibitors included in the following studies were targeting nucleobase and nuc-
leoside transporters, amino acid transporters, a glucose transporter as well as organic 
anion transporters (OATPs). The mentioned transport proteins were considered as po-
tential candidates for XA uptake due to the heterocyclic structure of their substrates.  
As inhibitors for the nucleobase transporter hFNT1 adenine and hypoxanthine were 
chosen that had previously been as competitive inhibitors of hFNT1 (Domin et al., 
1988; Wallace et al., 2002). NBTI (NBMPR) had been reported to inhibit the nucleoside 
transporter hENT1 (Plagemann and Woffendin, 1988; Mahony et al., 2004). The three 
substances were tested in two different types of exflagellation assays. Firstly, the inhibi-
tors were added directly to a mature gametocyte culture prior to and/or during incuba-
tion with XA at RT. All inhibitors tested, the concentrations used and references for 
published inhibitor studies are summarized in Tab. 8.1 (Appendix). 
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Fig. 3.42: A. The addition of 1 mM adenine to a mature gametocyte culture resulted in signifi-
cant reduction of the number of exflagellation centers. However, there was no significant reduc-
tion when comparing with the control containing the solvent of adenine, HCl. Combined results 
(Mean and SD) of three independent experiments, comprising eight counts per sample in total, 
are shown. B. When 1 mM adenine was added 15 min prior to activation of mature gametocytes 
and during the 15 min of incubation with XA no significant inhibition was observed. Mean and 
SD of one experiment are shown. C. The increased concentration of 2 mM adenine was tested in 
exflagellation assays without incubation of adenine prior to activation of gametocytes. The addi-
tion of 2 mM adenine inhibited exflagellation of male gametocytes significantly compared to the 
solvent control. Combined results (Mean and SD) of three independent experiments, comprising 
eleven counts per sample in total, are shown in percent of positive control (10 µM XA). 
P-values were determined by unpaired t test. 
The addition of 1 mM adenine to the gametocyte culture concurrently with XA resulted 
in a significant reduction of exflagellation centers compared to the sample containing 
10 µM XA only (p = 0.016, unpaired t-test). However, the results of 1 mM adenine did 
not differ significantly from that of the control containing the solvent of adenine 
(p = 0.32). The solvent control also inhibited exflagellation, although less pronounced as 
B A C 
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1 mM adenine (p =0.059, Fig. 3.42 A). When adding 1 mM adenine prior to and during 
incubation with XA exflagellation of male gametocytes exflagellation was not reduced 
significantly compared to the control containing the solvent of adenine (p = 0.38, Fig. 
3.42 B). The effect of adenine was additionally tested for a concentration of 2 mM, add-
ed to a gametocyte culture concurrently with XA at RT. The combined results of three 
independent experiments showed a significant decrease in the number of exflagellation 
centers as compared the positive control, 10 µM XA (p<0.001). The solvent of adenine, 
HCl at a final concentration of 6.7 mM, also had an inhibitory effect and a decreased 
number of exflagellation centers was observed (p = 0.017). However, when comparing 
results obtained after addition of 2 mM adenine with those of the solvent control the 
number of exflagellation centers was still significantly lower (p = 0.013, Fig. 3.42 C).  
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Fig. 3.43: A. The addition of 1 mM hypoxanthine to a mature gametocyte culture did not result 
in a significant reduction of number of exflagellation centers. B. When 1 mM hypoxanthine was 
added 15 min prior to activation of mature gametocytes and during the 15 min of incubation with 
XA the observed number of exflagellation centers was strongly decreased. Mean and SD of one 
experiment are shown, respectively, in percent of positive control (10 µM XA). P values were 
determined by unpaired t test (A, B). No solvent control has been included as hypoxanthine was 
dissolved in PBS. 
As a second inhibitor of the nucleobase transporter hFNT1, hypoxanthine was tested 
(see Appendix Tab. 8.1, Mahony et al. 2004). When 1 mM hypoxanthine was added 
simultaneously with XA to a mature gametocyte culture, no reduction of exflagellation 
of male gametocytes was observed in comparison to the positive control (10 µM XA) 
(Fig. 3.43 A). Additionally, gametocytes were incubated for 15 min at 37°C with hy-
poxanthine, and subsequently with hypoxanthine and XA to activate gamete formation. 
Under these conditions gametocytes treated with hypoxanthine showed a significantly 
decreased number of exflagellation centers (p = 0.017, unpaired t-test) (Fig. 3.43 B). 
To investigate if the nucleoside transporter hENT1 is involved in XA uptake, the pre-
viously described inhibitor NBTI (Mahony et al., 2004) was tested in exflagellation 
assays. When 5 µM NBTI were added to mature gametocytes, a slight reduction of ex-
flagellation was observed, compared to the positive control, 10 µM XA. However, the 
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results obtained for the solvent control (0.05 % DMSO) were similar (Fig. 3.44 A). 
When gametocytes were pre-incubated with NBTI prior to activation with XA and upon 
addition of XA, a significant reduction of exflagellation was observed. Incubation with 
0.05 % DMSO resulted in an even more pronounced inhibition (Fig. 3.44 B).  
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Fig. 3.44: A. The addition of 5 µM NBTI to a mature gametocyte culture did not result in a sig-
nificant reduction of number of exflagellation centers. B. When 5 µM NBTI were added 15 min 
prior to activation of mature gametocytes and during the 15 min of incubation with XA the ob-
served number of exflagellation centers was considerably decreased. Exflagellation was also 
inhibited upon addition of the solvent of NBTI, DMSO. Mean and SD of one experiment, re-
spectively, are shown in percent of positive control (10 µM XA). P values were determined by 
unpaired t test. (A, B). 
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Fig. 3.45: Influence of inhibitors of nucleobase/nucleoside transport on XA uptake by RBCs. 
RBCs were incubated for 30 min with the respective inhibitor followed by 30 min of incubation 
with XA and inhibitor. The subsequently obtained XA-RBCF was applied in exflagellation as-
says. Neither for adenine (A), hypoxanthine (B) nor for NBTI (C) a significant reduction of 
exflagellation was observed compared to the respective control. As control XA-RBCF of RBCs 
incubated with solvent instead of inhibitor were used. Mean and SD of one experiment, respec-
tively, are shown in percent of positive control (10 µM XA). P values were determined by un-
paired t test. 
The influence of inhibitors of nucleoside and nucleobase transport on XA uptake by 
RBCs was tested in a second type of exflagellation assay. Non-infected RBCs were in-
cubated with adenine, hypoxanthine or NBTI at RT for 30 min. Thereafter, an additional 
30 min of incubation with inhibitor and XA followed. As a control, RBCs were incu-
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bated with the solvent of the respective inhibitor. After incubation, RBCs were washed 
and XA-RBCFs were obtained as described above (2.2.8, 3.6.2). When XA-RBCFs 
were tested in exflagellation assays, for neither inhibitor a significant reduction of mi-
crogamete formation was observed (Fig. 3.45). The combined results on exflagellation 
assays employing inhibitors of RBC nucleobase and nucleoside transporters showed 
significant reduction of exflagellation when applying inhibitors of the nucleobase trans-
porter, but not of the nucleoside transporter. However, experiments with niRBCs re-
vealed that the inhibitors did affect XA uptake by RBCs. Thus, the impact of the inhibi-
tors on exflagellation was caused by distinct unknown mechanism. 
As a second group of potential inhibitors of XA transport the inhibitors of transporters 
of aromatic amino acids, system T and system L, were considered. While system T is 
responsible for transport of the amino acids tryptophan (Trp), tyrosine and phenylala-
nine, system L mediates uptake of tyrosine, phenylalanine (Phe), leucine (Leu) and iso-
leucine. L-Phe, L-Leu and L-Trp had been described to competitively inhibit the respec-
tive transport system (Lopez-Burillo et al., 1985; Tate et al. 1992, see Appendix, 
Tab. 8.1). The three amino acids were thus tested in exflagellation assays to investigate 
their potential to inhibit XA uptake. When applied to a mature gametocyte culture, none 
of the three inhibitors led to a reduction of exflagellation in male gametocytes (Fig. 
3.46).  
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Fig. 3.46: Influence of inhibitors of system T and system L on induction of gametogenesis in 
male gametocytes. All inhibitors were incubated with culture of mature gametocytes for 15 min 
prior to activation of gametocytes. Mean and SD are shown in percent of positive control 
(10 µM XA). P values are determined by unpaired t test. A. 2 mM of L-phenylalanine did not 
reduce exflagellation (1 experiment, 3 counts per sample). B. Addition of 2 mM of L-leucine did 
not affect exflagellation (1 experiment, 4 counts per sample). C. Incubation with 2 mM of L-
tryptophan did not influence exflagellation (combined data of two experiments, total of 5 counts 
per sample).  
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Fig. 3.47: The uptake of XA in the presence of inhibitors of aromatic amino acid transporters 
was measured via LC/ESI/MS/MS. A. Non-infected RBCs were incubated with 1 µM XA in the 
presence of either L-Trp or L-Phe of varying concentrations for 30 min at 37°C. Mean and SD 
of one experiment measured in triplicates is shown in percent of PBS control. B. RBCs were 
pre-incubated with L-Trp, L-Phe or L-Leu for 15 min at 37°C and further 30 min in the presence 
of inhibitors and 1 µM XA at RT. Values of one experiment shown in percent of PBS control. 
Secondly, competitive inhibitors of aromatic amino acid transport were tested in studies 
measuring the uptake of XA by RBCs via LC/ESI/MS/MS. RBCs were incubated with 
L-Trp or L-Phe in the presence of 1 µM XA for 30 min at 37°C. For L-Trp a slight re-
duction of XA uptake was observed which increased with L-Trp concentration. (Fig. 
3.47 A). For L-Phe no linearity between inhibitor concentration and inhibition of uptake 
was observed. The lowest XA concentration taken up was measured after incubation 
with 0.1 mM L-Phe. For other concentrations of L-Phe applied to the RBCs did not re-
sult in reduction of XA uptake (Fig. 3.47 A). The three inhibitors L-Trp, L-Phe and L-
Leu were also tested with pre-incubation of RBCs for 15 min before XA was added. 
Here, for RBCs incubated with 10 mM L-Trp 76 % of the XA concentration of the inhi-
bitor-free control was measured. L-Phe and L-Leu showed approximately 90 % and 
83 % of the XA uptake of the positive control (Fig. 3.48 B). 
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Fig. 3.48: The uptake of XA in the presence of the inhibitor of aromatic amino acid transport 
L-Leu was measured via LC/ESI/MS/MS. Non-infected RBCs were incubated with varying 
concentrations of XA in the presence of either 30 mM or 50 mM L-Leu for 30 min at 37°C. 
Mean and SD of one experiment measured in triplicates as percentage of control are presented. 
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The uptake of XA in the presence of the inhibitor of the system L, L-Leu was investi-
gated for varying XA concentrations applied with two high L-Leu concentrations which 
were described to inhibit the non-saturable component of the system L (Lopez-Burillo et 
al., 1985). The lowest uptake was observed when incubating 30 mM L-Leu with 1 mM 
XA. In that case XA uptake accounted for approximately 90 % of that of the inhibitor-
free control (Fig. 3.48). Thus, the combined results on inhibitors of aromatic amino acid 
transporters did not reveal involvement of these transporters on XA uptake by RBCs. 
As a third candidate for XA transports across the RBC plasma membrane the glucose 
transport protein 1 (GLUT1) was included into the uptake studies. GLUT1-mediated 
hexose transport had been reported to be inhibited by cytochalasin B (Concha et al., 
1997, see Appendix Tab. 8.1). RBCs were incubated with different concentrations of the 
inhibitor cytochalasin B for 15 min at RT, followed by further 30 min of incubation in 
the presence of inhibitor and XA. The measurement of XA via LC/ESI/MS/MS did not 
reveal a prominent reduction of XA uptake. After incubation of RBCS with 1 mM cyto-
chalasin B, XA uptake accounted for 83 % of the solvent control, containing ethanol in 
the same concentration as in the sample. For the other concentrations of cytochalasin B 
tested, no effect on XA uptake was detected (Fig. 3.49). 
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Fig. 3.49: The uptake of XA in the presence of the inhibitor of the glucose transporter GLUT1, 
cytochalasin B, was measured via LC/MS/MS. The inhibitor caused slightly reduced uptake of 
XA as compared to the corresponding control. XA uptake is depicted in percent of the respec-
tive control containing equal amounts of the solvent ethanol as the sample. Mean and SD of one 
experiment measured in triplicates are presented. 
Finally, inhibitors of the OATP transporter family were tested for their potential impact 
on XA uptake by RBCs (Vavricka et al., 2002; Seithel et al., 2006, see Appendix 
Tab. 8.1). The addition of rifampicin to a mature gametocyte culture 15 min prior to and 
during incubation with XA resulted in reduction of exflagellation. At 300 µM and at 
higher concentrations presence of rifampicin decreased the number of exflagellation 
centers significantly as compared to the positive control containing 10 µM XA and the 
solvent of rifampicin, DMSO (Fig. 3.50). Similar results were obtained for the second 
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OATP inhibitor tested, erythromycin. The addition of 200 µM erythromycin 15 min 
prior to and during incubation with 10 µM XA resulted in a significant reduction of ex-
flagellation of male gametocytes. At an erythromycin concentration of 500 µM this ef-
fect was even more pronounced (Fig. 3.50 B). 
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Fig. 3.50: A. The OATP inhibitor rifampicin caused a significant reduction of exflagellation of 
male gametocytes when applied at a concentration of 300 µM or higher with 15 min incubation 
prior to addition of XA. P values comparing samples with positive control (10 µM XA/ 1 % 
DMSO) were determined by unpaired t test. Data of independent experiments were combined 
(total of at least four counts per sample). B. The OATP inhibitor erythromycin caused a signifi-
cant reduction of exflagellation of male gametocytes when applied at a concentration of 200 µM 
or higher. Data of two independent experiments were combined (total of at least six counts per 
sample). Mean and SD are shown. P values comparing samples with positive control (10 µM 
XA) were determined by unpaired t test (A, B). 
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Fig. 3.51: A. XA-RBCF obtained after incubation of RBCs with 500 µM rifampicin did not 
show a significantly reduced exflagellation as compared to XA-RBCF of RBCs incubated with 
DMSO. Combined data of three independent experiments comprising at least nine counts per 
sample is depicted. B. XA-RBCF obtained after incubation of RBCs with 500 µM erythromycin 
did not show a significantly reduced exflagellation as compared to XA-RBCF of RBCs incu-
bated with ethanol. Combined data of two independent experiments comprising in total at least 
6 counts per sample is presented. P values were determined by unpaired t test. Mean and SD are 
shown. Data depicted in percent of positive control (10 µM XA) (A, B). 
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The influence of OATP inhibitors on XA uptake by RBCs was also tested with non-
infected RBCs. After incubation with the inhibitor for 15 min at 37°C XA was added at 
a final concentration of 10 µM and RBCs were incubated for further 15 min at RT. As a 
control, RBCs were incubated with the solvent of the respective inhibitor. After incuba-
tion, RBCs were washed and XA-RBCFs were obtained as described above (2.2.8). 
When XA-RBCFs were tested in exflagellation assays, for neither inhibitor a signifi-
cantly reduced microgamete formation was observed (Fig. 3.51). 
3.6.4 Effect of alterations of RBC membrane composition on XA uptake 
and gametogenesis 
Various RBC surface proteins are sensitive to protease treatment. This fact has been 
exploited to identify receptor proteins of the RBCM and to gain information on the 
structure of RBC surface proteins including transport proteins (Thompson, J.K. et al., 
2001; Poole et al., 1996). In order to investigate the structural properties of the putative 
transport protein responsible for XA uptake, influence of different proteases on XA up-
take was investigated (see Appendix Tab. 8.2 for overview on conditions). RBCs were 
subjected to protease treatment, washed several times and subsequently incubated with 
XA as described above (2.2.8 and 3.6.2). Firstly, niRBCs were treated with proteinase 
K. When employing the obtained XA-RBCF in exflagellation assays we found that pro-
teinase K treatment did not alter the ability of RBCs to take up XA. Both XA-RBCF of 
protease K treated RBCs and of RBCs treated with 1mM CaCl2 (solvent of protease K) 
induced exflagellation similarly to XA directly applied to the gametocyte culture in a 
final concentration of 10 µM (Fig. 3.52).  
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Fig. 3.52: A. XA-RBCF pre-treated with proteinase K (RBCs +PK) or CaCl2 (RBCs –PK) were 
tested in exflagellation assays. No significant difference was observed between the two diffe-
rently treated XA-RBCFs (p-value determined with unpaired t-test). Mean values and SD are 
shown. B. The efficiency of treatment with 0.5 mg/ml proteinase K was tested via WB analysis 
detecting glycophorin A. No glycophorin A was detected after protease treatment (+ Prot. K). 
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Furthermore, RBCs were treated with chymotrypsin or as a control with the solvent of 
the protease, CaCl2, prior to incubation with XA. No significant difference was ob-
served between the two XA-RBCF samples when tested in exflagellation assays 
(p = 0.7302, unpaired t-test). Compared to the positive control, XA added to a final con-
centration of 10 µM, both XA-RBCF samples were less efficient in the induction of ex-
flagellation (Fig. 3.53). 
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Fig. 3.53: A. XA-RBCF of RBCs pre-treated with chymotrypsin (RBCs +Ch) or CaCl2 (RBCs       
–Ch) were tested in exflagellation assays. No significant difference was observed between 
RBCs incubated with chymotrypsin and RBCs incubated with the solvent CaCl2 (p = 0.7302, 
unpaired t-test). B. WB detecting glycophorin A (GpA) confirmed efficiency of protease treat-
ment of RBCs. 
The effect of the protease chymotrypsin was also tested on parasitized RBCs since it 
had been shown to alter the permeability of the ‘new permeability pathways’ that are 
responsible for the uptake of several molecule classes (Baumeister et al., 2006).  
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Fig. 3.54: A. A culture of mature gametocytes was pre-incubated with ICM, chymoptrypsin or 
CaCl2 (solvent control) at 37°C. Subsequently, exflagellation was induced via addition of XA. 
No significant difference was observed between the different treatment groups (mean and SD 
shown). 10 pM XA/ICM served as negative control. B. WB detecting glycophorin A (GpA) 
confirmed efficiency of protease treatment of iRBCs. 
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Aliquots of a culture of mature gametocytes were pre-incubated at 37°C with ICM, 
chymotrypsin or CaCl2 (solvent of chymoptrypsin) prior to activation of gametogenesis 
via addition of XA. The number of exflagellation centers between chymotrypsin- and 
CaCl2-treated gametocytes did not differ significantly (Fig. 3.54, p-value: 0.2163, un-
paired t-test). 
In a second experiment manipulating the membranes surrounding the gametocytes, 
0.07 % saponin was added to a culture of mature gametocytes in order to permeabilize 
RBCM and PVM. Gametocytes treated with saponin were able to undergo exflagella-
tion when 10 µM XA was added. The observed reduction of the number of exflagella-
tion centers did not differ significantly from control gametocytes incubated with ICM 
instead of saponin (p = 0.0912, unpaired t-test, Fig. 3.55 A). As an additional control, 
gametocytes were treated with saponin, but instead of XA, ICM was added. Under these 
conditions, a small proportion of gametocytes was activated to undergo gametogenesis. 
Nevertheless, compared to gametocytes activated by addition of XA, the number of ex-
flagellation centers was significantly reduced (p = 0.0076, unpaired t-test). 
 
Fig. 3.55: A. A culture of mature gametocytes was treated with saponin in order to permeabilize 
RBCM and PVM. Subsequently, cells were activated with 10 µM XA and the number of exfla-
gellation centers was determined (shown as mean and SD). No significant difference was ob-
served between the positive control (incubated with ICM instead of saponin) and the saponin 
treated culture (unpaired t-test). Saponin treatment without addition of XA resulted only in low 
numbers of exflagellation centers. B. Absence of RBCM and PVM was confirmed via electron 
microscopy.  
The efficiency of permeabilization was confirmed via transmission electron microscopy 
(TEM, Fig. 3.55 B). Of each sample tested in the exflagellation assay, an aliquot was 
fixed immediately with PFA and glutaraldehyde and was processed for TEM. Per sam-
ple 20 gametocytes were examined electon microscopically. For the control sample 
treated with ICM instead of saponin, all gametocytes investigated showed a normal ap-
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pearance. Both PVM and RBCM were intact. In the samples activated with XA upon 
saponin treatment 34 of the 60 gametocytes investigated in total were devoid of RBCM 
and PVM (Fig. 3.56). The remaining 26 gametocytes were surrounded by a single 
membrane only, either PVM or RBCM. Samples that were treated with saponin and 
subsequently incubated with ICM showed absence of PVM and RBCM in 25 gameto-
cytes of 60 gametocytes investigated. 31 gametocytes were surrounded by RBCM only 
and 3 gametocytes by both PVM and RBCM. In all cases where gametocytes were sur-
rounded by RBCM after saponin treatment, the cytosol of the RBC was disintegrated, 
pointing at a permeabilization of the membrane in a way not detectable via the magnifi-
cation used. 
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Fig. 3.56: The efficiency of saponin treatment of gametocytes was quantified via electron mi-
croscopy by investigating the presence of the membranes surrounding the gametocytes. In three 
independently treated samples for each condition 20 gametocytes were examined. The com-
bined data for each condition (60 gametocytes) is shown. 
3.6.5 Influence of ionophores on induction of gamete formation 
In the Apicomplexan parasite T. gondii a decrease of the K+ concentration within the 
host cell renders the intracellular parasites motile and triggers egress from the host cell 
(Fruth and Arrizabalaga, 2007). Hence, we tested if membrane potential or ion gradients 
also play a role during gametocyte activation and egress of P. falciparum. The K+/H+ 
ionophore nigericin and the K+ ionophor valinomycin were tested in exflagellation as-
says. Nigericin was capable of inducing exflagellation of male gametocytes. The con-
centration most effective was 5 µM nigericin when incubated for 30 min at RT (Fig. 
3.57). The number of exflagellation centers observed under these conditions accounted 
for 48.7 ± 10.1 % of the value obtained for 10 µM XA incubated for 30 min at RT 
(p = 0.0013, unpaired t-test). With increasing concentration of nigericin the number of 
exflagellation centers decreased when nigericin was incubated for 30 min.  
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Fig. 3.57: Exflagellation of male gametocytes was induced by the addition of the K+/H+ iono-
phore nigericin with the lowest concentration tested being most effective. In contrast to XA, 
nigericin showed stronger activity when incubated with the gametocyte culture for 30 min. 
Combined data (mean and SD) of two independent experiments per incubation time comprising 
at least 6 counts per sample is presented. Values are depicted in percent of 10 µM XA incubated 
for 15 min. 
Very low numbers of exflagellation centers were observed when gametocytes were in-
cubated with nigericin only for 15 min. The nigericin concentrations of 50 µM and 
100 µM did not differ significantly from the negative control containing 1 % methanol 
(solvent of nigericin) (p values: 0.072 and 0.93). In contrast to nigericin, the number of 
exflagellation centers observed after 30 min of incubation with XA was significantly 
lower than after 15 min of incubation (p = 0.0053) indicating a faster action of XA (Fig. 
3.57). 
 
Fig. 3.58: Exflagellation of male gametocytes was induced when adding 100 µM of the K+ io-
nophore valinomycin. The lower concentration of 10 µM was not able to induce exflagellation 
and showed similar results as the negative control. Values are depicted in percent of 10 µM XA 
incubated for 15 min (one count per sample). 
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The K+ ionophore valinomycin also seemed to induce exflagellation in male gameto-
cytes. However, in contrast to nigericin valinomycin showed to be able to induce exfla-
gellation at an incubation time of 15 min already. The concentration of 100 µM was 
more effective than 10 µM of valinomycin (Fig. 3.58). 
3.6.6 Reverse genetics study on XA receptor candidate genes 
Our observations of the uptake of XA by niRBCs as well as the observation of activa-
tion of gametocytes devoid of both RBCM and PVM by addition of XA led us speculate 
that the perception of XA might occur at the PPM. We therefore carried out a database 
search in order to identify candidate genes of a potential XA receptor. The XA-induced 
signal transduction pathway includes a PLC (Martin et al., 1994; see Fig. 1.5) which has 
been described to be induced by G-protein coupled receptors in other organisms (re-
viewed in Dorsam and Gutkind, 2007). Hence, we searched for G-protein coupled re-
ceptors/ serpentine receptors in the PlasmoDB database. The search revealed five genes. 
Four of them, PfSR1, PfSR10, PfSR12 and PfSR25 had been identified as serpentine 
receptor-like proteins before (Madeira et al., 2008). The respective genes were de-
scribed to be expressed in asexual blood stages (Madeira et al., 2008). The fifth putative 
serpentine receptor of our database search had not been described before in the litera-
ture. Its PlasmoDB identifier is PF3D7_0525400 (previously PFE1265w) and it has 
been classified as putative G-protein coupled receptor. 
For two of the putative receptor proteins gene-disruptant mutants were generated in or-
der to gain information of the function of the respective protein. The above described 
strategy of gene disruption via plasmid integration after single crossing over homolog-
ous recombination was chosen. For PFE1265w integration of the PFE1265w-
KO/pCAM plasmid was observed 72 days after transfection. Limiting dilution was car-
ried out in order to obtain clonal parasite lines of the gene-disruptant mutant. Three 
clones were isolated and diagnostic PCR on genomic DNA was carried out to investi-
gate the respective genotype. Clone PFE1265w-KO 1H9 showed bands corresponding 
to the episomal plasmid and the wild-type locus, thus plasmid integration had not oc-
curred in this clone (Fig. 3.59 B). Clone PFE1265w-KO 1D12 showed bands corres-
ponding to episome and plasmid integration detected at the 5’ end of the PFE1265w 
locus. No PCR band for the wild-type locus was detected. The third clone, PFE1265w-
KO 2E6 was also devoid of the wild-type gene locus. Diagnostic PCR showed bands for 
plasmid integration both at 5’ and 3’ region of the gene. No episomal plasmid was de-
tected for this clone (Fig. 3.59 B).  
Further characterization of the two clones devoid of wild-type locus was carried out by 
Andreas von Bohl, MSc. Development of asexual blood stages in these gene-disruptant 
parasites was comparable to wild-type parasites. Gametocyte formation and maturation 
was not affected, neither, by disruption of the gene with the identifier PFE1265w. Stu-
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dies on further stages of parasite development are currently underway, however did not 
reveal any certain phenotyp of the mutants, yet. 
 
 
Fig. 3.59: A. Schematic depicting the PFE1265w wild-type (WT) gene locus and the modified 
KO locus resulting from vector integration via homologous recombination. Regions used for 
discrimination between wild-type and KO locus are marked with A – D. B. Diagnostic PCR on 
genomic DNA of three clones of PFE1265w-KO showed absence of wild-type locus for clones 
1D12 and 2E6. Clone 1H9 still possessed the wild-type locus and did not show bands corres-
ponding to plasmid integration. Gel lanes are labeled according to panel A. 
Transfection of wild-type NF54 parasites with the PfSR1/pCAM construct was carried 
out in two independent experiments. Parasites started to appear in the blood smear ap-
proximately four weeks after transfection. The parasite lines were kept in culture for 22 
weeks and 51 weeks respectively. However, no integration of the plasmid into the pfsr1 
gene locus was observed (Fig. 3.60).  
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Fig. 3.60: A. Schematic depicting the pfsr1 wild-type (WT) gene locus and the modified KO 
locus resulting from vector integration via homologous recombination. Regions used for dis-
crimination between WT and KO locus are marked with A – D. B. Diagnostic PCR on genomic 
DNA of parasites transfected with the PfSR1-KO/pCAM plasmid detected bands corresponding 
to episome and wild-type gene locus. No bands were detected for integration of the plasmid into 
the pfsr1 locus. A representative picture of two independent transfections is shown. Gel lanes 
are labeled according to panel A. 
3.6.7 Ultrastructural investigations of gametocyte activation 
In order to better understand the sequence of processes occurring at the cellular level 
during activation of gametocytes electron microscopical experiments were carried out. 
Mature gametocytes were activated to undergo gamete formation. At different time 
points post activation (p.act.) gametocytes were fixed and subsequently prepared for 
TEM. The observations were quantified and are summarized in Tab. 3.5. At time 
point 0, i.e. in the moment of adding XA, the gametocytes showed the typical foot print 
form of mature, non-activated gametocytes (Fig. 3.61). The gametocytes were sur-
rounded by the PVM, which separated gametocytes from the rather thin layer of the 
RBC cytosol. Beneath the PPM the IMC was visible. In close association with the IMC 
osmiophilic bodies were detected. At 2 min p.act. the RBC cytoplasm started to disinte-
grate and 90 % of investigated gametocyte sections showed rupture of PVM (Fig. 3.61, 
Tab. 3.5). In most cases, multiple rupture sites of the PVM were observed. In female 
gametocytes most of the osmiophilic bodies visible were associated with the rupture 
site, suggesting a role of these organelles in PVM lysis. At 6 min p.act. 80 % of the host 
cells of activated gametocytes were devoid of cytoplasm (Tab. 3.5). The PVM was ab-
sent in all activated gametocytes investigated and the parasites were only surrounded by 
the RBCM at that time point. In 35 % of the gametocytes investigated the IMC started to 
disintegrate. Both remnants of the PVM as well as parasite-derived membranes were 
observed as vesicular structures within the RBCM (Fig. 3.61 and Fig. 3.64). At 12 min 
p.act. all RBCs carrying activated gametocytes were devoid of RBC cytosol. The 
RBCM was ruptured in 60 % of the gametocytes investigated and similarly the IMC was 
disintegrated in the majority of all activated gametocytes (Tab. 3.5). At the next time 
point, 15 min p.act. only 20 % of gametocytes were still surrounded by an intact RBCM, 
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whilst 80 % had completed their egress from the host cell. (Fig. 3.61, Tab. 3.5). The 
parasites now exhibited the round, spherical shape typical for P. falciparum gametes. In 
contrast to the multiple rupture sites of the PVM (see Fig. 3.61, 2 min p.act.) RBCM 
rupture only occurred in a single rupture site (50 gametocytes investigated, Fig. 3.61, 
15 min). The data on the sequential processes occurring during gametocyte activation 
investigated at the ultrastructural level were kindly provided by L. Sologub and G. Pra-
del. 
Tab. 3.5: Observations on presence of RBC cytosol (RBCC) or membrane structures in the 
course of gametocyte activation. For each time point 20 sections were investigated. Quantifica-
tion was carried out by G. Pradel. 
 RBCC RBCM PVM IMC 
Time 
p.act. 
Present Absent Intact Ruptured Intact Ruptured Intact Disintegr. 
0 min 100 % 0  100 % 0 100 % 0 100 % 0 
2 min 100 % 0  100 % 0 10 % 90 % 100 % 0 
6 min  20 % 80 % 75 % 25 % 0 100 % 65 % 35 % 
12 min 0  100 % 40 % 60 % 0 100 % 20 % 80 % 
15 min 0  100 % 20 % 80 % 0 100 % 25 % 75 % 
30 min 0  100 % 0 100 % 0 100 % 0 100 % 
 
In order to resolve the very early proceedings of gametocyte activation, gametocytes 
were fixed for TEM at 0 sec, 30 sec, 60 sec and 90 sec p.act. As described above at 0 sec 
p.act. the gametocyte periphery exhibited the typical three-lamellar membrane structure 
comprising PVM, PPM and IMC. At 30 sec p.act. the three membranes were still 
present in 15 of 20 gametocytes investigated, however, the PVM appeared now in an 
undulated shape (Fig. 3.62). Subpellicular microtubules were detected similarly to non-
activated gametocytes. At 60 sec. p.act. the first rupture sites were detected in the PVM 
of 70 % of gametocytes investigated. No longitudinal microtubules were observed after 
60 sec p.act. Data were kindly provided by L. Sologub and G. Pradel. 
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Fig. 3.61: A timeline of gametocytes egress was investigated via electron microscopy. Gamete 
formation was induced by addition of XA to a final concentration of 100 µM and gametocytes 
were fixed at different time points after activation. The right panel shows a detailed view of the 
left panel. Arrow heads point at osmiophilic bodies and asterisks mark sights of PVM rupture. 
CS – cytostome, EM – erythrocyte membrane, ER - endoplasmic reticulum, FV - food vacuole, 
M – mitochondrion, N – nucleus, SPM – subpellicular membrane = IMC. Scale bar - 1 µm. Elec-
tron micrographs were kindly provided by L. Sologub and G. Pradel (Image from Sologub et 
al., 2011). 
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Fig. 3.62: PVM rupture was investigated in the first 90 seconds p.act. At 0 sec the PVM was 
intact and longitudinal microtubules (MT) were observed. At 30 sec p.act. the PVM appeared 
undulated. At 60 sec p.act. first rupture sites of PVM were visible (labeled with asterisk). At 
90 sec p.act. several ruptures sites were present and disintegration of RBC cytosol was observed. 
Osmiophilic bodies are labeled with arrow head. SPM – subpellicular membrane = IMC. Scale 
bar - 1 µm. Electron micrographs were kindly provided by L. Sologub and G. Pradel (Image 
from Sologub et al., 2011). 
Since several stimuli had been described to induce gametogenesis in mature gameto-
cytes we wanted to investigate the impact of the described stimuli on PVM rupture. 
Gametocytes were incubated under various conditions. Specimens for TEM were pre-
pared and evaluated quantitatively. Gametocytes incubated for 30 min in ICM (serum-
free RPMI medium) at 37°C (negative control) and at RT did not show rupture of PVM 
(Fig. 3.63). After incubation at 37°C in the presence of XA only a very small proportion 
of gametocytes showed absence of PVM. ICM medium of an increased pH value (8.0 
instead of 7.4) had been reported to induce gametocyte activation in concert with a drop 
of temperature from 37°C to ambient temperature (Nijhout and Carter, 1978). If pH was 
increased but temperature was kept constantly at 37°C PVM was shown to be intact in 
almost all gametocytes investigated. As expected, the drop in temperature combined 
with the presence of XA resulted in gametocyte activation reflected by PVM rupture. In 
the presence of human serum the proportion of activated gametocytes showing absence 
of PVM was even increased. In contrast, upon 30 min incubation with XA at RT in ICM 
of a lower pH value of 6.6 PVM rupture was almost completely inhibited. Upon treat-
ment with 5 µM of the K+/H+ ionophore nigericin for 30 min at RT a large proportion of 
gametocytes was devoid of the PVM similarly to the positive control incubated with 
XA. These observations show, that nigericin not only induces gamete formation in male 
gametocytes as seen in exflagellation assays (see 3.6.5), but it also stimulates female 
gametocytes to undergo gametogenesis. 
The divalent cation Ca2+ has been described as an important messenger during gameto-
genesis.  The addition  of the  calcium chelator  BAPTA-AM to  mature gametocytes re- 
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Fig. 3.63: Different stimuli were investigated for their effect on PVM rupture via electron mi-
croscopy. Only gametocytes treated with XA or nigericin showed rupture of PVM in the majori-
ty of gametocytes investigated (20 gametocytes per sample). Add. - additives, B - BAPTA-AM, 
D - DMSO, HS - human serum, N - nigericin. Preparation of specimens for electron microscopy 
was carried out in collaboration with L. Sologub. Quantification data was supplied by G. Pradel 
(Image from Sologub et al., 2011). 
sulted in an inhibition of exflagellation and of gametocyte egress from their host cells 
(Billker et al., 2004; McRoberts et al., 2008). We hence wanted to test whether 
BAPTA-AM would also prevent PVM rupture. A concentration of 25 µM BAPTA-AM 
that had previously shown to completely inhibit exflagellation of male gametocytes was 
added prior to activation of mature gametocytes as well as during activation. The pres-
ence of BAPTA-AM did not inhibit PVM rupture and only very few gametocytes 
showed an intact PVM. The number of gametocytes whose PVM was still present but 
ruptured was comparable to that of control gametocytes incubated with the solvent of 
BAPTA-AM, DMSO (Fig. 3.63). However, gametocytes activated in the presence of 
BAPTA-AM often showed an irregular shape (Fig. 3.64). In contrast to untreated acti-
vated gametocytes, gametocytes activated in the presence of BAPTA-AM in many cases 
still exhibited subpellicular microtubules and the IMC. Thus, the treatment with 
BAPTA-AM clearly resulted in a disturbed gametogenesis even if not affecting PVM 
rupture. 
In conclusion the study of gametocyte egress on the ultrastructural level revealed that 
P. falciparum gametocytes egress from the host cell by lysing firstly the PVM. Only 
thereafter the RBCM ruptures. Gametocyte egress including PVM rupture can be in-
duced by the K+/H+ ionophore nigericin, suggesting that that beside Ca2+ signal further 
changes in ion gradients are involved. Depletion of Ca2+ signaling does not inhibit PVM 
rupture, thus PVM rupture seems to be induced by an alternative signal. 
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Fig. 3.64: After activation both treated and untreated gametocytes show an accumulation of 
parasite derived membranes (PDM). After 30 min of incubation with 5 µM nigericin at RT ga-
metocytes were fixed and embedded for electron microscopy. PVM was absent, and IMC was 
partially disintegrated. If RBCM was not ruptured, RBC cytosol was absent, indicating disinte-
gration of RBCM. Treatment with BAPTA-AM does not affect PVM rupture, however mor-
phogenesis of the developing gamete is disturbed. Scale bar - 1 µm. Electron microscopy by 
carried out by G. Pradel (Image from Sologub et al., 2011). 
4 Discussion 
4.1 Surface proteins of sexual stages of Plasmodium 
falciparum 
4.1.1 Expression of PfCCp proteins  
The sexual phase of the malaria parasite P. falciparum starts with the differentiation of a 
proportion of blood-stage parasites into gametocytes. The gametocyte represents the 
parasite stage responsible for transmission of the disease from human to the insect vec-
tor and thus is crucial for completion of the life cycle. A great number of proteins en-
coded in the genome of P. falciparum is exclusively expressed in the sexual phase of the 
life cycle (Khan et al., 2005). Amongst these are many adhesion proteins locating to the 
parasite surface, such as the six members of the PfCCp protein family (reviewed in Pra-
del, 2007). The PfCCp protein family had been discovered due to the proteins’ architec-
ture comprising multiple adhesion domains (Pradel et al., 2004; Scholz et al., 2008). 
Most of these domains have been described in other organisms like animals and bacteria 
and presumably have been acquired via lateral transfer (Templeton et al., 2004; Pradel 
et al., 2004). In view of the diversity of adhesion domains found in these proteins a role 
in lipid, carbohydrate or protein binding has been suggested for the six proteins (Clau-
dianos et al., 2002; Pradel et al., 2004). The PfCCp proteins are widely conserved in 
Apicomplexan parasites (Pradel et al., 2004; Templeton et al., 2010; reviewed in Kuehn 
et al., 2010). 
Within the gene sequence of each PfCCp protein a signal peptide is encoded, thus it is 
anticipated that the proteins are secreted. However no sequence for a GPI anchor or 
transmembrane domains had been identified (Pradel et al., 2004). PfCCp1 to PfCCp3 
have been found to associate with the parasite plasma membrane within the PV (Pradel 
et al. 2004). Whilst expression of pfccp1 to pfccp4 and pffnpa starts in the gametocyte 
stage, PfCCp5 was detected in schizonts already (Scholz et al., 2008; Gieseke, 2010) 
Recently, minor expression of pfccp5 has also been detected in trophozoites (G. Pradel, 
unpublished results).  
While PfCCp1 to PfCCp3 are expressed in a spotted distribution, PfCCp5 and PfFNPA 
localize to the cell poles of gametocytes as had been shown by indirect IFAs (Pradel et 
al., 2004; Scholz et al., 2008). Immuno EM studies using alkaline phosphate secondary 
antibody showed that PfCCp5 and PfFNPA localize to both the cell surface and the cy-
tosol of gametocytes (Dude, 2009) as it had been shown before for PfCCp1 to PfCCp3 
(Pradel et al., 2004). 
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After gametocyte activation PfCCp proteins are present in macrogametes, but not in 
microgametes (Scholz et al., 2008). Approximately six hours after gametogenesis ex-
pression of the proteins ceases (Ngongang, 2010). In retort stages the proteins concen-
trate in a single spot in the residual body of the zygote. For PfCCp2 additionally a 
second focal expression site was observed in the apical end of the developing ookinete 
(Ngongang, 2010). PfCCp4 was found to be newly expressed in the ookinete stage ho-
mogenously in an intensity comparable to that in the gametocyte stage (Scholz, 2007; 
Ngongang, 2010). In the rodent malaria parasite Plasmodium berghei expression of the 
orthologous proteins of the six PfCCp proteins (termed PbLAP1 to PbLAP6) had been 
described to concentrate in one to two focal spots in ookinetes (Carter et al., 2008; 
Saeed et al., 2010; Saeed et al., 2013). These focal expression sites had been identified 
as crystalloid, a cluster of vesicles expressed exclusively in ookinetes and young oo-
cysts. The crystaloids have been suggested to serve as reservoir of proteins needed at 
later development stages, i.e. in the oocyst (Garnham, 1969; reviewed in Dessens et al., 
2011). In gametocytes of P. berghei the orthologs of PfCCp2, PfCCp4 and PfFNPA 
reveal a distribution comparable to that observed in P. falciparum gametocytes (Carter 
et al., 2008; Saeed et al., 2010). The other three orthologous genes have been reported to 
be translationally repressed. They are transcribed in gametocytes, but protein synthesis 
only starts upon gametocyte activation (Saeed et al., 2013). 
In this thesis the so far uncharacterized PfCCp5-KO and PfFNPA-KO parasite lines 
were focus of investigations in order to gain knowledge about a potential function of 
these proteins. Clonal parasite lines were obtained via limiting dilution and absence of 
wild-type allele of the respective gene of interest was verified. The development of 
asexual blood stages and gametocyte formation was for both PfCCp5-KO and PfFNPA-
KO clones comparable to that of wild-type parasites. Furthermore, the formation of 
male and female gametes as well as zygote formation after fertilization was not affected 
by the absence of functional PfCCp5 or PfFNPA protein. The same observations had 
been made for the gene-disruptant mutants for PfCCp1 to PfCCp4 (Pradel et al., 2004; 
Scholz et al., 2008; Simon et al., 2009). Thus, it can be concluded, that none of the 
PfCCp proteins is essential for the development of blood stage parasite and for the sex-
ual development until the zygote stage in vitro. Development in the mosquito was inves-
tigated for PfFNPA-KO parasites which was comparable to development of wild-type 
parasites until the ookinete stage. However a role of the PfCCp proteins during gameto-
genesis and fertilization had been anticipated as formation of microgametes was signifi-
cantly reduced in vitro in the presence of anti-PfCCp antisera and active complement 
(Scholz et al., 2008). Anti-PfCCp5 antisera did not show significant reduction at that 
time, however, an effect with more specific antiserum is probable. Transmission block-
ing assays using anti-PfCCp antisera showed an only moderate reduction of oocyst for-
mation by approximately 30 % (M. Scheuermayer, V. Ngongang, G. Pradel, unpub-
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lished results). Studies of gene-disruptant parasite lines however suggested an essential 
role of PfCCp2 and PfCCp3 during transition of the parasites from oocysts to the sali-
vary glands of the mosquito vector (Pradel et al., 2004). 
Expression of PfCCp5 during the life cycle had been investigated via Western blot. 
Here, the protein was detected in gametocyte lysate in its full length of 120 kDa and 
additional bands of 50, 60, 70 and 80 kDa were observed. In schizonts on the contrary, 
the main band was observed at 65 kDa, suggesting processing of the protein in this para-
site stage (Gieseke, 2010; G. Pradel unpublished results). In this thesis clonal parasite 
lines expressing PfCCp5 fused to a C-terminal HA tag were obtained. In Western blot 
analyses the full length fusion protein was detected both with anti-HA antibodies and 
with anti-PfCCp5 antiserum. However, until now, it was not possible to detect the 
PfCCp5-HA fusion protein in schizont lysate via Western blot. Thus it might be that the 
shorter version of PfCCp5 in schizonts comprises the N terminal part of the protein after 
proteolytical processing. However, further investigations are needed and it would be 
worth including an additional mutant expressing a protein tag fused to the N-terminal of 
PfCCp5.  
4.1.2 Co-dependent expression of PfCCp proteins and other sexual stage-
specific proteins 
Proteins of the PfCCp protein family have been reported to be expressed in co-
dependent manner. When one of the genes encoding for a PfCCp protein had been dis-
rupted all PfCCp proteins where either absent or present in reduced abundance (Pradel 
et al., 2006; Simon et al., 2009). This phenomenon of co-dependent expression has now 
been studied via IFAs for the PfCCp5 and PfFNPA gene-disruptant mutants, as well. It 
turned out, that the correct localization of the PfCCp proteins does depend on presence 
of PfCCp5 and PfFNPA. However, in these two mutants the reduction of PfCCp pro-
teins was – similar to that of PfCCp4 gene-disruptant parasites – less prominent as 
compared to the observations made for PfCCp1 to PfCCp3 (Simon et al., 2009). The 
disruption of pfccp5 and pffnpa gene loci did not impact on expression of PfCCp4. In 
PfFNPA-KO parasite co-dependent expression was also investigated via Western blot 
analyses, which detected reduced amounts of PfCCp proteins. Thus, as reported for the 
other PfCCp-proteins, not only correct localization of the PfCCp proteins does depend 
on presence of all other members of the protein family, but also the protein stability 
seems to be affected. As observed in IFAs the reduction of protein in Western blot was 
less prominent in PfFNPA-KO parasites as compared to PfCCp1- to PfCCp3-deficient 
parasite lines. In accordance with studies on PfCCp1- to PfCCp4-gene-disruptant para-
site lines (Simon et al., 2009), co-dependent expression was detected only on protein 
level, whilst transcript levels remained comparable to that in wild-type parasites. For the 
only recently obtained clones of the PfCCp5-KO parasite line it can be assumed that 
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here, too, co-dependent expression will only be observable at the protein level. As 
PfCCp5 is expressed in asexual parasites already, its expression was not only investi-
gated in gametocytes, but also in schizonts of PfCCp1-KO parasites. Here, PfCCp5 was 
expressed as in wild-type parasites. This observation, together with the observed pre-
sumably processed form of the proteins in schizonts suggest a different function of 
PfCCp5 in schizonts than in gametocytes, which is independent of the presence of other 
PfCCp proteins.  
For the orthologous proteins of the PfCCp proteins in P. berghei similar observations 
regarding the co-dependent expression of the members of the protein family have been 
described (Saeed et al., 2012). However, co-dependent expression was not observable in 
gametocytes, but only later during expression of the protein family, in the ookinete 
stage. Here, expression of PbLAP3 (ortholog of PfCCp5) was dramatically reduced in 
the absence of PbLAP1 (ortholog of PfCCp3). The authors suggested, that PbLAP3 was 
in a misfolded state in the absence of PbLAP1 and thus degraded. A possible explana-
tion of the later occurring lack of PbLAP3 was the shorter duration of gametocyte for-
mation as compared to P. falciparum (Saeed, et al., 2012). Investigation of interdepen-
dency between other members of the PbLAP protein family is needed as for other pro-
teins (e.g. orthologs of PfCCp1 to PfCCp3) the effect might be even more pronounced. 
Beside co-dependent expression within the PfCCp protein family co-dependent expres-
sion was also investigated with other proteins expressed in the sexual stages. However, 
no prominent differences were observed in the eight gene-disruptant parasite lines in-
vestigated. The only dramatically modified protein localization was observed for Pfacti-
nII in the two parasite lines expressing truncated versions of Pfs230 (discussed below). 
Co-dependent expression manifesting at the protein level has been described in other 
Apicomplexan parasites, as well. For instance, the microneme protein TGMIC6 of Tox-
oplasma gondii serves as an escorter for the soluble proteins TgMIC1 and TgMIC4 that 
in the absence of TgMIC6 do not localize to the micronemes as observed in wild-type 
parasites (Reiss et al., 2001).  
4.1.3 Interactions of sexual-stage adhesion proteins 
The members of the PfCCp protein family undergo multiple protein-protein interactions 
(reviewed in Kuehn et al., 2010). By means of co-immunoprecipitation it was shown 
that protein-protein interactions occur between all PfCCp proteins with exception of 
PfCCp4 and PfCCp5 (Simon et al., 2009). Thus the formation of multimeric protein 
complexes has been proposed (Simon et al., 2009; Kuehn et al., 2010). In view of the 
above described co-dependent expression of PfCCp proteins it is anticipated, that lack 
of one PfCCp protein leads to complex instability and disassembly of the protein com-
plex. A similar effect had been observed for the two TBV candidate proteins Pfs48/45 
and Pfs230. In gametes of a Pfs48/45-deficient parasite line, Pfs230 does not localize 
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homogenously to the cell surface as observed in wild-type parasites (Eksi et al., 2006). 
In addition it had been reported that Pfs230 and Pfs48/45 interact with each other thus it 
was suggested that the secreted Pfs230 is retained to the cell surface via binding to the 
GPI-anchored Pfs48/45 (Kumar et al., 1987; Kumar and Wizel, 1992; Eksi et al., 2006). 
It had been shown that the multimeric protein complex of PfCCp proteins might include 
further sexual stage-specific proteins such as Pfs230 and Pfs48/45 in gametocytes and 
Pfs25 after gametocyte activation (Kuehn, 2007; N. Simon, S.M. Scholz, and G. Pradel, 
unpublished observations). Such interaction with further sexual stage-specific proteins 
would explain, how PfCCp proteins that lack both GPI-anchor sequence and transmem-
brane domain are retained to the parasite plasma membrane after secretion. 
 
Fig. 4.1: Schematic depicting the manifold interactions between PfCCp proteins and further sexual stage 
proteins. It is anticipated the multimeric protein complex is retained to the gametocyte surface via the 
GPI-anchored Pfs48/45. After gametocyte activation Pfs25 provides an additional anchor site. (Kuehn et 
al., 2010). 
Retention of secreting proteins via interaction with a GPI-anchored protein has been 
observed for another pair of cysteine-rich domain proteins. Pf41 has been reported to 
form a stable complex with the GPI-anchored Pf12 on the surface of merozoites (Tae-
chalertpaisarn et al., 2012). As Pf41 is still detectable at the merozoite surface in Pf12-
KO parasites is has been suggested that the protein interacts with further merozoite sur-
face proteins (Taechalertpaisarn et al., 2012). Indeed, another multimeric protein com-
plex has been discovered on the merozoite surface, namely the protein complex around 
PfMSP-1. As Pfs25 PfMSP-1 possess EGF-like domains that can mediate contact to 
parasite or host proteins, and it is retained to the parasite surface via a GPI anchor 
(Blackman et al., 1991). PfMSP-1 has been reported form a complex with PfMSP-3 and 
PfMSP-6/PfMSP-7. The three proteins possess neither GPI anchor nor transmembrane 
domain and are retained to the merozoite surface via interaction with PfMSP-1. (Ranjan 
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et al., 2012). Recently, it was shown that PfMSP-1 might interact with seven additional 
merozoite proteins, including PfRhopH3, part of the RhopH complex (Ranjan et al., 
2011). Thus, it seems as the merozoite surface has an intensive network of interacting 
proteins. 
Very recently a new component of the PfCCp-based multimeric protein complex was 
identified. Via co-immunoprecipitation a so far uncharacterized protein was identified 
as interaction partner of PfCCp1 (Simon, 2012). Analysis of the protein sequence re-
vealed possession of several WD40 domains, thus the protein was named PfWLP1 
(Ngongang, 2012). The protein was observed to be expressed in asexual blood stages 
and gametocytes. Expression increased with gametocyte maturation, persisted in ma-
crogametes and ceased after fertilization with only low abundance of the protein in the 
residual body of the ookinete. In Western blot analyses protein bands of different mole-
cular weight were observed in different life cycle stages. Whilst in gametocytes both a 
band of 70 kDa and 95 kDa were observed, after gametocytes activation only the 70 kDa 
band was detected. It can thus be assumed that processing of the proteins takes place 
upon induction of gamete formation. This had been described for the TBV candidate 
protein Pfs230 which is postulated to be part of the multimeric protein complex of ga-
metocytes (Williamson et al., 1996; Brooks and Williamson, 2000). Both intensity of 
expression in the different life cycle stages and spotted to homogenous distribution of 
the proteins resemble expression of PfCCp proteins. These observations and the fact 
that WD40 proteins generally serve as scaffolds for protein complexes (reviewed in 
Stirnimann et al., 2010) suggests that the novel WD40 protein PfWLP1 is part of the 
PfCCp-containing multimeric protein complexes on the cell surface of P. falciparum 
gametocytes. Apart from the results of the original co-immunoprecipitation assays this 
hypothesis is supported by the observation that PfWLP1 co-localizes with Pfs230, inte-
raction partner of several PfCCp proteins (Ngongang, 2012). The investigation of co-
dependent expression via IFAs showed, that correct localization of PfWLP1 seemingly 
does not depend on presence of the PfCCp proteins. However, it will of special interest 
if absence of PfWLP1 will affect the correct assembly of the PfCCp containing protein 
complexes. As described above (3.5.3) the study of PfWLP1-disruptant parasite line is 
underway. As for PfCCp5 it would also be possible for PfWLP1 that it fulfills distinct 
rolls in asexual parasite stages, where other PfCCp proteins are absent, and in gameto-
cytes in conjunction with PfCCp proteins. 
4.1.4 Potential role of PfCCp-based multimeric protein complexes 
The numerous PfCCp and PbCCp gene-disruptant parasite lines studied did not show a 
phenotyp differing from that of WT parasites during gametocyte development or game-
togenesis (Pradel et al. 2004; Scholz et al., 2008; Simon et al., 2009; Claudianos et al., 
2002; Raine et al. 2007). Instead, the phenotype of the mutants was observed at a later 
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time point of the life cycle – the sporogonic phase. Whilst in PfCCp mutants the transi-
tion of sporozoites from midgut oocyst to the salivary glands was disturbed, in PbCCp 
mutants sporulation within the oozyst was impaired. This leads to speculate whether 
PfCCp proteins have two different functions in the life cycle of Plasmodium spp.: One 
redundant function in gametocytes, where loss of PCCp proteins can be compensated by 
other proteins, and a second role for sporozoite development. Alternatively, absence of 
the proteins in gametocytes might have a quantitative rather than a qualitative effect 
(Saeed et al., 2010). Development from gametocyte to oocyst represents one of the ma-
jor population bottlenecks in the parasite’s life cycle. The reduced number of success-
fully formed zygotes might thus lead to fewer healthy oocysts that can give rise to infec-
tive sporozoites. 
In gametocytes PfCCp proteins might be responsible for ensuring contact between ga-
metes followed by fertilization. A protein termed HAP2 has been reported to be respon-
sible for membrane fusion in the course of fertilization of macrogamete by microgamete 
(Liu et al., 2008). However it remains elusive, how the initial contact of the gametes 
within the midgut is achieved. The predominantly in female gametes expressed PfCCp 
proteins with their numerous adhesion domains thus represent promising candidates for 
binding to a surface protein of microgametes such as Pfs230 or Pfs48/45. 
Another role of PfCCp proteins in gametocytes might also be the protection of the 
emerging gametes after gametocyte activation. The mosquito midgut contains a variety 
of harmful components such as digestion enzymes, midgut bacteria and also factors of 
the mosquito immune system might be present. In addition to vector-specific factors, the 
blood meal also bears antagonistic components such as antibodies of the human host 
and the human complement system. As it had been reported, the PfCCp proteins and 
other proteins like Pfs230 become processed upon gametocyte activation and egress and 
might thus function as a shield captivating hostile factors of the mosquito midgut. 
4.2 The inner membrane complex of gametocytes and 
cytoskeleton proteins  
4.2.1 Molecular composition of the inner membrane complex of 
gametocytes 
The motile stages of Apicomplexan parasites possess a trilaminar pellicle comprising 
the plasma membrane and flat membrane cisternae which in their entity are also referred 
to as IMC. This IMC is scaffold for the molecular motor, a complex structure compris-
ing several proteins which in concert enable the movement of parasites during gliding 
motility on surfaces and during invasion. Gametocytes of Plasmodium spp. exhibit a 
similar membrane structure, referred to as subpellicular membrane. Until recently nei-
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ther the exact composition nor the function of this subpellicular membrane was known. 
In this thesis expression of six genes encoding components of the IMC of asexual para-
sites, pfmyoA, pfgap45, pfgap50, pfmtip, pfaldo and pfactinI, was confirmed in gameto-
cytes via RT-PCR. The presence of two of the respective proteins, PfGAP50 and 
PfmyoA was further investigated via IFA. Whilst PfmyoA showed distribution in a ra-
ther punctuate pattern in the entire gametocyte, PfGAP50 located to a great part to the 
cell periphery (see Fig. 3.15 and Fig. 8.5). PfactinI which in the motor complex interacts 
with PfmyoA showed a distribution similar to that of PfGAP50 (see Fig. 3.22 and 
Fig. 8.5). Thus it can be concluded that the components of the molecular motor are ex-
pressed in gametocytes. Staining of PfactinI was similar to that observed in P. berghei 
ookinetes, except of a local concentration of the protein at the apical pole of ookinetes 
(Sidén-Kiamos et al., 2006). PfmyoA staining on the other hand was rather diffuse in 
gametocytes, whilst in P. berghei ookinetes it was restricted to the cell periphery 
(Sidén-Kiamos et al., 2006).  
A number of publications addressed the composition of the subpellicular membrane of 
gametocytes recently (Dearnley et al., 2012; Kono et al., 2012; reviewed in Dixon et al., 
2012). Results were in good concordance with the here described observations. IFAs on 
P. falciparum stage II – IV gametocytes detected PfGAP50, PfGAP45, PfMTIP and 
PfMyoA, in a similar pattern as in the present work (Dearnley et al., 2012) Kono et al., 
(2012) reported the presence of five further IMC proteins in gametocytes. Thus, the 
combined results show that the molecular composition of the IMC of the motile parasite 
stages is analogous to the subpellicular membrane complex of gametocytes. As gameto-
cytes are amotile a structural role of the IMC is plausible. More than 30 years ago, a 
structural role of the microtubules that run beneath the IMC in determining the crescent 
shape of P. falciparum gametocytes had been suggested already (Sinden, 1982; Sinden, 
1983). Several recent publications confirmed this hypothesis. It was reported that de-
formability of gametocytes decreases with establishing the IMC and the microtubules 
during gametocyte maturation (Aingaran et al., 2012; Dearnley et al., 2012; Tibúrcio et 
al., 2012). With further maturation and reaching stage V gametocytes become less rigid 
coincident with disassembly of the longitudinal microtubules. Up to date no adhesins 
responsible for sequestration of immature gametocytes have been identified (Saeed et 
al., 2008). It has therefore been suggested that increased rigidity of stage II – IV gameto-
cytes and maybe of their host cell, too, is mediating mechanical sequestration. Reaching 
stage V, the gametocytes become more flexible. They enter the circulation by an un-
known mechanism and thereafter are available to be taken up by Anopheline mosqui-
toes during their blood meal. 
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4.2.2 Expression of myosin isoforms in P. falciparum gametocytes 
Six myosin genes have been described to be encoded in the P. falciparum genome 
(Chaparro-Olaya et al., 2003; reviewed in Vale, 2003). Expression of the myosins has 
been investigated in asexual blood stages via RT-PCR and in part via IFA. Until now, 
nothing was known about expression of myosins in sexual stage parasites of P. falcipa-
rum. In the course of this PhD thesis and a recently submitted Bachelor thesis (Tews, 
2011) the expression of the six myosin was investigated via RT-PCR. We were able to 
detect transcripts of all myosin genes with the exception of pfmyoE in cDNA obtained 
from total RNA gametocytes of the NF54 strain. Our data was in partial agreement with 
the observations of Chaparro-Olaya et al. (2005). We were able to detect transcripts of 
pfmyoA, pfmyoB, pfmyoC and pfmyoE in mixed asexual blood stages of the gametocyte-
less strain F12 (Tews, 2011; Simon et al., 2012). The differences might result from dif-
ferent experimental procedures of RNA isolation. The isolation of mRNA via a com-
mercial kit as obtained by Chaparro-Olaya et al. (2005) might have been more efficient 
as isolation of total RNA with TRIzol. Until today only for PfMyoA a role has been 
assigned. As described above PfMyoA is part of the molecular motor mediating inva-
sion and gliding on surfaces (reviewed in Baum et al., 2008). According to its expres-
sion profile with a peak in mature schizonts and merozoites for PfmyoB a role during 
invasion has been proposed as well (Chaparro-Olaya et al., 2003). For PfmyoD a role in 
formation of merozoites has been implicated according to its cellular location in matur-
ing schizonts (Chaparro-Olaya et al., 2005). As the six P. falciparum myosins cluster 
with other Apicomplexan myosin in an own class within the myosin superfamily it is 
difficult to draw any conclusions about their function according to the protein structure 
(Chaparro-Olaya et al., 2005; reviewed in Heintzelman and Schwartzman, 2001). Myo-
sin functions are as diverse as the filament sliding as observed for conventional class II 
myosins, vesicle transport, trafficking of cell surface receptors, transport of protein 
complexes, cell migration and adhesion (reviewed in Krendel and Mooseker, 2005; 
Hartman and Spudich, 2012). 
In order to gain knowledge on function of myosins in gametocytes more detailed studies 
focusing on proteins localization as well as reverse genetic approaches might be useful. 
In a recent work PbMyoA which is essential for asexual blood stage development was 
expressed under the promoter of PfAMA1 (Sidén-Kiamos et al., 2011). Thereby expres-
sion of pbmyoA in asexual blood stages was as in wild-type parasite, however from ga-
metocyte stage onwards, expression was abolished. No altered phenotype was observed 
in gametocytes and gametes. Viable ookinetes were formed. However, ookinetes were 
amotile and thus not able to cross the midgut epithelium (Sidén-Kiamos et al., 2011). In 
the background of the novel findings on the IMC in gametocytes of P. falciparum it 
would be of special interest to see whether PfMyoA is likewise dispensable during ga-
metocytes development. In contrast to the spherical P. berghei gametocytes, PfMyoA 
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might be important for stability of the IMC of gametocytes and thus, the formation of 
the crescent shape of P. falciparum gametocytes. 
4.3 Characterization of PfactinII 
4.3.1 Expression of PfactinII 
The genome of P. falciparum encodes two distinct actin genes sharing 75 % of identity 
at the transcript level and 79 % at the protein level (PlasmoDB). Early studies reported 
that pfactinI is expressed in all blood stages whilst transcript pfactinII was only detected 
in sexual parasite stages (Wesseling et al., 1989). However, no details on the location of 
PfactinII or on the function of the protein were known. As observed during IFAs in this 
thesis, PfactinII is indeed specific to sexual parasite stages. In contrast to PfactinI which 
showed even distribution both in cytosol and gametocyte periphery, PfactinII was found 
predominantly at the periphery of the gametocytes and was further expressed in macro-
gametes and zygotes at the periphery. Western blot analyses confirmed these observa-
tions showing ubiquitous expression of PfactinI in all blood stages, whilst PfactinII was 
detected almost exclusively in gametocytes and activated gametocytes (Fig. 3.18, Rupp 
et al., 2011). A faint band was detected in lysate of asexual blood stage parasite of the 
gametocyte-less F12 strain. A similar observation had been made in RT-PCR on cDNA 
of a culture of mixed blood stages of the gametocyte-less F12 strain (Fig. 3.11). How-
ever it is not known, at what exact stage of gametocytogenesis the F12 strain is defec-
tive (Alano et al., 1995). Thus, it is possible that the faint signal observed for PfactinII 
in this strain resulted from sexually determined parasites. As IFAs double-labeled with 
the early gametocyte marker Pfs16 showed, expression of PfactinII, indeed starts very 
early. 
In a recent report the orthologous protein, PbactinII was characterized in P. berghei. In 
this study expression of pbactinII started as early as 15 h post invasion of the RBC by 
the determined merozoite. No transcript was detected in asexual parasites (Deligianni et 
al., 2011). As observed in this thesis, the distributions of PactinI and PactinII were 
clearly distinct from one another in IFAs in P. berghei. It can thus be assumed that both 
in P. falciparum and in P. berghei the proteins carry out different functions in the sexual 
stages. However there were also differences observed in the expression of PactinII in 
P. berghei and P. falciparum. In the present study absence of PfactinII from the nucleus 
seemed to be likely in some gametocytes. However no detailed analysis on nuclear ex-
pression was carried out due to technical restrictions. Another discrepancy was observed 
regarding the expression in microgamets. In the present study PfactinII was not detected 
on microgametes. However in an earlier study employing antisera targeting the same 
region of the protein, P. falciparum microgametes were clearly positive for PfactinII 
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(Rupp et al., 2011). It thus is possible that PfactinII is present in microgametes. In con-
trast to the weak expression of PbactinII in P. berghei, both in Rupp et al. (2011) and in 
the present thesis PfactinII showed high abundance in macrogametes. In P. falciparum 
the pfactinII thus does not seem to be gender-specifically expressed (Rupp et al., 2011). 
4.3.2 Interaction of Pfs230 and PfactinII 
Indirect IFA studies on the two mutants expressing truncated version of the pfs230 gene 
revealed that PfactinII and Pfs230 are co-dependently expressed. In the mutant express-
ing the first 950 amino acids, Pfs230-KOd2, a patchy distribution of PfactinII was ob-
served. Thus protein abundance as detected by IFA was dramatically reduced compar-
ing in contrast to wild-type parasite. In the second mutant synthesizing the first 542 
amino acids (Pfs230-KOd1) no PfactinII was detectable via IFA. Co-localization expe-
riments showed that PfactinII and Pfs230 were co-localizing. This was also true for the 
Pfs230-KOd2 mutant in which Pfs230 and PfactinII showed exactly the same patchy 
distribution. RT-PCR showed expression of pfactinII at a level comparable to wild-type 
parasites in the two mutants, thus demonstrating that the co-dependent expression is 
occurring exclusively at the protein level as observed for PfCCp proteins. However, in 
contrast to co-dependent expression amongst PfCCp proteins, stability of PfactinII did 
not depend on presence of Pfs230. In Western blot analyses PfactinII was detected in 
gametocyte lysates of both Pfs230-KOd1 and Pfs230-KOd2. In view of these results it 
might be possible that in absence of full length Pfs230 PfactinII reveals a slightly differ-
ent conformation that is not recognized by the antibody used in this study. Such “con-
fomational interdependence” had been reported for the PfCCp orthologs in P. berghei. 
In that study PbCCp5 (termed PbLAP3) had been detected by Western blot but not by 
IFA when expression of pbcpp3 (pblap1) was abolished by gene KO (Saeed et al., 
2012). Co-immunoprecipitation assays were carried out in order to see if the co-
dependent expression is a result of a protein-protein interaction between PfactinII and 
Pfs230. Indeed, an interaction between the two proteins was observed. However the 
results were not clear, as PfactinI and Pfs230 also seemed to interact, even if not in such 
pronounced way as observed for PfactinII and Pfs230. The results of co-
immunoprecipitation assays not necessarily reflect interactions actually occurring in 
vivo. It is thus possible that Pfs230 interacts (directly or indirectly) with PfactinII in the 
gametocyte, but in vitro it also interacts with PfactinI due to structural similarity with 
PfactinII. Functions of actins and actin-related proteins in general are manifold and 
therefore many actin-binding protein exist. Other controls used (e.g. the ER protein 
Pf39 and the proteasom β-subunit) showed similarly contradictory results (data not 
shown). It is therefore necessary to chose additional approaches such as protein cros-
slinking for investigating the interaction of PfactinII and Pfs230 within the gametocyte. 
What also remains unclear is the exact localization of PfactinII. If it was for instance in 
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association with the IMC interaction with Pfs230 would be possible via a transmem-
brane adaptor protein. Pfs230 itself has been reported to possess a potential transmem-
brane domain (reviewed in Williamson, 2003). 
It might also be possible that the co-dependent expression of PfactinII and Pfs230 is an 
indirect effect. As studies on the ultrastructure of mutants with truncated Pfs230 
showed, the typical trilaminar membrane structure of those gametocytes was disturbed. 
Pfs230 is a very large protein of 363 kDa which is quite abundant in gametocytes. Alte-
ration of the membrane structure might interfere with correct localization of PfactinII 
which like Pfs230 is expressed in the gametocyte periphery. However, until now, no 
further gametocyte proteins revealed an alteration in expression site upon disruption of 
Pfs230.  
4.3.3 Possible functions of PfactinII 
In order to gain information on possible functions of PfactinII a KO mutant was gener-
ated via single crossing-over homologous recombination. However in this PfactinII-KO 
mutant PfactinII was still detectable in a quite high abundance, even if reduced in com-
parison to wild-type parasites. The protein was also detected via Western blot in game-
tocyte lysate of the PfactinII-KO (A. von Bohl, MSc, personal communication). A poss-
ible explanation for these observations is the reversion to wild-typic allele due to expul-
sion of the plasmid via single crossing-over recombination. Resistances against Blasti-
cidin S had been reported (Hill et al., 2007; Lisk et al., 2010) and the mechanism resis-
tance is based on was discovered recently (Mira-Martínez et al., 2013). Thus it is im-
aginable that a small subpopulation of resistant parasites expressing PfactinII had de-
veloped. Another reason for detection of PfactinII is that expression of the residual gene 
is driven by the plasmid-internal calmodulin promoter (Crabb and Cowman, 1996; 
Crabb et al., 1997; Sanders et al., 2006). As the location for plasmid integration was in 
proximity to the 5’ end of the gene, downstream of the integrated linearized plasmid a 
large fragment of the gene would still be intact which might be transcribed via the pro-
moter activity of the plasmid and an alternative start codon. To circumvent these diffi-
culties observed in some cases of single crossing-over homologous recombination, a 
new mutant is currently created (A. von Bohl, MSc, personal communication). This 
approach is based on double crossing homologous recombination, by which the major 
part of the gene will be removed from the respective chromosome. 
In view of the here observed increase of expression of PfactinII in the course of game-
tocyte maturation it seems likely that PfactinII fulfills a function during gamete forma-
tion or fertilization. This assumption is corroborated by the observed decrease of ex-
pression in zygotes and retort stages. In a prevoious study of our laboratory PfactinII 
had been detected in filamentous cell protrusions formed by macro- and microgametes 
(Rupp et al., 2011). These filaments resemble a type of cell-cell connections termed 
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nanotubes. Nanotubes have been described in a variety of mammalian cells like HEK 
(human embryonic kidney) cells, neuronal cells (Rustom et al., 2004) and immune cells 
(B cells, T cells natural killer cells and macrophages) (Stinchcombe et al., 2001; Önfelt 
et al., 2004). Nanotubes contain filamentous actin (F-actin) and up to 11 filaments had 
been observed to protrude from activated gametocytes and gametes of P. falciparum. It 
has been suggested that the filaments formed by gametes are facilitating the contact 
between gametes in the mosquito midgut, thus promoting fertilization (Rupp et al., 
2011). In P. berghei a role of PbactinII motility of microgamtes was suggested (Deli-
gianni et al., 2011). PbactinII-deficient microgametocytes formed structurally normal 
microgametes. However, those were amotile and unable to egress from their host cell 
(Deligianni et al., 2011). As egress of microgametes seems to be promoted by flagellar 
movement it is not surprisingly that the amotile microgametes remain trapped within the 
RBC. Taken together PactinII seems to be of great importance for sexual development 
and therefore further studies are promising for identifying valuable targets for interven-
tion strategies. 
4.4 Gametocyte activation and egress 
4.4.1 Induction of gametogenesis by xanthurenic acid 
The signaling pathway resulting in gametocyte activation and gamete formation are 
quite well studied already. However, until today it remains elusive, how the triggering 
factors, a drop in temperature by at least 5 degrees and XA, a molecule present in the 
mosquito midgut, are perceived by mature gametocytes. In the present study we ad-
dressed the question how XA is perceived by the parasite. We observed that XA is taken 
up by niRBCs and characterized the transport of XA via LC/MS/MS. XA uptake in-
creased linearly with increasing incubation time or concentration applied. Uptake was 
saturable when increasing XA concentrations were applied. The properties observed are 
thus suggestive for facilitated diffusion being the mechanism for XA uptake (reviewed 
Carruthers, 1990). 
Several inhibitors were used in uptake studies with niRBC as well as in exflagellation 
assays with mature gametocyte cultures. Adenine was used as competitive inhibitor of 
the nucleobase transporter hFNT1. Inhibitor studies with human RBCs had shown that a 
concentration of 1 mM adenine inhibited the uptake of 7 µM of the carbocyclic nucleo-
side analogues carbovir and abacavir by 94 % and 25 %, respectively (Mahony et al., 
2004). Application of 3 mM adenine resulted in a similar inhibition of uptake of the nuc-
leoside analogues by RBCs. In the exflagellation assay an inhibition of approximately 
40 % of the solvent control had been achieved. Thus, the observed reduction is not as 
pronounced as for uptake of the nucleoside analogue carbovir. The low reduction of 
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abacavir had been interpreted as unspecific and uptake of abacavir by RBCs was re-
ported to by mediated via non-facilitated diffusion (Mahony et al., 2004). Another study 
also showed a very efficient inhibition of hFNT1. Here, 1 mM adenine resulted in 92 % 
inhibition of permeant uptake (Wallace et al., 2002). 
The second inhibitor of the nucleobase transporter, hypoxanthine resulted in a similar 
inhibition of exflagellation of approximately 33 %. Reduction of exflagellation by the 
nucleoside transporter inhibitor NBTI (5 µM) was not significant as compared to the 
solvent control. In contrast, Plagemann and Woffendin (1988) reported an IC50 value of 
10 nM for the uptake of uridine. When using the same inhibitors for investigating the 
uptake of XA by niRBCs no differences were observed when applying inhibitor or sol-
vent control. Thus it can be concluded, that neither the nucleobase transporter hFNT1 
nor nucleoside transporter hENT1 are involved in uptake of XA by niRBC. 
Further inhibitor tested were the amino acids L-Trp, L-Phe and L-Leu, that had been 
described as competitive inhibitors of transporters of aromatic amino acids (Lopez-
Burillo et al., 1985; Tate et al., 1992). Furthermore the influence of cytochalasin B, in-
hibitor of the glucose transporter GLUT1 (Basketter and Widdas, 1978; Concha et al., 
1997; Lu et al., 1997, Kasahara et al., 2009) was tested during XA uptake. And finally 
the OAPT inhibitors rifampicin and erythromycin (Vavricka et al., 2002; Seithel et al., 
2006) were tested. None of these inhibitors showed an influence on XA uptake by 
niRBCs. Thus a potential transporter for XA remains elusive. 
Beside transport proteins of the RBC parasitized erythrocytes possess a number of para-
site-derived proteins that have been transported to the RBC cytosol or the RBC mem-
brane (Ginsburg et al., 1983; Elford et al., 1985). Furthermore, the modification of trans-
port properties of RBC-owned proteins by the parasite have been proposed (reviewed in 
Staines et al., 2004). Thus, it is possible that in the gametocyte-infected RBC XA uptake 
is even more efficient due to alteration of RBC transport proteins or insertion of parasite 
derived proteins into the RBCM. 
We therefore tested the influence of the protease chymotrypsin on XA-mediated egress 
of male gametocytes from their host cells. Chymotrypsin had been described to inhi-
bited uptake of NPP mediated transport (Baumeister et al., 2006). However there was 
only a weak, non-significant reduction of exflagellation centers when mature gameto-
cytes were incubated with chymotrypsin prior to activation with XA. Similarly the up-
take of XA by niRBCs was not affected by incubation with chymotrypsin prior to incu-
bation with XA. Proteinase K has been used to study the conformation of transmem-
brane proteins (Poole et al., 1996). For instance, treatment of RBCs with proteinase K 
had been described to digest GpA. However treatment of niRBC likewise did not influ-
ence the uptake of XA. 
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However, a very intriguing observation was made when mature gametocytes were incu-
bated with saponin before activation. Microgametocytes were activated and underwent 
exflagellation when RBCM and PVM were removed prior to addition of XA. This ob-
servation supported our hypothesis that XA is detected beyond the RBCM. Thus the 
putative receptor for XA most probably is located at the PPM. 
The combined results on exflagellation assays employing inhibitors of RBC nucleobase 
and nucleoside transporters showed significant reduction of exflagellation when apply-
ing inhibitors of the nucleobase transporter, but not of the nucleoside transporter. How-
ever, experiments with niRBCs revealed that the inhibitors did not have an effect on XA 
uptake by RBCs. Thus, the impact of nucleobase/nucleoside transporter inhibitors on 
exflagellation was caused by another unknown mechanism. 
4.4.2 Reverse genetics study on XA receptor candidate genes 
In order to identify a potential receptor protein for XA we searched the PlasmoDB data-
base for G-protein coupled receptors/ serpentine receptors, as these are known to induce 
PLC (reviewed in Dorsam and Gutkind, 2007), which is a component of the XA-
induced signal cascade (Martin et al., 1994). For two of the five identified genes, gene-
disruptant mutant were generated. Generating a KO mutant for the pfsr1 gene was at-
tempted in two independent transfections. In both attempts integration of the 
PfSR1/pCAM-KO plasmid was not achieved, even after prolonged cultivation of trans-
fectants. As the pfsr1 gene is expressed in asexual blood stages, with a peak in the schi-
zont stage, an essential role, for instance in egress of parasites from the iRBC is possible 
(Madeira et al., 2008). In contrast, it was possible to disrupt the gene with the gene iden-
tifier PFE1265w (new PlasmoDB identifier PF3D7_0525400). Preliminary results show 
that PfE1265w is predominantly expressed in gametocytes, however the PFE1265w-
disruptant parasite line is able to form macro- and microgametes (A. von Bohl, MSc, 
personal communication). Thus, the protein is not involved in perception of XA. A role 
for development in the mosquito vector is anticipated as preliminary results showed a 
reduced number of oocysts and sporozoites during infection of An. stephensi (A. v. 
Bohl, M. Scheuermayer, G. Pradel, unpublished results). 
In view of these results it will be necessary to generate and screen further gene-
disruptant parasite lines in order to identify the receptor of XA. An alternative approach 
would be the labeling of XA in order to be able to identify the putative receptor via pull-
down followed by mass-spectrometry. The generation of a biotinylated XA was at-
tempted, but seems to be technically challenging. Thus, labeling of XA with tritium 
seems to be more promising in the search for a potential XA receptor. 
Recently, a GPCR has been described to be involved in signaling processes preceding 
egress of asexual blood stages from the iRBC. The GPCR has been reported to be of 
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erythrocytic origin and induction by a parasite-derived ligand has been supposed (Mill-
holland et al., 2013). However, the signal proteins downstream of the GPCR have been 
suggested to be entirely of host cell origin (Millholland et al., 2013), being in contrast to 
studies on P. berghei gametocytes where involvement of a parasite-derived PLC has 
been suggested (Raabe et al., 2011). 
4.4.3 Influence of ionophores on gametocyte activation 
Previously it had been shown for the Apicomplexan parasite T. gondii (Fruth and Arri-
zabalaga, 2007), that egress from the host cell was inducible by the K+/H+ ionophore 
nigericin. In the present study similar observations were made in P. falciparum gameto-
cytes. The effect of nigericin was visible both for male gametocytes in exflagellation 
assays and for gametocytes of both genders in EM studies. As observed by Fruth and 
Arrizabalaga (2007) incubation with the ionophore for 30 min was more efficient than 
incubation for 15 min. It is thus possible that whilst XA signal reaches various down-
stream signal molecules (see Fig. 1.5), nigericin only activates one of these pathways. In 
contrast to T. gondii egress of male P. falciparum gametocytes was less efficient with 
only approximately 40 % of male gametocytes exflagellating (as compared to nearly 
100 % of parasites egressed in T. gondii) (Fruth and Arrizabalaga, 2007). When investi-
gating nigericin-induced egress on the ultrastructural level 85 % of the investigated ga-
metocytes showed lyses of the PVM. One explanation for this observation would be that 
nigericin activates female gametocytes more efficiently. Until today only few data have 
been gathered on activation of female gametocytes, thus, differences between the two 
genders are possible. 
The antibiotic nigericin has been described to have a variety of effects. It acts as iono-
phore for K+, H+ and Pb2+ (Shavit et al., 1968). Valinomycin on the other hand has been 
described as ionophore for K+ ions (Heinen et al., 2007). Preliminary results indicated 
that valinomycin was able to induce exflagellation of male gametocytes as described for 
nigericin. However, EM studies investigating PVM rupture upon valinomycin treatment 
did not show activation of the gametocytes investigated.  
Due to the conflicting results obtained for valinomycin it is not clear, whether the 
change of permeability of H+ or K+ ions is responsible for gametocyte activation. To test 
whether nigericin was changing permeability of K+ ions, we activated exflagellation by 
nigericin in the presence of high extracellular K+ concentrations (100 - 150 mM, data not 
shown). Under these conditions gametocyte activation was completely abolished. For 
T. gondii similar results were observed, however no complete inhibition by high K+ 
concentrations was reported (Fruth and Arrizabalaga, 2007). It thus remains to be tested 
whether parasite viability was affected by these high K+ concentrations or whether the 
nigericin-mediated ion efflux was abolished. Further experiments are necessary to in-
vestigate this. A possibility would be to employ zaprinast, inhibitor of phosphodieste-
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rase (McRobert et al., 2008) that supposedly acts downstream of the nigericin-induced 
alteration of K+ permeability. If parasites were still viable and able to undergo gameto-
genesis in the presence of high K+ concentrations zaprinast would induce exflaggelation 
even under these conditions. In T. gondii exgress from the host cell is also inducible via 
host cell lysis which results in decrease of intracellular K+ concentration of the host cell 
(Moudy et al., 2001). Upon host cell lysis with saponin there was also activation of a 
small proportion of gametocytes observed (see Fig. 3.55 vs. Fig. 3.54), however this 
effect was much smaller as in T. gondii where egress was induced in more than 70% of 
parasites upon host cell lysis. 
The combined results of the ionophore experiments point at an influence of changes in 
host cell K+ concentrations, however this is much less pronounced as observed in 
T. gondii (Moudy et al., 2001; Fruth and Arrizabalaga, 2007). It is probable that K+ con-
centrations play only a minor role and that nigericin-induced exflagellation is partially 
due to changes in H+ permeability. This would make sense considering the influence of 
changes of pH that have been reported to influence gametogenesis (Sinden, 1983, Nij-
hout and Carter, 1978). 
4.4.4 Ultrastructural investigations of gametocyte activation 
The study of gametocyte egress on the ultrastructural level showed the sequence of 
steps finally resulting in gamete formation and parasite egress from the host cell. Rup-
ture of the PVM was observed as early as one minute upon induction of gametogenesis. 
Subsequently the RBC cytoplasm started to disintegrate and from 12 min p. act. on-
wards rupture of the RBCM was observed. Thus, the inside-out model, describing rup-
ture of PVM prior to RBCM in asexual parasites (Wickham et al., 2003; Aikawa, 1971) 
is also true for gametocytes. These observations are also in agreement with an early 
study reporting PVM rupture prior to rupture of RBCM (Quakyi et al., 1989). The in-
side-out model also applies for liver schizonts. After rupture of the PVM merozoites are 
released into the blood stream within the so-called merosome, which is derived from the 
hepatocyte plasma membrane (Sturm et al., 2006; Sturm and Heussler, 2007, reviewed 
in Wirth and Pradel, 2012).  
We further studied PVM rupture as sign for occurring gamete formation under several 
conditions. We wanted to see if one of the signals perceived by the parasite within the 
mosquito midgut, drop in temperature by at least 5°C or XA, is sufficient for induction 
of gamete formation. However, neither of the signals applied by itself was capable to 
induce PVM rupture. Thus, it seems as if at the very beginning gametocyte activation 
both signals are integrated and transduced in a common signal cascade. We further ob-
served that incubation of mature gametocytes in a very low pH of 6.6 had an inhibitory 
effect on induction of gamete formation. Considering reports of the capability of extra-
cellular pH to induce gamete formation (Sinden, 1983, Nijhout and Carter, 1978) our 
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result affirms the assumption of an increase of intracellular H+ concentration playing an 
important signal during gamete formation. In an environment of very low pH such high 
intracellular pH most likely was not achievable. A high extracellular pH had been de-
scribed to be able to replace the decrease of intracellular H+ concentration as response 
of extracellular signals in mammalian cells (Kawamoto et al., 1991). In the budding 
yeast Saccharomyces cerevisiae H+ ions have been described as secondary messengers. 
A rise of cytosolic pH here leads to activation of a cAMP-dependent proteinase kinase 
A (Dechant et al., 2010). The observations on nigericin being able to induce gamete 
formation would hence point at action as H+/K+ exchanger (Shavit et al., 1968) trans-
porting K+ ions from the RBC cytosol to the extracellular and simultaneously transport-
ing H+ into the RBC cytosol thus increasing the pH surrounding the gametocyte.  
The signal cascade induced by XA and the drop in temperature (Fig. 1.5) finally leads to 
activation of several effector proteins mediating the egress of gametocytes from the host 
cell. Several types of proteases seem to participate in host cell lyses (Sologub et al., 
2011). Those might include as recently reported for asexual blood stage parasites host 
cell proteases that mediate disintegration of the RBC cytoskeleton (Millholland et al., 
2013). An additional class of proteins involved in RBC rupture are the perforins. A re-
cent study reported that the perforin-like protein PPLP2 plays an important role for 
RBCM lysis (Deligianni et al., 2013). 
4.4.5 Conclusions 
In the present thesis several adhesion proteins of P. falciparum gametocytes were stu-
died. Two newly obtained gene-disruptant parasite lines, PfCCp5-KO and PfFNPA-KO, 
completed the set of KO parasite lines of the PfCCp protein family. In contrast, for 
P. berghei only five of the six genes encoding the orthologous PbLAP proteins have 
been disrupted until today. The characterization of PfCCp5-KO and PfFNPA-KO para-
sites was in concordance with previous reports on the other PfCCp proteins. Although 
expressed in gametocytes, the PfCCp proteins are not essential for gametocyte devel-
opment and gamete formation. The phenomenon of co-dependent expression amongst 
PfCCp proteins was confirmed for the two new gene-disruptant parasite lines as well. In 
the absence of PfCCp5 or PfFNPA most PfCCp proteins were present in reduced abun-
dance whilst transcript levels were unchanged. PfCCp5 was shown to differ in certain 
extent from the other members of the protein family. It was detected already in tropho-
zoites and expression of different isoforms upon proteolytical processing seems likely. 
Expression of two so far barely characterized proteins, PfactinII and the recently dis-
covered PfWLP1, was investigated, thus providing new promising targets for interven-
tion strategies against P. falciparum transmission stages. The interaction and co-
localization of PfactinII with Pfs230, a protein most important during fertilization, em-
phasizes the potential importance of PfactinII.  
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After being neglected for decades, after its first mention in the literature, the IMC of 
gametocyte was now studied on the molecular level. Considering findings from other 
groups the IMC seems to be a structural feature crucial for gametocyte development 
within the human host organism. Hence, the IMC also warrants further research in order 
to identify targets for interventions strategies. 
The results on gametocyte egress shed light on the sequential processes occurring dur-
ing this crucial part of the P. falciparum life cycle. In analogy to asexual blood stage 
parasites gametocytes egress via an inside-out mechanism, first lysing the PVM and 
thereafter the RBCM. The ability of the K+/H+ ionophore nigericin pointed at the possi-
ble involvement of K+ ion concentration to play a role during gametocyte activation. 
The observation of gametocytes devoid of PVM and RBCM being able to percept XA 
provides information about the site of XA perception, possibly at the gametocyte PPM. 
 
5 Summary 
Transmission of the malaria parasite from man to the mosquito requires the formation of 
sexual parasite stages, the gametocytes. The gametocytes are the only parasite stage that 
is able to survive in the mosquito midgut and to undergo further development – gamete 
formation and fertilization. Numerous sexual stage-specific proteins have been discov-
ered, some of which play crucial roles for parasite transmission. However, the functions 
of many sexual stage proteins remain elusive. Amongst the sexual stage-specific pro-
teins are the proteins of the PfCCp proteins family, which exhibit numerous adhesion 
domains in their protein structures. For four members of the protein family, PfCCp1 to 
PfCCp4 gene-disruptant parasite lines had been already studied. Amongst these, 
PfCCp2 and PfCCp3 showed an important role for development of the parasites in the 
mosquito. In the present work the study of gene-disrupted parasites of the PfCCp pro-
tein family was completed. PfCCp5-KO and PfFNPA-KO parasite lines were characte-
rized to a great extent and many properties were similar to those of other PfCCp pro-
teins. The co-dependent expression previously reported to be a phenomenon of PfCCp 
proteins was also observed in these two mutants, although to lesser extent. When either 
PfCCp5 or PfFNPA were absent, all other proteins were detected in reduced abundance 
only. Co-dependent expression manifests exclusively on the protein level. Transcript 
levels were not altered as RT-PCR showed. Amongst PfCCp proteins numerous protein-
proteins interactions are taking place. The previously described multimeric protein 
complexes also include further sexual stage-specific proteins like Pfs230, Pfs48/45 and 
Pfs25. Recently, a new component of PfCCp-based multimeric protein complexes had 
been identified. The protein was named PfWLP1 (WD repeat protein-like protein 1) due 
to its possession of several WD40 repeats. In the present study expression of this uncha-
racterized protein was investigated via indirect IFA. It was expressed in asexual blood 
stages and gametocytes. Upon gamete formation and fertilization its expression ceased. 
Another sexual stage protein studied in this work was PfactinII. It was shown to be ex-
clusively expressed in sexual stages. In gametocytes it co-localizes with Pfs230 and 
correct localization of PfactinII depends on presence of Pfs230.  
Transcript analysis by means of RT-PCR revealed the expression of several components 
of the IMC in gametocytes. Furthermore, five or six myosin genes encoded in the 
P. falciparum genome were detected in gametocytes. Gametocyte egress was studied on 
the ultrastructural level via transmission electron microscopy and an inside-out type of 
egress was observed. Firstly, the membrane of the parasitophorous vacuole (PVM) was 
lysed and only thereafter the membrane of the red blood cell (RBCM) ruptured. Fur-
thermore, a new inductor of gametogenesis was identified: The K+/H+ ionophore nigeri-
cin induced gametocytes activation in the absence of xanthurenic acid (XA), which is 
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responsible for gamtetocyte activation in the mosquito midgut. Selective permeabiliza-
tion of RBCM and PVM by the mild detergent saponin, showed that in the absence of 
these membranes male gametocytes were still able to perceive both XA and the drop in 
temperature. Thus, the receptors for both factors signaling the parasite transmission to 
the mosquito, seem to be of parasitic origin. LC/MS/MS analysis confirmed the ability 
of RBCs to take up XA.. 
With malaria eradication on the agenda of malaria research targeting the sexual stages 
becomes a crucial part of intervention strategies. The sexual stages are especially attrac-
tive target as they represent a population bottleneck. The here reported findings on 
P. falciparum gametocytes provide several potential candidate proteins for developing 
tools to interrupt transmission from man to mosquito. Such tools might include trans-
mission blocking vaccines and drugs. 
 
 
6 Zusammenfassung 
Die Übertragung der Malaria vom menschlichen Wirt auf die Überträgermücke erfor-
dert die Bildung von Sexualstadien, der Gametozyten. Dieses Parasitenstadium ist in der 
Lage im Mitteldarm der Mücke zu überleben und sich zu Gameten zu entwickeln, ge-
folgt von Befruchtung und Zygotenbildung. Eine Vielzahl von in den Sexualstadien 
exprimierter Proteine wurde bereits entdeckt. Einige von diesen haben essentielle Funk-
tionen für die Transmission der Parasiten auf die Mücke. Die Rolle der meisten dieser 
spezifisch exprimierter Protein ist jedoch ungeklärt. Zu den sexualstadienspezifischen 
Proteinen gehören die Proteine der PfCCp-Proteinfamilie. Für vier Proteine diese Pro-
teinfamilie wurden bereits KO-Mutanten untersucht. Zwei Mutanten, PfCCp2-KO und 
PfCCp3-KO besitzen eine wichtige Funktion während der Entwicklung der Parasiten in 
der Mücke. In der vorliegenden Arbeit wurde die Studie der PfCCp-Proteine komplet-
tiert. PfCCp5- und PfFNPA-defiziente Parasitenlinien wurden zu einem Großteil cha-
rakterisiert. Viele Eigenschaften dieser beiden Parasitenlinien wiesen Ähnlichkeiten zu 
den bisher untersuchten PfCCp-KO-Mutanten auf. Die ko-abhängige Expression welche 
in der PfCCp-Proteinfamilie vorkommt, wurde auch in diesen beiden Mutanten beo-
bachtet, wenngleich in geringerem Ausmaß. In den Mutanten, in welchem entweder 
PfCCp5 oder PfFNPA fehlten, waren alle übrigen PfCCp-Proteine nur in reduzierter 
Menge nachzuweisen. Diese ko-abhängige Expression ist ausschließlich auf dem Pro-
teinlevel zu beobachten. Die Transkription der jeweiligen Gene hingegen ist unbeeinf-
lusst. Zahlreiche Protein-Protein-Interaktionen finden zwischen den Proteinen der Pro-
teinfamilie statt. The zuvor beschriebenen multimeren Proteinkomplexe schließen auch 
weitere sexualstadienspezifische Proteine ein, wie Pfs230, Pfs48/45 und Pfs25. Kürzlich 
wurde eine neue Komponente der PfCCp-basierten Multiproteinkomplexe identifiziert. 
Dieses Protein wurde PfWLP1 (WD repeat protein-like protein 1) genannt, da es mehre-
re WD40 repeat Domänen besitzt. In der vorliegenden Arbeit wurde das bisher unbe-
schriebene Protein mittels indirekter Immunfluoreszenzstudien charakterisiert. PfWLP1 
ist sowohl in asexuellen Blutstadien als auch in Gametozyten exprimiert. Nach der Ga-
metenbildung und Fertilisation nimmt die Expression des Proteins ab. Ein weiteres Pro-
tein der Sexualstadien, welches in dieser Arbeit untersucht wurde, ist PfactinII. Es wur-
de gezeigt, dass dieses Protein ausschließlich in den Sexualstadien vorliegt. In Gameto-
zyten ko-lokalisiert es mit Pfs230 und die korrekte Lokalisierung ist abhängig von der 
Anwesenheit von Pfs230. 
Mittels RT-PCR wurden mehrere Komponenten des inneren Membrankomplexes in 
Gametozyten nachgewiesen. Weiterhin wurden Transkripte für fünf der sechs Myosin-
Gene, welche im Genom von P. falciparum exprimiert sind, nachgewiesen. Der Austritt 
der Gametozyten aus der Wirtszelle wurde auf ultrastruktureller Ebene mittels Trans-
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missionselektronenmikroskopie untersucht. Hierbei wurde gezeigt, dass die Lyse der 
den Parasiten umgebenden Membranen von innen nach außen geschieht. Das heißt, dass 
zunächst die Membran der parasitophoren Vakuole (PVM) lysiert wird, und erst an-
schließend die Erythrozyten-Plasmamembran (RBCM). Als neuer Induktor der Game-
tozytenaktivierung wurde Nigericin identifiziert. Nigericin ist ein K+/H+-Ionophor, wel-
cher in Abwesenheit von XA in der Lage ist, die Gametenbildung zu identifizieren. Die 
selektive Permeabilisierung der beiden den Gametozyten umgebenden Membranen, 
PVM und RBCM, zeigte, dass männliche Gametozyten nach Entfernung der beiden 
Membranen, in der Lage sind, den Temperaturabfall und XA zu perzipieren. Somit kann 
geschlussfolgert werden, dass die Rezeptoren beider Stimuli parasitischen Ursprungs 
sind. LC/MS/MS-Analysen bestätigten, dass Erythrozyten in der Lage sind, XA aufzu-
nehmen. 
Die Sexualstadien des Malariaparasiten nehmen mehr und mehr an Bedeutung zu, da 
langfristig nicht nur eine Eindämmung der Malaria in endemischen Gebieten sondern 
die Auslöschung der Malaria angestrebt wird. Die Sexualstadien sind ein attraktiver 
Angriffspunkt aufgrund ihrer Bedeutung für die Transmission der Krankheit. Zum ande-
ren ist die auf den Vektor übertragene Parasitenanzahl vergleichsweise gering. Die Er-
gebnisse der vorliegenden Arbeit zeigen mehrere potentielle Kandidatenproteine auf, 
welche für die Entwicklung von Interventionsstrategien von Bedeutung sein könnten. 
Als Interventionsstrategien wären sowohl transmissionsblockierenden Vakzine als auch 
transmissionsblockierende Wirkstoffe denkbar. 
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8 Appendix 
8.1 Vector maps 
 
Fig. 8.1: Vector map of the expression vector pGEX-4T-1 used for the generation of GST fu-
sion proteins. 
 
Fig. 8.2: Vector map of the expression vector pIH902 used for the generation of MBP fusion 
proteins (vector kindly provided by Prof. Kim Williamson, Chicago). 
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Fig. 8.3: Vector map of the vector pCAM-BSD (kindly provided by Prof. Christian Doerig, 
Melbourne). 
 
Fig. 8.4: Vector map of the vector pCAM-BSD-HA (kindly provided by Prof. Christian Doerig, 
Melbourne). 
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8.2 Substances employed in exflagellation assays 
Tab. 8.1: Previously described inhibitors of transport pathways were tested on their potential influence on XA uptake by RBCs. The inhibitors were 
applied directly to gametocyte cultures during exflagellation assays (iRBCs). Secondly, non-infected RBCs were incubated with inhibitor and XA and 
the subsequently obtained XA-RBCF was tested in exflagellation assays (niRBCs). Thirdly, XA uptake by RBCs in the presence of XA was measured 
via LC/ESI/MS/MS. 
Inhibitor Target 
Conc. 
Stock 
Solvent 
Concentration used Concencentra-
tion literature Reference iRBCs niRBCs LC/MS/MS 
Adenine hFNT1 148 mM 
0.5 M 
HCl/PBS 
1-2 mM 1 mM – 0.1-3 mM 
Domin et al., 1988; Wallace et al., 
2002; Mahony et al. 2004 
Hypoxanthine hFNT1 10 mM PBS* 1 mM 1 mM – 1 mM Mahony et al. 2004 
NBTI hENT1 10 mM DMSO 0.005 mM 0.005 mM – 0.001- 0.004 mM 
Plagemann and Woffedin, 1988; Ma-
hony et al. 2004 
L-Leu 
System L 
20 mM ICM 
2 mM – 2-10 mM 1 mM Tate et al. 1992 
Non-saturable 
uptake of L-Trp 
– – 30-50 mM 30-50 mM Lopez-Burillo et al., 1985 
L-Phe 
System L/ System 
T 
10 mM ICM 2 mM – 0.01-25 mM 10 mM Lopez-Burillo et al., 1985 
L-Trp System T 10 mM ICM 2 mM – 0.01-25 mM 2 mM Lopez-Burillo et al., 1985 
Cytochalasin B GLUT1/ GLUT5 20 mM Ethanol – – 0.5-10 mM 0.0001-0.1 mM 
Concha et al., 1997; Kasahara et al., 
2009 
Rifampicin OATP 50 mM DMSO 0.1-0.5 mM 0.5 mM – 0.01-0.1 mM Vavricka et al., 2002 
Erythromycin OATP 50 mM Ethanol 0.2-0.5 mM 0.5 mM – 0.00001-1 mM Seithel et al., 2006 
*Hypoxanthine was solubilized by heating of powder in PBS at 90°C 
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Tab. 8.2: Substances applied in exflagellation assays and their previously described effect. 
Substance Effect 
Conc. 
Stock 
Solvent 
Conc. 
used 
Conc. litera-
ture 
Reference 
BABTA-AM 
Ca2+ chelator, inhibition 
of Gc egress 
10 mM DMSO 25 µM 100 µM 
Billker et al., 2004; 
McRobert et al., 2008 
Chymotrypsin 
proteolysis of band 3, 
inhibition of NPP 
20 mg/ml 
1 mM HCl/ 
2 mM CaCl2 
3 mg/ml 0.2-2 mg/ml Baumeister et al., 2006 
Nigericin 
egress of T. gondii from 
host cell 
10 mM Methanol 5-100 µM 2-10 µM 
Fruth and Arrizabalaga, 
2007 
Proteinase K 
digestion of glyco-
phorin A, B, C 
1 mg/ ml PBS 500 µg/ml 
6.7- 
66.7 µg/ml 
Poole et al., 1996; 
Thompson et al., 2001 
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8.3 Parameters used in LC/ESI/MS/MS analyses 
Tab. 8.3: Parameters for HPLC and mass spectrometry. 
HPLC Parameter Specification  MS Parameter Specification 
Column Synergi MAX-RP 50 x 2.0 mm 4 µm  Source ESI 
Mobile Phase 
A: 0.1 % Formic acid   Polarity positive 
B: Acetonitrile  Dry gas temperature 300°C 
Flow rate 0.6 ml/min  Dry gas flow 8.0 l/min 
Gradient 
2.5 – 25 % B, 0 – 4 min (chromatography)  Nebulizer 45 psi 
100 % B, 4 – 6 min (rinsing of column)  Capillary voltage 3500 V 
2.5 % B, 6 – 10 min (re-equilibration)  Sheat gas temperature 300°C 
Injection volume 20 µl  Sheat gas flow 10.0 l/min 
Column thermostat 30°C  Nozzle voltage 500 V 
   Quad temperature 100°C 
   Scan type MRM 
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Tab. 8.4: Parameters for detection of analytes.  
Time 
Segment 
Time 
(min) 
Valve 
Delta  
EMV (V) 
Compound 
Precursor 
Ion (m/z) 
Product 
Ions (m/z) 
Fragmentor 
Voltage (V) 
Collision Energy (V) 
1 0.0 to waste – – – – – – 
2 2.0 to MS 100 
XA 206.1 160.0a 110 17 
XA 206.1 132.0b 110 29 
KA (IS) 190.1 144.0a 100 17 
KA (IS) 190.1 89.0b 100 45 
3 4.0 to waste – – – – – – 
a, quantifier ion, b, qualifier ion, IS, internal standard 
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8.4 Indirect IFAs investigating co-dependent expression  
PfCCp1
PfCCp2
PfCCp4
PfFNPA
PfPeg3
PfCCp5
WT 1KO 4KO FKO
Pfs16
PfCCp3
PfGAP50
PfWLP1
5KO
 
Fig. 8.5 (part 1) 
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a-TubulinII
Pfs25
Pfs28
PfactinII
PfactinI
PfsMR5
Pfs230
Pfs47
Tubulin
WT 1KO 4KO FKO5KO
MYO1C/
PfmyoA
*
 
* Combination was not investigated due to shortage of antiserum. 
Fig. 8.5 (part 2) 
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PfCCp1
PfCCp2
PfCCp4
PfFNPA
PfPeg3
PfCCp5
WT 48/45KO 230KOd1 230KOd2
Pfs16
PfCCp3
PfGAP50
PfWLP1
377KO
 
Fig. 8.5 (part 3) 
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Tubulin
PfsMR5
PfactinII
Pfs28
Pfs230
Pfs47
PfactinI
a-TubulinII
Pfs25
MYO1C/
PfmyoA
WT 48/45KO 230KOd1 230KOd2 377KO
 
Fig. 8.5 (part 4): Indirect IFA investigating expression of 20 proteins in sexual stage parasites 
of eight gene-disruptant parasite lines. Genes of interest are labeled with Alexa Fluor-488, 
RBCs are counterstained with Evans Blue. 1KO, PfCCp1-KO, 4KO, PfCCp4-KO, 5KO, 
PfCCp5-KO, FKO, PfFNPA-KO, 48/45KO, Pfs48/45-KO, 230KOd1, Pfs230-KOd1, 230KOd2, 
Pfs230-KOd2, 377KO, Pfg377-KO, WT, wild-type Bar – 4 µm. 
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8.5 Abbreviations 
aa  Amino acids 
APAD 3-Acetylpyridine adenine dinucleotide 
BAPTA-AM 1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid te-
trakis(acetoxymethyl ester) 
BCIP 5-Bromo-4-chloro-3-indolyl phosphate disodium salt 
BSA Bovine serum albumin 
BSD Blasticidin S 
cGMP Cyclic guanosine monophosphate 
CIP Calve intestinal phosphatase 
Co-IP Co-immunoprecipitation 
DAG Diacylglycerol 
ddH2O Double-distilled water 
dH2O Deionised water 
DEPC Diethylpyrocarbonate 
Dipl.-Biol. Diplombiologin 
DIG Digoxigenin 
DNA Deoxyribonucleic acid 
dNTP Deoxynucleotide 
dsDNA Double-stranded DNA 
DTT 1,4-Dithiothreitol 
Eds. Editors 
EDTA Ethylenediaminetetraacetic acid 
EGF Epidermal growth factor 
EGTA Ethylene glycol tetraacetic acid 
Epon  Epoxy resin 
ER Endoplasmatic reticulum 
GlcNAc N-Acetyl-D-glucosamin 
GpA Glycophorin A 
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GpC glycophorin C 
GPI Glycosyl-phosphatidyl inositol 
HA Hemagglutinin 
hENT1 Human equilibrative nucleoside transporter 1 
HEPES 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid, N-(2-
Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) 
hFNT1 Human facilitative nucleobase transporter 1 
ICM Incomplete medium 
IFA Immunofluorescence assay 
IMC Inner membrane complex 
IPTG Isopropyl-β-D-thiogalactopyranoside 
IP3 Inositol 1,4,5-triphosphate 
iRBC Infected RBC 
kDa Kilodalton 
KO Knock-out 
LB Lysogeny broth 
LCCL domain Limulus coagulation factor C-like domain 
LC/ESI/MS/MS Liquid chromatography/ electrospray injection/ tandem mass 
spectrometry 
MQH2O Milli-Q water 
mRNA Messenger RNA 
NBT Nitroblue tetrazolium 
NBTI (NBMPR) 6-[(4-Nitrobenzyl)thio]-9-β-D-ribofuranosylpurine 
NGS Normal goat serum 
niRBCs Non-infected RBCs 
NP-40 Nonidet™ P 40 
NPP New permeability pathways 
OD Optical density 
p.a.  para analysum 
p.act.  post activation 
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PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PDE Phosphodiesterase 
PFA Paraformaldehyde 
PIC Protease inhibitor cocktail 
PIP2  Phosphatidylinositol 4,5-bisphosphate 
PI-PLC Phosphoinositide phospholipase 
PNK Polynucleotide kinase 
pp. Pages 
PPM Parasite plasma membrane 
PV Parasitophorous vacuole 
PVM Parasitophorous vacuole membrane 
RBC Red blood cell 
RBCM Red blood cell membrane 
RNA Ribonucleic acid 
rpm Rounds per minute 
RT Room temperature 
SD Standard deviation 
SDS Sodium dodecyl sulphate 
SOC Super optimal broth with catabolite repression 
spp. species (plural) 
Tab. Table 
TAE buffer Tris-acetate-EDTA buffer 
TBS Tris buffered saline 
TBSM 3 % milk powder in TBS 
TBV Transmission blocking vaccine 
TEM Transmission electron microscopy 
TEMED N,N,N′,N′-Tetramethylethylenediamine 
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tRNA transfer RNA 
WHO World Health Organization 
XA Xanthurenic acid 
XA-RBCF Filtrate of homogenized RBCs that had been incubated with XA 
and  
XA-RBCH Homogenized RBCs that had been incubated with XA followed 
by extensive washing 
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